Persons with potential health hazards related to communicable diseases

Z21_PERSONS_W_POTEN_HEALTH_HAZARDS_RELATED_COMMUNICAB_DISEA

No definition available.

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — Z20-Z29 Cause of death: ICD-10 — Z20-Z29 2 out of 7 registries used, show all original rules.	20257
4. Check minimum number of events None	20257
5. Include endpoints Z21_CONTACT_W_EXPOS_COMMUNICAB_DISEA Z21_ASYMP_HUMAN_IMMUNODEFICIENCY_VIRUS_HIV_INFECTION_STATUS Z21_CARRIER_INFECTIOUS_DISEA Z21_NEED_IMMUNI_SINGLE_BACTERIAL_DISEA Z21_NEED_IMMUNI_CERTA_SINGLE_VIRAL_DISEA Z21_NEED_IMMUNI_OTH_SINGLE_VIRAL_DISEA Z21_NEED_IMMUNI_OTH_SINGLE_INFECTIOUS_DISEA Z21_NEED_IMMUNI_COMBINA_INFECTIOUS_DISEA Z21_IMMUNI_NOT_CARRIED Z21_NEED_OTH_PROPHYLACT_MEASU	20257
6. Filter based on genotype QC (FinnGen only)	20257

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

Level in the ICD hierarchy: 2
First used in FinnGen datafreeze: DF4
Parent code in ICD-10: Z

NAME	Z21_PERSONS_W_POTEN_HEALTH_HAZARDS_RELATED_COMMUNICAB_DISEA
CONTROL_EXCLUDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE	Z21_CONTACT_W_EXPOS_COMMUNICAB_DISEA\|Z21_ASYMP_HUMAN_IMMUNODEFICIENCY_VIRUS_HIV_INFECTION_STATUS\|Z21_CARRIER_INFECTIOUS_DISEA\|Z21_NEED_IMMUNI_SINGLE_BACTERIAL_DISEA\|Z21_NEED_IMMUNI_CERTA_SINGLE_VIRAL_DISEA\|Z21_NEED_IMMUNI_OTH_SINGLE_VIRAL_DISEA\|Z21_NEED_IMMUNI_OTH_SINGLE_INFECTIOUS_DISEA\|Z21_NEED_IMMUNI_COMBINA_INFECTIOUS_DISEA\|Z21_IMMUNI_NOT_CARRIED\|Z21_NEED_OTH_PROPHYLACT_MEASU
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	Z2
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	Z2
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Persons with potential health hazards related to communicable diseases based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	20257	13395	6862
Unadjusted period prevalence (%)	4.04	4.57	3.03
Median age at first event (years)	42.65	40.67	46.53

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
18160: Matched controls
180208

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

Z20.2

ICD-10 Finland

Contact with and exposure to infections with a predominantly sexual mode of transmission

27.3

323.0

3226

1416

Z22.3

ICD-10 Finland

Carrier of other specified bacterial diseases

206.0

323.0

406

EB1CA

NOMESCO Finland

Tooth X-ray additional picture

3.0

323.0

2412

8838

LX1AE

NOMESCO Finland

Gynecological ultrasound examination as part of clinical examination

2.6

323.0

2962

12490

Z25.8

ICD-10 Finland

Need for immunization against other specified single viral diseases

6.0

323.0

5053

10908

Z29.9

ICD-10 Finland

Prophylactic measure, unspecified

123.2

323.0

727

Z20.9

ICD-10 Finland

Contact with and exposure to unspecified communicable disease

630.1

323.0

5795

132

Z29.8

ICD-10 Finland

Other specified prophylactic measures

6.5

323.0

956

1538

Z25.1

ICD-10 Finland

Need for immunization against influenza

9.3

323.0

2475

3008

Z29.0

ICD-10 Finland

Isolation

528.7

323.0

469

Z20.8

ICD-10 Finland

Contact with and exposure to other communicable diseases

17.9

323.0

8066

7700

WW200

NOMESCO Finland

Immunization

5.6

300.9

938

1744

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

3.2

293.5

1725

5754

B23.1

ICD-10 Finland

HIV disease resulting in (persistent) generalized lymphadenopathy

29.3

248.8

342

118

SAD01

NOMESCO Finland

Assessment of need for oral health care, standard

2.1

225.5

2924

14983

Z20.6

ICD-10 Finland

Contact with and exposure to human immunodeficiency virus [HIV]

212.9

224.4

233

Z21

ICD-10 Finland

Asymptomatic human immunodeficiency virus [HIV] infection status

507.3

203.5

203

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

3.9

201.0

878

2294

Z20.1

ICD-10 Finland

Contact with and exposure to tuberculosis

20.0

200.4

308

155

Z48.0

ICD-10 Finland

Attention to surgical dressings and sutures

4.3

195.8

776

1853

Z71.8

ICD-10 Finland

Other specified counselling

1.7

194.8

4708

30033

Z46.8

ICD-10 Finland

Fitting and adjustment of other specified devices

5.4

176.6

559

1051

IHA10

NOMESCO Finland

Structured mapping of problematic alcohol use

18.8

172.7

271

145

U07.1

ICD-10 Finland

Emergency use of U07.1 | COVID-19, virus identified

1.7

170.1

4189

26676

R5110

SPAT

5.6

157.7

487

889

B24

ICD-10 Finland

Unspecified human immunodeficiency virus [HIV] disease

27.6

138.7

193

R39.1

ICD-10 Finland

Other difficulties with micturition

4.4

134.8

515

1183

R4110

SPAT

4.1

133.7

560

1404

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.5

133.2

9192

74044

Z29.2

ICD-10 Finland

Other prophylactic chemotherapy

73.7

128.1

147

ZX120

NOMESCO Finland

Intravenous

2.2

124.6

1427

6804

Z22.9

ICD-10 Finland

Carrier of infectious disease, unspecified

1167.5

119.6

117

WX723

NOMESCO Finland

CPAP therapy

3.2

119.3

666

2107

SAD02

NOMESCO Finland

Assessment of need for oral health care, extensive

2.3

114.7

1110

4882

IHA10

SPAT

11.3

113.3

219

194

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.7

109.7

2386

14391

Z20.3

ICD-10 Finland

Contact with and exposure to rabies

183.0

105.1

110

Z22.38

ICD-10 Finland

Carrier of other specified bacterium diseases

343.3

102.9

104

WX402

NOMESCO Finland

General anaesthesia

1.7

100.8

2682

17112

Z13.9

ICD-10 Finland

Special screening examination, unspecified

11.3

96.7

187

166

Z11.2

ICD-10 Finland

Special screening examination for other bacterial diseases

15.4

95.1

160

104

ZXA05

NOMESCO Finland

Left side

1.6

94.4

2894

19135

ZXA00

NOMESCO Finland

Right side

1.6

91.9

3090

20888

Z22.30

ICD-10 Finland

Latent tuberculosis

+∞

89.4

MA2XE

NOMESCO Finland

Other obstetric ultrasound examination

1.9

88.8

1464

8026

R2120

NOMESCO Finland

Counselling and guidance concerning rehabilitation services and social security

7.2

88.4

222

309

XG470

NOMESCO Finland

Measurement of diffusion capastity of the lungs

3.6

88.0

415

1152

J12.8

ICD-10 Finland

Other viral pneumonia

7.6

86.9

210

276

SCA01

NOMESCO Finland

Simple analysis and advice of nutrition with regard to dentistry

1.4

86.2

5682

44094

A02BC02

ATC

pantoprazole; systemic

1.4

86.1

8913

74684

SPAT1260

SPAT

Consultation of another employee

1.6

84.5

2621

17327

SPAT1312

SPAT

General health counselling

1.4

84.1

5629

43746

ZXM10

NOMESCO Finland

Intraoperative use of conventional X-ray imaging

2.3

83.7

823

3637

WZA10

NOMESCO Finland

Long statement of health and health related matters

4.1

83.5

342

840

M79.6

ICD-10 Finland

Pain in limb

1.4

83.3

5071

38725

WYA30

NOMESCO Finland

Preparations for expected poor cooperation

1.8

83.1

1462

8189

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

2.1

82.0

1047

5201

P01AB01

ATC

metronidazole; oral, rectal

1.4

81.7

5933

46715

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.5

77.8

3653

26458

R4110

NOMESCO Finland

Physiotherapy

1.5

77.8

3473

24897

Z01.8

ICD-10 Finland

Other specified special examinations

1.5

77.1

2985

20743

Z24.6

ICD-10 Finland

Need for immunization against viral hepatitis

5.7

76.6

229

403

WX780

NOMESCO Finland

Remote monitoring CPAP

2.5

75.5

610

2433

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.5

74.6

2889

20064

SPAT1301

SPAT

No procedures

1.4

74.3

4600

35076

SPAT1263

SPAT

Sampling

1.3

72.3

6828

55798

Z39.0

ICD-10 Finland

Care and examination immediately after delivery

3.6

72.3

343

958

R4190

NOMESCO Finland

Nutritional therapy

2.4

71.9

666

2855

Z22.5

ICD-10 Finland

Carrier of viral hepatitis

68.0

71.0

Z34.9

ICD-10 Finland

Supervision of normal pregnancy, unspecified

1.6

69.9

2289

15270

R07.0

ICD-10 Finland

Pain in throat

1.8

69.0

1178

6516

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

1.8

68.4

1178

6534

B23.8

ICD-10 Finland

HIV disease resulting in other specified conditions

31.3

68.0

Z26.8

ICD-10 Finland

Need for immunization against other specified single infectious diseases

4.7

67.0

235

497

R50.9

ICD-10 Finland

Fever, unspecified

1.6

63.6

2077

13822

SPAT1325

SPAT

Vaccination

1.4

63.5

4512

35042

J01DB01

ATC

cefalexin; oral

1.3

63.0

13741

125718

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

2.0

62.5

831

4185

A56.3

ICD-10 Finland

Chlamydial infection of anus and rectum

10.3

61.2

123

119

Z20.0

ICD-10 Finland

Contact with and exposure to intestinal infectious diseases

95.4

60.6

WKEHK

NOMESCO Finland

19.3

60.5

R03AC02

ATC

salbutamol; inhalant

1.3

60.0

8344

71412

A49.9

ICD-10 Finland

Bacterial infection, unspecified

1.8

59.6

1031

5720

X59

ICD-10 Finland

Exposure to unspecified factor

1.5

59.1

2711

19403

Z00.0

ICD-10 Finland

General medical examination

1.5

58.9

2683

19177

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.5

58.3

2350

16374

XF404

NOMESCO Finland

Ambulatory ECG

1.8

57.8

1008

5609

XKD00

NOMESCO Finland

Uroflowmetry

1.7

56.9

1253

7502

123

Kela drug reimbursment

Chronic disorders of vitamin D metabolism

3.3

56.5

297

900

Z00.8

ICD-10 Finland

Other general examinations

1.7

56.1

1145

6696

A56.0

ICD-10 Finland

Chlamydial infection of lower genitourinary tract

2.4

56.0

504

2130

S02.51

ICD-10 Finland

Fracture of tooth, open

1.7

55.9

1338

8203

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.3

55.6

5691

46530

WX740

NOMESCO Finland

Nitrogen oxide therapy

6.1

54.7

153

249

R19.8

ICD-10 Finland

Other specified symptoms and signs involving the digestive system and abdomen

4.0

53.9

227

574

A54.6

ICD-10 Finland

Gonococcal infection of anus and rectum

31.2

53.9

XG405

NOMESCO Finland

Education on PEF monitoring

3.5

53.7

263

755

R01AD12

ATC

fluticasone furoate; nasal

1.3

53.6

5160

41762

R5140

SPAT

9.2

53.6

114

123

Z39.2

ICD-10 Finland

Routine postpartum follow-up

1.4

53.5

2913

21500

HAHOM

NOMESCO Finland

3.2

53.5

294

922

Z22.8

ICD-10 Finland

Carrier of other infectious diseases

525.6

53.4

R06.0

ICD-10 Finland

Dyspnoea

1.4

53.3

2813

20644

N05CF01

ATC

zopiclone; oral

1.4

53.2

3590

27507

TPH04

NOMESCO Finland

Cathetrisation of vein

1.4

52.9

2526

18185

-1

NOMESCO Finland

1.3

52.9

6121

50814

-1

ICD-10 Finland

2.0

52.7

740

3804

SCA02

NOMESCO Finland

Analysis and advice of nutrition with regard to dentistry

1.5

52.6

2021

13914

WZC00

NOMESCO Finland

Planning of intervention or health care consultation

1.3

52.1

5019

40590

J01MA02

ATC

ciprofloxacin; systemic

1.3

52.0

4679

37466

Z20.5

ICD-10 Finland

Contact with and exposure to viral hepatitis

23.3

52.0

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

3.2

51.5

284

893

Z49.1

ICD-10 Finland

Extracorporeal dialysis

4.0

51.1

212

530

N18.0

ICD-10 Finland

End-stage renal disease

4.6

50.7

183

400

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.4

50.7

2315

16509

M54.5

ICD-10 Finland

Low back pain

1.3

50.6

4856

39211

Z20.7

ICD-10 Finland

Contact with and exposure to pediculosis, acariasis and other infestations

19.7

50.6

Z01.0

ICD-10 Finland

Examination of eyes and vision

1.5

50.3

2125

14912

Z23.5

ICD-10 Finland

Need for immunization against tetanus alone

4.9

49.3

168

346

Z01.9

ICD-10 Finland

Special examination, unspecified

2.0

48.8

689

3550

R53

ICD-10 Finland

Malaise and fatigue

1.4

48.7

2813

20944

UJF30

NOMESCO Finland

Ileoscopy through colon

1.7

48.6

1192

7348

A02BC01

ATC

omeprazole; systemic

1.4

48.4

3255

24866

XG404

NOMESCO Finland

Peak expiratory flow (PEF) measurement

4.3

48.1

187

440

R07.4

ICD-10 Finland

Chest pain, unspecified

1.4

47.4

2798

20900

WZC20

NOMESCO Finland

Multidisciplinary treatment meeting

2.0

47.3

632

3188

TK800

NOMESCO Finland

Hemodialysis

2.9

46.4

287

977

S02.59

ICD-10 Finland

Tooth fracture UNS

2.6

46.1

362

1424

Y25

ICPC

Fear sexually transm disease male

2.3

46.1

452

1995

A11CC03

ATC

alfacalcidol; systemic

2.9

46.0

289

993

N02BE01

ATC

paracetamol; systemic, rectal

1.3

45.7

13301

122775

HMAK

NOMESCO Finland

1.5

45.5

1960

13788

R05

ICD-10 Finland

Cough

1.4

44.7

2456

18101

N30.0

ICD-10 Finland

Acute cystitis

1.5

44.4

1843

12868

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

1.6

44.3

1285

8273

N02AX02

ATC

tramadol; systemic, rectal

1.3

44.2

5005

41175

YHMAS

NOMESCO Finland

3.7

44.1

203

556

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

2.3

43.8

420

1832

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

1.7

43.5

970

5817

R5140

NOMESCO Finland

Monitoring the use of the aid

1.6

43.5

1114

6943

R51.80

ICD-10 Finland

Headache

1.4

43.4

2440

18046

ZXA10

NOMESCO Finland

Bilateral

1.4

42.7

2103

15176

A06AC01

ATC

ispaghula (psylla seeds); oral

1.4

42.6

2593

19435

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.3

42.6

3130

24191

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.3

42.5

4731

38785

UDC00

NOMESCO Finland

Ear microscopy

1.7

42.5

956

5746

R4120

NOMESCO Finland

Occupational therapy

1.8

42.3

812

4652

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.5

42.2

1716

11922

R4160

SPAT

43.1

42.0

MAX99

NOMESCO Finland

Assistance to normal delivery

0.6

42.0

977

14624

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

1.7

41.8

1014

6224

QXE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in uspecified region

6.0

41.7

117

193

A54.0

ICD-10 Finland

Gonococcal infection of lower genitourinary tract without periurethral or accessory gland abscess

9.4

41.6

J01MA12

ATC

levofloxacin; systemic

1.4

41.2

1898

13519

SPAT1310

SPAT

Counselling related to known health issue

1.3

41.1

4749

39086

A63.0

ICD-10 Finland

Anogenital (venereal) warts

1.7

40.5

815

4738

Z23.8

ICD-10 Finland

Need for immunization against other single bacterial diseases

10.0

40.4

A51.0

ICD-10 Finland

Primary genital syphilis

17.9

40.2

R5599

SPAT

16.3

39.5

EB1SA

NOMESCO Finland

Dental X-ray, bite-wing X-ray on one side of the mouth

1.2

39.4

9496

84916

H61.2

ICD-10 Finland

Impacted cerumen

1.9

39.1

627

3384

R74

ICPC

Upper respiratory infection acute

1.3

39.0

5521

46520

WW200

SPAT

0.6

39.0

679

10823

ZXH09

SPAT

0.2

38.9

1972

ZX109

NOMESCO Finland

Instruction on medicine inhalation technique

3.8

38.9

169

442

Z01.7

ICD-10 Finland

Laboratory examination

1.5

38.8

1473

10080

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.2

38.4

8376

74022

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

1.8

38.3

693

3897

WX722

NOMESCO Finland

PEEP

2.1

38.3

468

2276

Z76.0

ICD-10 Finland

Issue of repeat prescription

1.4

37.8

2161

15997

LC2BE

SPAT

13.4

37.6

Z49.0

ICD-10 Finland

Preparatory care for dialysis

4.3

37.6

144

336

-48

ICPC

Clarification/discussion RFE/demand

1.9

37.5

544

2831

Z26.9

ICD-10 Finland

Need for immunization against unspecified infectious disease

2.5

37.4

302

1206

SDA02

NOMESCO Finland

Parodonthologic therapy

1.3

37.4

5059

42351

J01FA10

ATC

azithromycin; systemic

1.2

36.8

10089

91138

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

1.6

36.5

927

5761

R1240

NOMESCO Finland

Social assessment of need and possibilities of rehabilitation

3.4

36.4

180

524

PBL10

NOMESCO Finland

Construction of arteriovenous fistula from radial artery

3.9

36.3

154

395

Z27.1

ICD-10 Finland

Need for immunization against diphtheria-tetanus-pertussis, combined [DTP]

12.2

36.1

UKC02

NOMESCO Finland

Cystoscopy

1.5

36.0

1304

8826

190

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

4.0

36.0

149

374

O47.0

ICD-10 Finland

False labour before 37 completed weeks of gestation

1.4

35.9

1670

11899

ZXC84

NOMESCO Finland

Bloodless operation space

5.0

35.8

117

232

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

1.8

35.7

627

3491

J02AC01

ATC

fluconazole; systemic

1.2

35.3

6127

52671

Z23.2

ICD-10 Finland

Need for immunization against tuberculosis [BCG]

+∞

35.3

A12AA04

ATC

calcium carbonate; oral

3.2

35.2

190

591

QDH05

NOMESCO Finland

Correction of deformity of toe nail

6.7

35.2

135

A54.5

ICD-10 Finland

Gonococcal pharyngitis

11.1

35.1

N02AJ06

ATC

codeine and paracetamol; systemic

1.2

35.0

5267

44557

R69

ICD-10 Finland

Unknown and unspecified causes of morbidity

2.5

34.7

288

1169

PG5DE

NOMESCO Finland

Ultrasound examination of injection gate to artery or vein with Doppler method

9.6

34.3

M03BC01

ATC

orphenadrine (citrate); systemic

1.3

34.3

3426

27558

NOMESCO Finland

Other rehabilitation services

38.9

34.1

G47.3

ICD-10 Finland

Sleep apnoea

1.3

34.1

2329

17729

B03XA02

ATC

darbepoetin alfa; parenteral

3.0

34.1

200

661

H02AB06

ATC

prednisolone; systemic

1.2

33.7

6019

51834

WX602

NOMESCO Finland

Repeated or continuing anesthesia shots throug a catheter

1.4

33.6

1505

10638

B18.2

ICD-10 Finland

Chronic viral hepatitis C

2.7

33.6

241

904

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.4

33.4

1584

11322

Z01.1

ICD-10 Finland

Examination of ears and hearing

1.4

33.2

1509

10696

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.2

33.2

6403

55564

J05AB01

ATC

aciclovir; systemic

1.3

32.6

2784

21898

SPAT1249

SPAT

Treatment-related counselling outside office

1.2

32.2

6114

52917

H92.0

ICD-10 Finland

Otalgia

1.6

31.7

785

4846

Z37.0

ICD-10 Finland

Single live birth

1.4

31.6

1828

13532

X23

ICPC

Fear sexually transm dis female

1.5

31.4

1209

8287

D82

ICPC

Teeth/gum disease

1.2

31.4

5812

50140

B23.0

ICD-10 Finland

Acute HIV infection syndrome

26.7

31.3

M54.9

ICD-10 Finland

Dorsalgia, unspecified

1.4

30.8

1461

10432

XJH00

NOMESCO Finland

Transanal ultrasonography

2.0

30.8

413

2088

V03AE01

ATC

polystyrene sulfonate; oral

3.7

30.8

136

363

MA2DE

NOMESCO Finland

Detailed ultrasound examination of fetus including color doppler method

1.4

30.8

1630

11883

SPAT1262

SPAT

Handing over of treatment supplies

1.4

30.6

1811

13450

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.3

30.5

2897

23099

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.3

30.4

3668

30147

LDA20

NOMESCO Finland

Biopsy of vaginal cervix

1.5

30.2

1109

7521

SPAT1324

SPAT

Screening procedure

0.8

30.2

1853

23666

SPAT1377

SPAT

Polysomnography

2.0

29.9

417

2141

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

1.5

29.9

1085

7341

PG5RT

NOMESCO Finland

PTA of arterio-venous shunt for dialysis

8.2

29.8

ZA8.4

ICD-10 Finland

Fault, injury or disease in the lumbar spine

10.3

29.8

SCA03

NOMESCO Finland

Preventive oral health care, extensive

1.6

29.8

812

5136

SPAT1264

SPAT

Quick test at office or at home

4.2

29.7

116

278

SPAT1229

SPAT

Assessment of need for aid

1.7

29.6

632

3738

OAB47

SPAT

0.3

29.6

2040

QDE99

NOMESCO Finland

Other excision or repair of lesion of skin of lower limb

3.6

29.5

138

386

SPAT1373

SPAT

Combined screening in early pregnancy

0.3

29.5

2417

R11

ICD-10 Finland

Nausea and vomiting

1.5

29.4

1064

7194

N05BA04

ATC

oxazepam; oral

1.3

29.4

3203

25987

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

1.5

29.3

1082

7347

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.4

29.3

1254

8781

WZC30

NOMESCO Finland

Teaching

1.4

29.2

1405

10060

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

1.6

29.1

740

4598

QXA25

NOMESCO Finland

Destruction of lesion of skin, site unspecified

2.6

28.9

219

849

FM1QE

NOMESCO Finland

Extensive ultrasound of fetal heart

2.8

28.9

185

649

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

2.3

28.7

277

1218

NH3EA

NOMESCO Finland

Feet X-ray examination with load

2.3

28.7

270

1172

C03CA01

ATC

furosemide; systemic

1.4

28.7

1765

13189

J01EA01

ATC

trimethoprim; systemic

1.3

28.5

3147

25556

Z94.0

ICD-10 Finland

Kidney transplant status

2.9

28.5

174

592

M25.5

ICD-10 Finland

Pain in joint

1.2

28.4

3865

32177

N06AX11

ATC

mirtazapine; oral

1.2

28.1

4128

34650

J01EE01

ATC

sulfamethoxazole and trimethoprim; systemic

1.6

28.0

672

4110

TNX10

NOMESCO Finland

Arthrocentesis, unspecified region, unspecified region

1.6

28.0

797

5095

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.3

27.9

3507

28923

J45.9

ICD-10 Finland

Asthma, unspecified

1.3

27.8

2136

16510

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.2

27.6

6195

54269

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.3

27.6

2097

16189

ULA02

NOMESCO Finland

Kolposcopy

1.4

27.5

1511

11074

A28

ICPC

Limited function/disability NOS

1.5

27.3

962

6465

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.3

27.3

3223

26369

I49.9

ICD-10 Finland

Cardiac arrhythmia, unspecified

1.4

27.2

1301

9300

XLD00

NOMESCO Finland

Sytologyspecimen from mouth of uterus

1.4

27.2

1732

13008

R52.9

ICD-10 Finland

Pain, unspecified

1.5

27.1

1007

6848

L04AA06

ATC

mycophenolic acid; systemic

2.4

26.9

239

1010

ZX114

NOMESCO Finland

Intramuscular

2.4

26.9

225

919

AA1AD

NOMESCO Finland

CT of head and brain

1.3

26.9

2139

16618

-35

ICPC

Urine test

2.3

26.7

243

1039

WZA00

NOMESCO Finland

Short statement of of health and health related matters

1.5

26.3

898

5989

Z76.8

ICD-10 Finland

Persons encountering health services in other specified circumstances

1.8

26.3

492

2800

XCW99

NOMESCO Finland

Other investigative procedure of eye

1.5

26.3

1041

7173

127

Kela drug reimbursment

Transplant complication

2.5

26.2

215

873

R4120

SPAT

7.2

26.2

Z12.4

ICD-10 Finland

Special screening examination for neoplasm of cervix

1.9

26.1

378

1974

UDQ12

NOMESCO Finland

Flexible laryngoscopy

1.7

26.0

595

3595

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

1.5

26.0

997

6825

XX3DW

NOMESCO Finland

Time consuming IT work

1.5

25.7

944

6404

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.4

25.6

1186

8428

N18.8

ICD-10 Finland

Other chronic renal failure

2.4

25.3

227

964

A03FA01

ATC

metoclopramide; systemic, rectal

1.3

25.1

2338

18553

KAS10

NOMESCO Finland

Allogenic transplantation of kidney from cadaver donor

3.2

24.9

131

403

TPH90

NOMESCO Finland

Removal of fixed intravenous catheter

2.4

24.8

213

886

Z27.4

ICD-10 Finland

Need for immunization against measles-mumps-rubella [MMR]

12.5

24.6

K03.64

ICD-10 Finland

Dental calculus supragingival

1.2

24.6

4661

40069

WYA00

NOMESCO Finland

Screening and health check-up

2.3

24.5

226

975

R4130

NOMESCO Finland

Speech therapy

2.3

24.3

238

1056

A51.9

ICD-10 Finland

Early syphilis, unspecified

27.3

24.3

J01AA02

ATC

doxycycline; systemic

1.2

24.3

10910

101087

SPAT1291

SPAT

Other function in accordance with NCSP classification

2.4

24.2

202

828

S06.0

ICD-10 Finland

Concussion

1.4

24.0

1387

10242

XX2XT

NOMESCO Finland

Other injection with other radiological guidance

4.2

24.0

218

J01CA04

ATC

amoxicillin; systemic

1.2

23.9

14169

134426

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

1.3

23.9

1599

12094

XG466

NOMESCO Finland

Sleep oxymetry

2.0

23.8

316

1597

ZST00

NOMESCO Finland

Procedure related to previous procedure classified in chapter T

9.0

23.7

L04AX03

ATC

methotrexate; systemic (immunosuppressants)

1.4

23.5

1074

7613

SPAT1292

SPAT

Other function in accordance with SHToL (Finnish classification of nursing interventions)

0.6

23.4

332

5559

R5130

SPAT

9.7

23.3

N03AX16

ATC

pregabalin; oral

1.3

23.0

2519

20376

J01DA01

ATC

[U] cefalexin; systemic

1.2

23.0

9269

84929

A02BC05

ATC

esomeprazole; systemic

1.2

22.9

4786

41466

N30.9

ICD-10 Finland

Cystitis, unspecified

1.6

22.9

636

4046

320

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

4.1

22.9

219

TDW99

NOMESCO Finland

Other minor procedure in surgery of ear, nose and larynx

1.9

22.8

363

1959

V03AE03

ATC

lanthanum carbonate; oral

5.4

22.7

128

N05BA01

ATC

diazepam; systemic, rectal

1.4

22.7

1422

10645

TQW40

NOMESCO Finland

Remowal of suture of skin

1.5

22.6

752

4990

WX610

NOMESCO Finland

Patient controlled analgesia

3.1

22.4

124

397

Y94.8

ICD-10 Finland

Other leisure activity accident

1.9

22.2

342

1825

SPAT1238

SPAT

Brief therapy

1.9

22.2

352

1900

ZX140

NOMESCO Finland

Intra articular

3.2

22.1

117

363

XA421

NOMESCO Finland

Nocturnal polygraphy

4.3

22.1

189

MBA96

NOMESCO Finland

Other removal of retained products of conception after delivery or abortion

1.9

22.0

330

1744

KA1AE

NOMESCO Finland

Kidney ultrasound examination

2.1

22.0

245

1154

PG1DE

NOMESCO Finland

Other extensive ultrasound examination of artery

1.8

22.0

416

2380

M01AE03

ATC

ketoprofen; systemic, rectal

1.2

21.9

4234

36382

TNX32

NOMESCO Finland

Custom moulded splint, unspecified region

1.6

21.9

542

3344

XF402

NOMESCO Finland

ECG with work load test

1.5

21.9

874

6030

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

1.8

21.9

415

2375

SPAT1368

SPAT

Periodic check-up in occupational healthcare

0.4

21.9

1861

UJF32

NOMESCO Finland

Coloscopy

1.3

21.8

2438

19760

XG460

NOMESCO Finland

Short time oxymetry

2.7

21.7

148

543

B01AB10

ATC

tinzaparin; parenteral

1.6

21.7

632

4066

FP4B5

NOMESCO Finland

ECG, prolonged recording (24 h)

3.0

21.7

128

429

SAA01

NOMESCO Finland

Simple examination of mouth

1.2

21.6

12061

113130

QBB10

NOMESCO Finland

Major dressing of wound of skin of trunk

1.7

21.6

426

2467

SAA02

NOMESCO Finland

Basic examination of mouth

1.2

21.6

11441

106864

C07AB07

ATC

bisoprolol; oral

1.2

21.5

4048

34691

Z24.1

ICD-10 Finland

Need for immunization against arthropod-borne viral encephalitis

4.8

21.4

150

LDA10

NOMESCO Finland

Curettage of cervix uteri

1.6

21.4

599

3819

R68.88

ICD-10 Finland

Other specified general symptoms and signs, not elsewhere classified.

3.1

21.4

116

367

TPH07

NOMESCO Finland

Cathetrisation of artery

1.4

21.3

896

6244

R68.8

ICD-10 Finland

Other specified general symptoms and signs

2.9

21.3

131

451

J04AB02

ATC

rifampicin; systemic

2.9

21.3

134

466

MA2JE

NOMESCO Finland

Ultrasound screening of fetal nuchal translucency

0.7

21.3

1009

13404

TQW99

NOMESCO Finland

Other minor procedure on skin

1.7

21.1

422

2451

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.3

21.1

2185

17541

A41.0

ICD-10 Finland

Sepsis due to Staphylococcus aureus

2.5

21.1

172

697

-1

SPAT

1.5

21.1

644

4193

WX002

NOMESCO Finland

Sedation and analgesia

1.3

21.1

1981

15711

LC2HE

NOMESCO Finland

Hystero-salpingography with ultrasound

1.5

21.1

747

5027

H25.1

ICD-10 Finland

Senile nuclear cataract

1.4

21.0

1129

8233

SPAT1131

SPAT

Colonoscopy

1.9

21.0

304

1589

CL2S4

SPAT

3.8

21.0

237

K03.66

ICD-10 Finland

Tooth plaque

1.5

20.9

825

5676

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

1.6

20.9

533

3316

MA2AE

SPAT

4.9

20.9

137

XF655

NOMESCO Finland

Measurement of heart muscle perfusion with exercise

2.3

20.9

200

879

B03XA03

ATC

methoxy polyethylene glycol-epoetin beta; parenteral

4.2

20.8

191

SAA04

NOMESCO Finland

Special inverstigation of mouth

1.5

20.8

803

5507

WD225

NOMESCO Finland

Demanding therapy of methastized malignancy with hormones

3.8

20.6

236

AA3AI

NOMESCO Finland

Cone beam CT of facial bones

2.6

20.5

148

563

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

1.4

20.4

841

5840

KA2AE

NOMESCO Finland

Ultrasound examination transplanted kidney

3.3

20.4

104

315

EB1AA

NOMESCO Finland

Tooth X-ray examination

1.2

20.4

8463

77405

J01FF01

ATC

clindamycin; systemic

1.2

20.3

3332

28150

N18.5

ICD-10 Finland

Chronic kidney disease, stage 5

6.4

20.3

X58

ICD-10 Finland

Exposure to other specified factors

1.3

20.1

1885

14938

WZB00

NOMESCO Finland

Telephone receipt or other advice

1.2

20.1

4506

39199

SDA01

NOMESCO Finland

Simple parodonthologic therapy

1.2

20.0

4133

35682

196

Kela drug reimbursment

Paricalcitol and cinacalcet

4.3

20.0

175

R09.8

ICD-10 Finland

Other specified symptoms and signs involving the circulatory and respiratory systems

3.8

20.0

223

KDE20

NOMESCO Finland

Removal of foreign body from urethra

4.4

19.7

164

Z24.2

ICD-10 Finland

Need for immunization against rabies

35.5

19.7

SPAT1094

SPAT

Continuous Positive Airway Pressure

2.8

19.7

130

469

R03BA01

ATC

beclometasone; inhalant

1.3

19.6

1584

12304

SPAT1196

SPAT

Monitoring of normal pregnancy

1.3

19.6

1314

9932

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

1.7

19.6

418

2479

KA2AT

NOMESCO Finland

Biopsy of transplanted kidney with ultrasound guidance

3.5

19.6

267

XKD06

NOMESCO Finland

Physiologic investigation of micturition

2.0

19.6

258

1303

V03AE02

ATC

sevelamer; oral

3.9

19.5

208

Z87.5

ICD-10 Finland

Personal history of complications of pregnancy, childbirth and the puerperium

2.3

19.5

189

838

G47.9

ICD-10 Finland

Sleep disorder, unspecified

1.9

19.5

299

1595

WX302

NOMESCO Finland

Thoracal epidural anesthesy

1.6

19.5

489

3033

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.2

19.5

5168

45577

WX307

NOMESCO Finland

Obstetric epidural analgesia

1.3

19.3

1612

12581

R4180

NOMESCO Finland

Podiatric therapy

2.8

19.2

123

435

F51.0

ICD-10 Finland

Nonorganic insomnia

1.3

19.2

1919

15333

R60.0

ICD-10 Finland

Localized oedema

1.4

19.1

914

6533

Z11.5

ICD-10 Finland

Special screening examination for other viral diseases

2.9

19.1

117

403

R42

ICD-10 Finland

Dizziness and giddiness

1.3

19.0

2096

16942

R21

NOMESCO Finland

Counselling and guidance in rehabilitation

3.1

18.9

102

323

D06BB04

ATC

podophyllotoxin; topical

1.4

18.8

940

6767

S93.4

ICD-10 Finland

Sprain and strain of ankle

1.3

18.8

1721

13596

O65.5

ICD-10 Finland

Obstructed labour due to abnormality of maternal pelvic organs

5.4

18.8

103

N32.82

ICD-10 Finland

Instability of the detrusor vesicae muscle

2.6

18.7

134

508

D07AC01

ATC

betamethasone; topical

1.2

18.7

4131

35844

NK6QA

NOMESCO Finland

Measurement of bone density from tow or more locations with X-ray

1.5

18.5

576

3764

J03.9

ICD-10 Finland

Acute tonsillitis, unspecified

1.4

18.5

1036

7610

A06AD11

ATC

lactulose; oral

1.4

18.5

1081

7996

Y96.0

ICD-10 Finland

Work-related condition

2.3

18.4

175

767

M03BX02

ATC

tizanidine; oral

1.1

18.4

9092

83947

Z49.2

ICD-10 Finland

Other dialysis

3.3

18.4

276

E11.5

ICD-10 Finland

Type 2 diabetes mellitus, with peripheral circulatory complications

2.7

18.4

124

455

R06AE07

ATC

cetirizine; oral

1.2

18.3

6785

61351

XF400

NOMESCO Finland

ECG with 12 standard connections

1.3

18.2

1508

11751

PH1AE

NOMESCO Finland

Ultrasound examination of upper extremity veins

2.3

18.2

171

746

W90

ICPC

Uncompl labour/delivery livebirth

1.4

18.2

904

6501

J02.9

ICD-10 Finland

Acute pharyngitis, unspecified

1.4

18.2

879

6294

LCA06

NOMESCO Finland

Biopsy of endometrium

1.3

17.9

1346

10344

J01MA14

ATC

moxifloxacin; systemic

1.4

17.9

855

6106

202

Kela drug reimbursment

Connective tissue diseases, rheumatoid arthritis and comparable disease

1.3

17.9

1204

9101

TGC00

NOMESCO Finland

Bronchial lavation

2.1

17.9

212

1027

L04AD02

ATC

tacrolimus; systemic (calcineurin inhibitors)

2.6

17.8

134

521

M01AE01

ATC

ibuprofen; systemic, rectal

1.2

17.7

15277

146913

QXA50

NOMESCO Finland

Skin cryotherapy, unspecified location

2.8

17.6

110

385

E78.5

ICD-10 Finland

Hyperlipidaemia, unspecified

1.5

17.5

633

4282

ZX012

NOMESCO Finland

Radiotherapy with large shaped fields - isocentric therapy

1.6

17.5

414

2532

S15

ICPC

Foreign body in skin

1.5

17.4

616

4150

WNF00

NOMESCO Finland

Infection source and contact determination

4.7

17.3

126

H91.9

ICD-10 Finland

Hearing loss, unspecified

1.8

17.3

314

1776

R31

ICD-10 Finland

Unspecified haematuria

1.5

17.1

694

4804

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

1.3

17.1

1659

13196

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

1.5

17.1

620

4199

J01CA08

ATC

pivmecillinam; oral

1.2

17.0

5684

50918

W22

ICD-10 Finland

Striking against or struck by other object(s)

1.4

17.0

868

6279

F41.2

ICD-10 Finland

Mixed anxiety and depressive disorder

1.3

16.9

1557

12300

SPAT1311

SPAT

Counselling and guidance related to occupational health

0.5

16.9

163

3019

A31

ICPC

General and Unspecified, Medical examin/health eval partial

1.7

16.9

352

2076

N71.0

ICD-10 Finland

Acute inflammatory disease of uterus

1.6

16.9

466

2965

WZC30

SPAT

0.3

16.7

1031

KA3AT

NOMESCO Finland

Biopsy of kidney with ultrasound guidance

2.3

16.7

155

675

TQW11

NOMESCO Finland

Vacuum treatment of wound

2.1

16.7

182

855

A53.9

ICD-10 Finland

Syphilis, unspecified

13.9

16.7

ZX100

NOMESCO Finland

Oral

2.4

16.6

143

599

XPX08

NOMESCO Finland

Intraoperative flow measurement

3.9

16.6

174

E0000UV

ATC

1.2

16.5

5700

51159

W19

ICD-10 Finland

Unspecified fall

1.3

16.4

1014

7569

QDB05

NOMESCO Finland

Revision of wound of skin of lower limb

2.0

16.4

218

1107

OAB72

NOMESCO Finland

Weight control and weight loss guidance

2.8

16.3

105

375

K30

ICD-10 Finland

Functional dyspepsia

1.3

16.2

1166

8905

L03AA02

ATC

filgrastim; parenteral

1.9

16.2

244

1300

WD325

NOMESCO Finland

Demanding therapy of methastized malignancy with biomodifiers

2.9

16.2

332

ZXM00

NOMESCO Finland

Intraoperative use of ultrasonographic imaging

2.8

16.1

104

371

K04.0

ICD-10 Finland

Pulpitis

1.3

16.1

1520

12046

137

Kela drug reimbursment

Uraemia requiring dialysis

2.8

16.1

103

365

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.2

16.0

4318

38005

J01CE02

ATC

phenoxymethylpenicillin; oral

1.1

16.0

11718

110616

Z29.1

ICD-10 Finland

Prophylactic immunotherapy

29.8

16.0

L89

ICD-10 Finland

Decubitus ulcer and pressure area

2.7

16.0

112

420

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

1.4

16.0

652

4520

XFP20

NOMESCO Finland

Check up of cardiac pacemaker

1.7

16.0

350

2095

W00

ICD-10 Finland

Fall on same level involving ice and snow

1.3

16.0

1190

9136

N39.4

ICD-10 Finland

Other specified urinary incontinence

1.5

16.0

604

4125

D07AC14

ATC

methylprednisolone aceponate; topical

1.5

15.9

524

3477

TK810

NOMESCO Finland

Hemofiltration

3.3

15.9

237

N06AB04

ATC

citalopram; systemic

1.2

15.9

2554

21478

I50.9

ICD-10 Finland

Heart failure, unspecified

1.5

15.8

581

3945

N19

ICD-10 Finland

Unspecified kidney failure

2.1

15.8

187

908

H02AB09

ATC

hydrocortisone; systemic

1.8

15.8

292

1665

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

1.4

15.8

840

6119

PG5AC

NOMESCO Finland

Contrast examination of injection gate to artery or vein

9.9

15.8

XJC00

NOMESCO Finland

Oesophageal manometry

4.2

15.7

140

K02.1

ICD-10 Finland

Caries of dentine

1.1

15.7

9666

90146

F32.9

ICD-10 Finland

Depressive episode, unspecified

1.2

15.7

1980

16237

N05CD07

ATC

temazepam; oral

1.4

15.6

842

6146

QCB10

NOMESCO Finland

Major dressing of wound of skin of upper limb

1.9

15.6

233

1236

PBU84

NOMESCO Finland

Plastic repair of arteriovenous fistula from artery of upper extremity

7.9

15.6

J32.0

ICD-10 Finland

Chronic maxillary sinusitis

1.4

15.6

910

6733

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

1.9

15.5

230

1216

VALMI

NOMESCO Finland

1.2

15.5

4085

35875

UGC12

NOMESCO Finland

Flexible bronchoscopy

1.5

15.5

534

3576

K05.0

ICD-10 Finland

Acute gingivitis

1.7

15.5

338

2025

PA6DE

NOMESCO Finland

Neck artery ultrasound examination with Doppler method

1.7

15.4

299

1726

TEKHI

NOMESCO Finland

21.9

15.4

MA2AE

NOMESCO Finland

Ultrasound examination of pregnancy (at 12. week of gestaion or later) including basic examination of fetus

1.2

15.4

2825

24048

TPX10

NOMESCO Finland

Implantation of vascular injection port

1.8

15.3

284

1619

J45

ICD-10 Finland

Asthma

1.3

15.3

1133

8685

WX320

NOMESCO Finland

Spinalanesthesy

1.2

15.3

2335

19526

QDG20

NOMESCO Finland

Operation for chronic ulcer or fistula of skin of lower limb

3.1

15.3

271

M79.1

ICD-10 Finland

Myalgia

1.3

15.3

1663

13408

Y94.0

ICD-10 Finland

Accident at home

2.1

15.2

173

826

R03AK07

ATC

formoterol and budesonide; inhalant

1.2

15.2

2417

20300

WX408

NOMESCO Finland

General anesthesy, balanced

1.2

15.2

3264

28178

313

Kela drug reimbursment

Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab, tocilizumab and ustekinumab (rheumatoid diseases)

1.6

15.2

377

2337

Z10.0

ICD-10 Finland

Occupational health examination

1.4

15.1

896

6644

N17.9

ICD-10 Finland

Acute renal failure, unspecified

1.9

15.1

234

1259

J22

ICD-10 Finland

Unspecified acute lower respiratory infection

1.5

15.1

521

3492

A02BC03

ATC

lansoprazole; oral

1.2

15.1

2902

24813

H05BX01

ATC

cinacalcet; oral

3.7

15.0

175

WX290

NOMESCO Finland

Other blockade of nerve

1.1

14.9

7820

72062

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

1.6

14.9

428

2749

B01AB05

ATC

enoxaparin; parenteral

1.2

14.9

2926

25057

SPAT1379

SPAT

Health check-up of pregnant person

1.2

14.8

2364

19856

I15.1

ICD-10 Finland

Hypertension secondary to other renal disorders

2.4

14.8

122

501

L04AD01

ATC

ciclosporin; systemic

1.9

14.8

226

1209

M03BC51

ATC

orphenadrine, combinations; systemic

1.2

14.8

3596

31358

QDH

NOMESCO Finland

Operations on toe nails

7.2

14.8

R03AK06

ATC

salmeterol and fluticasone; inhalant

1.3

14.8

1423

11302

R13

ICD-10 Finland

Dysphagia

1.5

14.8

528

3565

SXA20

NOMESCO Finland

Local application of medicine to mouth

1.3

14.8

900

6701

K58.0

ICD-10 Finland

Irritable bowel syndrome with diarrhoea

1.4

14.8

730

5250

B03XA01

ATC

erythropoietin; parenteral

3.1

14.8

262

L03.0

ICD-10 Finland

Cellulitis of finger and toe

1.4

14.7

837

6165

SPAT1130

SPAT

Esophagoscopy, gastroscopy and duodenoscopy

1.7

14.7

280

1611

M54.4

ICD-10 Finland

Lumbago with sciatica

1.2

14.7

1896

15582

J31.0

ICD-10 Finland

Chronic rhinitis

1.3

14.7

943

7079

N05CF02

ATC

zolpidem; oral

1.2

14.7

2073

17200

B05DA

ATC

Isotonic solutions

2.9

14.6

291

UDH02

NOMESCO Finland

Rhinopharyngoscopy

1.4

14.6

739

5340

S02.5

ICD-10 Finland

Fracture of tooth

1.7

14.5

287

1669

M47.82

ICD-10 Finland

Other spondylosis, cervical region

1.7

14.5

308

1830

EB1SA

SPAT

0.6

14.5

220

3618

OAB74

NOMESCO Finland

Nutritional guidance related to treatment and rehabilitation for medical condition

2.7

14.5

368

R03BB04

ATC

tiotropium bromide; inhalant

1.4

14.5

651

4603

281

Kela drug reimbursment

Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab and tocilizumab

1.6

14.4

357

2214

CK2S4

NOMESCO Finland

Plain photography of ocular fundus

0.6

14.4

221

3624

SPAT1322

SPAT

Pre-employment physical examination

0.5

14.3

1853

GX1K5

NOMESCO Finland

Diffusion capacity

5.8

14.3

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

1.3

14.3

1170

9099

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

1.5

14.3

516

3493

FN1CC

NOMESCO Finland

Very extensive angiography of heart and/or coronary arteries

2.7

14.3

365

C01CA24

ATC

epinephrine; parenteral

1.3

14.2

906

6796

G04CA02

ATC

tamsulosin; oral

1.3

14.2

1264

9939

L04AX01

ATC

azathioprine; systemic

1.5

14.2

544

3728

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

1.3

14.2

993

7551

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

1.4

14.2

657

4670

N63

ICD-10 Finland

Unspecified lump in breast

1.4

14.1

745

5417

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

1.4

14.1

641

4542

GX1L5

NOMESCO Finland

Exhaled nitric oxide analysis

3.0

14.1

269

J38.7

ICD-10 Finland

Other diseases of larynx

3.0

14.1

260

SBA00

NOMESCO Finland

Microbiological examinations

1.8

14.1

243

1357

JN3AD

NOMESCO Finland

Abdominal CT examination

1.4

14.0

678

4858

Z39.1

ICD-10 Finland

Care and examination of lactating mother

1.6

14.0

364

2283

A60.0

ICD-10 Finland

Herpesviral infection of genitalia and urogenital tract

1.6

14.0

320

1945

WX110

NOMESCO Finland

Local anesthesy

1.1

14.0

11364

107457

H66.9

ICD-10 Finland

Otitis media, unspecified

1.3

14.0

989

7539

WX730

NOMESCO Finland

Conventional respirator

2.1

14.0

154

727

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.2

13.9

2800

24016

S60.2

ICD-10 Finland

Contusion of other parts of wrist and hand

1.4

13.9

616

4344

XF603

NOMESCO Finland

Direct intraarterial blood pressure measurement

1.7

13.9

279

1631

N06AB03

ATC

fluoxetine; oral

1.3

13.9

1505

12125

A51.3

ICD-10 Finland

Secondary syphilis of skin and mucous membranes

5.4

13.9

ICD-10 Finland

0.4

13.8

1304

Z73.9

ICD-10 Finland

Problem related to life-management difficulty, unspecified

2.3

13.8

125

542

A23

ICPC

Risk factor NOS

0.8

13.8

786

10186

J45.8

ICD-10 Finland

Mixed asthma

1.6

13.7

324

1985

C07AA05

ATC

propranolol; systemic

1.2

13.7

2626

22425

LX1AE

SPAT

7.7

13.7

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.2

13.7

4120

36503

XX1ZW

NOMESCO Finland

Very extensive written report from radiologist

3.5

13.6

180

Z01.2

ICD-10 Finland

Dental examination

1.1

13.6

6524

59663

S97

ICPC

Chronic ulcer skin

1.6

13.6

363

2293

FM1BE

NOMESCO Finland

Cardiac ultrasound examination through oesophagus

1.5

13.6

482

3252

ZX108

NOMESCO Finland

Inhalation

2.7

13.6

336

M81.9

ICD-10 Finland

Osteoporosis, unspecified

1.8

13.5

221

1215

R07.3

ICD-10 Finland

Other chest pain

1.3

13.5

880

6630

WX204

NOMESCO Finland

Axillary plexus blockaced

1.7

13.4

302

1826

O68.8

ICD-10 Finland

Labour and delivery complicated by other evidence of fetal stress

2.1

13.4

150

713

TKC20

NOMESCO Finland

Catheterisation of bladder

1.5

13.4

519

3565

XW000

NOMESCO Finland

Bone marrow biopsy

1.6

13.4

314

1922

A04.7

ICD-10 Finland

Enterocolitis due to Clostridium difficile

1.9

13.4

188

980

R03BA05

ATC

fluticasone; inhalant

1.2

13.4

2392

20299

R33

ICD-10 Finland

Retention of urine

1.5

13.3

451

3012

-31

ICPC

Medical examin/health eval partial

1.4

13.3

795

5904

J09

ICD-10 Finland

Influenza due to identified zoonotic or pandemic influenza virus

1.8

13.3

207

1118

ZX110

NOMESCO Finland

Intracutaneous

5.6

13.3

PBL09

NOMESCO Finland

Construction of arteriovenous fistula from brachial artery

4.7

13.3

J03.0

ICD-10 Finland

Streptococcal tonsillitis

1.4

13.2

567

3976

R87.6

ICD-10 Finland

Abnormal findings in specimens from female genital organs, abnormal cytological findings

1.3

13.2

1377

11040

Z50.5

ICD-10 Finland

Speech therapy

2.0

13.2

176

898

A97

ICPC

No disease

1.2

13.2

1908

15857

M10.9

ICD-10 Finland

Gout, unspecified

1.6

13.2

362

2307

ZZA00

NOMESCO Finland

Split skin graft

1.8

13.2

212

1157

Z53.2

ICD-10 Finland

Procedure not carried out because of patient's decision for other and unspecified reasons

1.9

13.2

176

901

F93.89

ICD-10 Finland

Other childhood emotional disorders

1.9

13.2

188

985

V03AE04

ATC

calcium acetate and magnesium carbonate; systemic

8.9

13.1

D64.9

ICD-10 Finland

Anaemia, unspecified

1.4

13.1

675

4893

R03DC03

ATC

montelukast; oral

1.2

13.1

2066

17327

T86.1

ICD-10 Finland

Kidney transplant failure and rejection

7.5

13.0

N06AB10

ATC

escitalopram; oral

1.2

13.0

3130

27244

Z35.8

ICD-10 Finland

Supervision of other high-risk pregnancies

1.2

13.0

1458

11795

R21

ICPC

Throat symptom/complaint

1.2

12.9

3779

33384

S13.4

ICD-10 Finland

Sprain and strain of cervical spine

1.4

12.9

573

4048

U08.9

ICD-10 Finland

Personal history of COVID-19, unspecified

2.9

12.8

266

MBW96

NOMESCO Finland

Other operation after delivery or abortion

3.9

12.8

129

F43.22

ICD-10 Finland

Adaptation disorder with mixed anxiety and depression

1.4

12.8

623

4472

R2110

NOMESCO Finland

Giving the first information

1.3

12.8

894

6805

J45.1

ICD-10 Finland

Nonallergic asthma

1.4

12.7

749

5548

I84.2

ICD-10 Finland

Internal hemorrhoids without complication

1.4

12.7

666

4841

D48.5

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Skin

1.5

12.7

471

3207

XG474

NOMESCO Finland

Exhalation nntrogen oxide

1.6

12.7

331

2081

I95.9

ICD-10 Finland

Hypotension, unspecified

2.4

12.7

109

461

R00.2

ICD-10 Finland

Palpitations

1.3

12.7

845

6381

N76.0

ICD-10 Finland

Acute vaginitis

1.3

12.7

1022

7935

A12AA12

ATC

[U] calcium acetate anhydrous; systemic

6.5

12.6

I48.9

ICD-10 Finland

Atrial fibrillation and atrial flutter, unspecified

1.7

12.6

262

1549

A98

ICPC

Health maint/preventive medicine

0.8

12.6

16810

169329

WX203

NOMESCO Finland

Infraclavicular plexus blockade

1.8

12.6

231

1316

L28

ICPC

Limited function/disability (L)

1.3

12.5

1154

9111

SPAT1182

SPAT

Ultrasound examination of uterus, appendages and lower abdomen

1.9

12.5

168

859

M54.8

ICD-10 Finland

Other dorsalgia

1.5

12.5

445

3007

ZX112

NOMESCO Finland

Subcutaneous

1.8

12.5

195

1057

J39.9

ICD-10 Finland

Disease of upper respiratory tract, unspecified

2.6

12.5

353

R06.5

ICD-10 Finland

Mouth breathing

1.3

12.5

907

6941

N05AH04

ATC

quetiapine; oral

1.2

12.4

2382

20333

N48.1

ICD-10 Finland

Balanoposthitis

1.8

12.4

217

1221

SPAT1375

SPAT

Structural ultrasound screening, weeks 18+0-21+6

0.4

12.4

1397

A41.8

ICD-10 Finland

Other specified sepsis

2.3

12.4

115

505

SPAT1211

SPAT

Application of soft bandage

1.3

12.4

1000

7764

N08.39*E11.2

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic nephropathy

2.5

12.3

367

TEW99

NOMESCO Finland

Other minor procedure in surgery of teeth, jaws, mouth and pharynx

1.4

12.3

534

3754

DAX08

NOMESCO Finland

Fitting of hearing aid

0.4

12.3

1242

K59.1

ICD-10 Finland

Functional diarrhoea

1.4

12.3

497

3449

R03AK08

ATC

formoterol and beclometasone; inhalant

1.5

12.2

379

2483

R03AK11

ATC

formoterol and fluticasone; inhalant

1.7

12.2

255

1512

J01FA06

ATC

roxithromycin; oral

1.1

12.2

5052

45690

B02.9

ICD-10 Finland

Zoster without complication

1.5

12.2

426

2868

ZXC80

NOMESCO Finland

Use of magnet

37.3

12.1

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.3

12.1

1105

8715

L01BA01

ATC

methotrexate; systemic (folic acid analog.)

1.5

12.1

373

2443

T78.4

ICD-10 Finland

Allergy, unspecified

1.4

12.1

647

4719

J02.0

ICD-10 Finland

Streptococcal pharyngitis

1.6

12.1

326

2071

SPAT1364

SPAT

Health check-up performed during second study year in students of upper secondary schools, vocational schools etc.

0.7

12.1

423

5893

R02

ICPC

Shortness of breath/dyspnoea

1.3

12.1

1202

9586

TKC22

NOMESCO Finland

Catheterisation instruction

2.0

12.0

152

764

DM1AI

NOMESCO Finland

Cone beam CT of paranasal sinus

1.6

12.0

293

1813

G44.2

ICD-10 Finland

Tension-type headache

1.2

12.0

1742

14479

ZX090

NOMESCO Finland

Other technic of radiotherapy

1.8

12.0

213

1204

TNX33

NOMESCO Finland

Custom moulded cast, unspecified region

1.4

12.0

524

3692

A46

ICD-10 Finland

Erysipelas

1.3

11.9

1070

8423

MA3AE

SPAT

2.4

11.9

407

O26.88

ICD-10 Finland

Other specified pregnancy-related conditions

1.7

11.9

246

1455

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

1.5

11.9

370

2430

J05AB11

ATC

valaciclovir; oral

1.2

11.9

1464

11969

R03BC03

ATC

nedocromil; inhalant

1.4

11.8

687

5082

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

1.2

11.8

1590

13116

L82

ICD-10 Finland

Seborrhoeic keratosis

1.3

11.8

1207

9656

CS5Z4

NOMESCO Finland

Specialised imaging for glaucoma

0.3

11.8

836

P06

ICPC

Sleep disturbance

1.3

11.8

1267

10195

ZZH40

NOMESCO Finland

Substitute of bone

2.3

11.8

102

433

SPAT1226

SPAT

Implementation of occupational therapy rehabilitation plan

1.8

11.7

196

1087

M21.1

ICD-10 Finland

Varus deformity, not elsewhere classified

4.1

11.7

106

H10.9

ICD-10 Finland

Conjunctivitis, unspecified

1.3

11.7

697

5179

G45.9

ICD-10 Finland

Transient cerebral ischaemic attack, unspecified

1.5

11.7

436

2977

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

1.3

11.7

1182

9445

D07AB02

ATC

hydrocortisone butyrate; topical

1.2

11.6

3544

31373

K22

ICPC

Risk factor cardiovascular disease

0.5

11.6

119

2159

H03AA01

ATC

levothyroxine sodium; systemic

1.2

11.6

2564

22142

JN3BD

NOMESCO Finland

Extensive abdominal CT

1.3

11.6

999

7828

WVA30

SPAT

0.5

11.5

1669

CS494

NOMESCO Finland

Other visual field testing

0.4

11.5

1016

N73.9

ICD-10 Finland

Female pelvic inflammatory disease, unspecified

1.7

11.5

251

1509

LC2BE

NOMESCO Finland

Transvaginal ultrasound examination of uterus, parametria and lower abdomen

1.1

11.5

4154

37208

G03CA03

ATC

estradiol; nasal, systemic, rectal, transdermal, vaginal

1.2

11.4

3461

30618

LAA06

NOMESCO Finland

Transvaginal puncture of ovarian cyst

2.2

11.4

114

519

N06AX16

ATC

venlafaxine; oral

1.2

11.4

1910

16097

E000003

ATC

1.4

11.4

533

3799

H10.3

ICD-10 Finland

Acute conjunctivitis, unspecified

1.3

11.3

720

5402

TK820

NOMESCO Finland

Peritoneal dialysis

3.2

11.3

181

F19.1

ICD-10 Finland

Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, harmful use

2.0

11.3

133

650

SPAT1193

SPAT

Pap smear

0.8

11.3

1170

14140

B18.1

ICD-10 Finland

Chronic viral hepatitis B without delta-agent

4.5

11.3

R21

ICD-10 Finland

Rash and other nonspecific skin eruption

1.4

11.2

443

3062

TQW80

NOMESCO Finland

Local dermatologic skincare

1.7

11.2

246

1480

H01.0

ICD-10 Finland

Blepharitis

1.4

11.2

645

4767

Z72.2

ICD-10 Finland

Drug use

2.2

11.2

109

490

F15.2

ICD-10 Finland

Mental and behavioural disorders due to use of other stimulants, including caffeine, dependence syndrome

2.6

11.1

303

L02.9

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle, unspecified

1.5

11.1

326

2113

U09.9

ICD-10 Finland

Post COVID-19 condition, unspecified

2.1

11.1

119

560

D07AD01

ATC

clobetasol; topical

1.2

11.0

1555

12886

WD315

NOMESCO Finland

Multiple therapy of methastized malignancy with biomodifiers

5.4

11.0

J45.0

ICD-10 Finland

Predominantly allergic asthma

1.2

11.0

1189

9579

C05AA08

ATC

fluocortolone; rectal, topical

1.2

10.9

1360

11124

EBA10

NOMESCO Finland

Surgical removal of tooth

1.2

10.9

2215

18984

K62.5

ICD-10 Finland

Haemorrhage of anus and rectum

1.4

10.9

442

3068

M01AH01

ATC

celecoxib; oral (coxibs)

1.2

10.9

1617

13470

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.2

10.8

1274

10363

J01MA06

ATC

norfloxacin; oral

1.2

10.8

1287

10484

SPAT1341

SPAT

Referral to physician or dentist

2.2

10.8

109

500

GX1R5

NOMESCO Finland

Peak expiratory flow (PEF) measurement

15.4

10.8

TJG22

NOMESCO Finland

Enema instruction

15.4

10.8

R06.2

ICD-10 Finland

Wheezing

1.4

10.7

489

3472

M70.6

ICD-10 Finland

Trochanteric bursitis

1.3

10.7

932

7309

XX1XN

NOMESCO Finland

Other isotope examination

2.4

10.6

343

R12

NOMESCO Finland

Examination to settle the need for rehabilitation

21.3

10.6

SPAT1236

SPAT

Informing family of child’s disability

0.4

10.6

1219

R20.2

ICD-10 Finland

Paraesthesia of skin

1.3

10.6

782

6001

K05

ICD-10 Finland

Gingivitis and periodontal diseases

1.9

10.6

151

797

S61.0

ICD-10 Finland

Open wound of finger(s) without damage to nail

1.3

10.6

1098

8802

QXB99

NOMESCO Finland

Other procedure to treat skin wound, unspecified location

1.9

10.5

152

804

504

Kela drug reimbursment

Conditions requiring daily forced enteral nutrition

2.1

10.5

115

547

J01AA07

ATC

tetracycline; systemic

1.2

10.5

2257

19437

J01DA06

ATC

[U] cefuroxime; systemic

1.2

10.5

1702

14297

J20

ICD-10 Finland

Acute bronchitis

1.3

10.5

1015

8071

B05DB

ATC

Hypertonic solutions

2.8

10.5

236

C08CA01

ATC

amlodipine; oral

1.2

10.5

2488

21600

Z43.1

ICD-10 Finland

Attention to gastrostomy

5.9

10.5

S80.0

ICD-10 Finland

Contusion of knee

1.3

10.5

796

6133

WXQ27

NOMESCO Finland

UVB narrow spectrum light therapy

1.9

10.4

147

769

AB14W

NOMESCO Finland

9.9

10.4

XQ800

NOMESCO Finland

Prick test

1.3

10.4

1088

8727

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

1.4

10.4

536

3892

OAB24

NOMESCO Finland

Assessment of medical rehabilitation needs in occupational health care

+∞

10.4

J44.0

ICD-10 Finland

Chronic obstructive pulmonary disease with acute lower respiratory infection

1.7

10.4

214

1267

J84.9

ICD-10 Finland

Interstitial pulmonary disease, unspecified

2.1

10.4

114

543

GD1ED

NOMESCO Finland

Extensive high resolution CT examination of lungs

1.7

10.4

223

1339

KA9AE

NOMESCO Finland

Ultrasound examination transplanted kidney

4.8

10.4

ZX121

NOMESCO Finland

Central venous catheter

2.9

10.4

210

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

1.3

10.4

621

4621

RS220

NOMESCO Finland

1.8

10.3

166

910

K59.09

ICD-10 Finland

Constipation, unspecified

1.4

10.3

459

3246

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.2

10.3

1172

9497

F32.1

ICD-10 Finland

Moderate depressive episode

1.3

10.3

868

6786

JAK10

NOMESCO Finland

Laparotomy and insertion of peritoneal dialysis catheter

2.9

10.2

212

O98.4

ICD-10 Finland

Viral hepatitis complicating pregnancy, childbirth and the puerperium

4.5

10.2

SPAT1041

SPAT

Comprehensive hearing test

2.2

10.2

421

Z24.4

ICD-10 Finland

Need for immunization against measles alone

18.6

10.2

A04AA01

ATC

ondansetron; systemic, rectal

1.3

10.2

609

4530

OAA67

SPAT

0.8

10.2

749

9396

O28.8

ICD-10 Finland

Other abnormal findings on antenatal screening of mother

1.8

10.1

176

992

ZY010

SPAT

0.2

10.1

533

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

1.6

10.1

227

1379

H66.0

ICD-10 Finland

Acute suppurative otitis media

1.2

10.1

1144

9267

PB1DE

NOMESCO Finland

Upper extremity arteries ultrasound examination with Doppler method

3.3

10.1

143

H57.1

ICD-10 Finland

Ocular pain

1.5

10.0

373

2551

S02.50

ICD-10 Finland

Fracture of tooth, closed

1.6

10.0

265

1677

TNX50

NOMESCO Finland

Removal of cutom molded cast and internal stretch

1.4

10.0

485

3484

G04CA01

ATC

alfuzosin; oral

1.3

10.0

670

5075

M01AH05

ATC

etoricoxib; oral

1.1

10.0

7848

73404

L04AA13

ATC

leflunomide; oral

1.6

9.9

222

1347

Z96.1

ICD-10 Finland

Presence of intraocular lens

1.4

9.9

572

4230

Z92.2

ICD-10 Finland

Personal history of long-term (current) use of other medicaments

9.0

9.9

B20.6

ICD-10 Finland

HIV disease resulting in Pneumocystis jirovecii pneumonia

39.7

9.9

M13.9

ICD-10 Finland

Arthritis, unspecified

1.3

9.9

710

5427

N06AB06

ATC

sertraline; oral

1.2

9.9

1506

12573

E86

ICD-10 Finland

Volume depletion

1.9

9.9

149

802

F43.29

ICD-10 Finland

Adaptation disorder UNS

1.5

9.9

293

1906

X57

ICD-10 Finland

Unspecified privation

1.6

9.8

224

1364

XA402

NOMESCO Finland

ENMG

0.5

9.8

1572

F19.20

ICD-10 Finland

Addiction relationship caused by several drugs in combination and by other psychoactive substances currently independent

2.4

9.8

331

J32.4

ICD-10 Finland

Chronic pansinusitis

1.8

9.8

150

813

NHQ40

NOMESCO Finland

Amputation of toe

2.2

9.7

444

M54.2

ICD-10 Finland

Cervicalgia

1.3

9.7

765

5925

S91.3

ICD-10 Finland

Open wound of other parts of foot

1.6

9.7

252

1589

SBB00

NOMESCO Finland

Fotograf of mouth and teeth

1.4

9.7

520

3803

Z73.3

ICD-10 Finland

Stress, not elsewhere classified

1.7

9.7

200

1186

Z13.6

ICD-10 Finland

Special screening examination for cardiovascular disorders

2.4

9.7

317

E78.01

ICD-10 Finland

Pure hypercholesterolaemia

1.2

9.6

1271

10462

JN4BD

NOMESCO Finland

Extensive body CT

1.3

9.6

791

6161

TJG20

NOMESCO Finland

Transanal irrigation

4.4

9.6

PBU99

NOMESCO Finland

Other repair after previous reconstruction of arteries of upper extremity

13.2

9.6

M35.7

ICD-10 Finland

Hypermobility syndrome

1.6

9.6

213

1290

SPAT1305

SPAT

Counselling and guidance related to physical exercise

1.3

9.6

978

7826

WD305

NOMESCO Finland

Simple therapy of methastized malignancy with biomodifiers

2.3

9.6

389

AA3AD

NOMESCO Finland

CT of face

2.5

9.6

276

M01AB05

ATC

diclofenac; systemic, rectal

1.1

9.5

9152

86391

WVA20

NOMESCO Finland

Medicine administration

1.7

9.5

207

1246

L08.8

ICD-10 Finland

Other specified local infections of skin and subcutaneous tissue

1.6

9.5

261

1673

A07AA09

ATC

vancomycin; oral

2.1

9.5

105

504

N39.9

ICD-10 Finland

Disorder of urinary system, unspecified

1.9

9.5

133

697

R35

ICD-10 Finland

Polyuria

1.4

9.5

465

3352

A56.4

ICD-10 Finland

Chlamydial infection of pharynx

4.2

9.5

SPAT1190

SPAT

Insertion or removal of intrauterine contraceptive device

1.2

9.4

1097

8909

U08

ICD-10 Finland

Personal history of COVID-19

2.9

9.4

195

SPAT1275

SPAT

Drug rehabilitation and replacement therapy of opioid-dependent person

2.2

9.4

396

NE1AA

NOMESCO Finland

Pelvis X-ray examination

1.4

9.4

427

3032

SAB01

NOMESCO Finland

Restricted oral and dental health check by dental hygienist or dental assistant

1.2

9.4

1413

11786

B23

ICD-10 Finland

Human immunodeficiency virus [HIV] disease resulting in other conditions

99.3

9.4

ED1AA

NOMESCO Finland

Mandipular X-ray examination

2.4

9.4

301

R55

ICD-10 Finland

Syncope and collapse

1.3

9.4

873

6911

A41.9

ICD-10 Finland

Sepsis, unspecified

1.6

9.4

253

1612

A55

ICD-10 Finland

Chlamydial lymphogranuloma (venereum)

29.8

9.4

QAJ99

NOMESCO Finland

Other aesthetic operations on skin of head or neck

7.4

9.3

M05BX04

ATC

denosumab; parenteral

1.6

9.3

254

1622

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

1.2

9.3

1316

10909

XX2VW

NOMESCO Finland

Radiologic consultation

2.7

9.3

236

E87.1

ICD-10 Finland

Hypo-osmolality and hyponatraemia

1.6

9.3

238

1497

G04BD12

ATC

mirabegron; oral

1.3

9.3

628

4764

TMA00

NOMESCO Finland

Episiotomy

0.7

9.2

287

4070

GX1D5

NOMESCO Finland

Flow volume spirometry

6.8

9.2

RS221

NOMESCO Finland

1.7

9.2

173

999

KOPCD

NOMESCO Finland

4.0

9.2

Z97.4

ICD-10 Finland

Presence of external hearing-aid

1.6

9.2

214

1313

JAH01

NOMESCO Finland

Laparoscopy

1.4

9.2

519

3830

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

1.4

9.2

370

2572

P01BA02

ATC

hydroxychloroquine; oral

1.3

9.2

782

6124

N31.2

ICD-10 Finland

Flaccid neuropathic bladder, not elsewhere classified

2.4

9.1

301

WX234

NOMESCO Finland

Paracervical blockade

0.7

9.1

228

3364

N83.2

ICD-10 Finland

Other and unspecified ovarian cysts

1.2

9.1

1212

9989

A02BA02

ATC

ranitidine; systemic

1.2

9.1

1618

13706

XKC03

NOMESCO Finland

Water cystometry

1.6

9.1

236

1492

M05BA04

ATC

alendronic acid; oral

1.4

9.1

400

2832

C79.8

ICD-10 Finland

Secondary malignant neoplasm of other specified sites

1.6

9.0

206

1258

F19.29

ICD-10 Finland

Addiction caused by several drugs in combination and by other psychoactive substances UNS

2.2

9.0

404

ABC30

NOMESCO Finland

Decompression of cervical nerve roots

2.2

9.0

381

WX202

NOMESCO Finland

Supraclavicular plexus blockade

1.9

9.0

130

691

Z01.5

ICD-10 Finland

Diagnostic skin and sensitization tests

1.2

9.0

1222

10091

M54

ICD-10 Finland

Dorsalgia

1.2

9.0

1404

11753

NG1DA

NOMESCO Finland

X-ray of knees

1.8

9.0

143

784

DAX00

NOMESCO Finland

Adjustment or review of hearing aid

0.5

9.0

1342

W10

ICD-10 Finland

Fall on and from stairs and steps

1.4

9.0

451

3267

S40.0

ICD-10 Finland

Contusion of shoulder and upper arm

1.4

9.0

404

2871

SBB10

NOMESCO Finland

Teeth copy

1.2

8.9

1001

8099

Z73.6

ICD-10 Finland

Limitation of activities due to disability

2.5

8.9

262

L04AB04

ATC

adalimumab; parenteral

1.6

8.9

247

1586

A29

ICPC

General symptom/complaint other

0.8

8.9

700

8716

R03AK10

ATC

vilanterol and fluticasone furoate; inhalant

1.4

8.9

393

2782

N07CA01

ATC

betahistine; oral

1.3

8.9

510

3776

S20.2

ICD-10 Finland

Contusion of thorax

1.4

8.9

448

3245

321

Kela drug reimbursment

Paricalcitol and cinacalcet

3.0

8.9

164

PBM10

NOMESCO Finland

Closure of arteriovenous fistula of radial artery

5.0

8.8

R06AE09

ATC

levocetirizine; oral

1.2

8.8

2026

17529

K86

ICPC

Hypertension uncomplicated

0.7

8.8

375

5057

GX1E5

NOMESCO Finland

Flow volume spirometry and bronchodilation test

3.8

8.8

G04BD08

ATC

solifenacin; oral

1.4

8.8

407

2906

M75.1

ICD-10 Finland

Rotator cuff syndrome

1.2

8.7

2193

19105

F11.25

ICD-10 Finland

Relationship caused by opiates continuously used

2.4

8.7

288

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

1.3

8.7

871

6954

A07DA03

ATC

loperamide; oral

1.6

8.7

241

1547

SPAT1283

SPAT

Restricted health certificate

1.1

8.7

3650

32923

SPAT1323

SPAT

Health check-up related to work causing occupational hazard

0.5

8.7

1189

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

1.3

8.7

508

3774

IHA14

SPAT

13.9

8.6

N08.39*E10.2

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic nephropathy

2.1

8.6

415

M10.0

ICD-10 Finland

Idiopathic gout

1.7

8.6

169

989

C02AC05

ATC

moxonidine; oral

1.5

8.6

254

1656

MA5AE

SPAT

2.1

8.6

428

N90.9

ICD-10 Finland

Noninflammatory disorder of vulva and perineum, unspecified

2.3

8.6

342

A43

ICPC

General and Unspecified, Other diagnostic procedure

2.5

8.6

238

N06AX26

ATC

vortioxetine; oral

1.3

8.6

792

6266

Y76

ICPC

Condylomata acuminata male

4.8

8.6

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic (ophth., corticosteroids and antiinfectives in comb.)

1.1

8.6

3057

27293

RJ129

NOMESCO Finland

7.5

8.6

W0X00

NOMESCO Finland

Estimation of continuous need for medical therapy

7.5

8.6

B34.9

ICD-10 Finland

Viral infection, unspecified

1.4

8.6

404

2896

F43.1

ICD-10 Finland

Post-traumatic stress disorder

1.4

8.5

398

2844

F11.29

ICD-10 Finland

Addiction caused by opiates UNS

2.8

8.5

186

XX9TE

NOMESCO Finland

Compementary ultrasound examination

2.3

8.5

307

J01.1

ICD-10 Finland

Acute frontal sinusitis

1.6

8.5

192

1173

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

1.4

8.5

449

3284

ZZH21

NOMESCO Finland

Graft of patients own bone, small pieces

1.7

8.5

178

1065

N12

ICD-10 Finland

Tubulo-interstitial nephritis, not specified as acute or chronic

1.8

8.4

127

686

JHB30

NOMESCO Finland

Rubber band ligature of haemorrhoids or prolapse of mucosa

1.4

8.4

467

3440

CJB10

NOMESCO Finland

Laser discission of secondary cataract

1.4

8.4

350

2449

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.3

8.4

614

4712

R22.9

ICD-10 Finland

Localized swelling, mass and lump, unspecified

1.3

8.4

794

6301

SPAT1388

SPAT

Extensive health check-up based on individual need

2.1

8.4

441

TK824

NOMESCO Finland

Replacement of peritoneal dialysis catheter extension tube

5.1

8.4

ZX070

NOMESCO Finland

Intensity modified radiotherapy

1.8

8.4

132

724

M54.6

ICD-10 Finland

Pain in thoracic spine

1.3

8.4

769

6083

SPAT1315

SPAT

Periodic health check-up of children and adolescents

1.2

8.3

1749

15024

I63.9

ICD-10 Finland

Cerebral infarction, unspecified

1.4

8.3

471

3478

G03DB02

ATC

megestrol; oral (pregnadien derivatives)

1.6

8.3

218

1380

Z96.6

ICD-10 Finland

Presence of orthopaedic joint implants

1.6

8.3

215

1359

JAP01

NOMESCO Finland

Laparoscopic freeing of adhesions in the peritoneal cavity

1.7

8.3

161

939

L02.4

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of limb

1.4

8.3

359

2533

GD1LA

NOMESCO Finland

2.1

8.3

430

TJW99

NOMESCO Finland

Other minor procedure in gastrointestinal endoscopy

3.9

8.3

L04AA01

ATC

[U] ciclosporin; systemic

1.8

8.3

139

776

WX400

NOMESCO Finland

Inhalation anesthesy

1.3

8.3

552

4182

OAB95

SPAT

0.8

8.3

490

6314

M04AA01

ATC

allopurinol; systemic

1.3

8.3

683

5325

U14

ICPC

Kidney symptom/complaint

2.0

8.3

482

R01AD01

ATC

beclometasone; nasal

1.2

8.3

1763

15161

SPAT1231

SPAT

Assessment of adjustments needed in living environment

1.9

8.3

109

561

K42.9

ICD-10 Finland

Umbilical hernia without obstruction or gangrene

1.4

8.3

431

3143

L02.2

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of trunk

1.4

8.2

403

2908

QXA20

NOMESCO Finland

Skin abrasion, unspecified location

2.9

8.2

166

W92

ICPC

Compl labour/ delivery livebirth

1.4

8.2

360

2546

A69

ICPC

General and Unspecified, Other reason for encounter NEC

1.5

8.2

231

1491

T74.1

ICD-10 Finland

Physical abuse

1.5

8.2

284

1920

U13

ICPC

Bladder symptom/complaint other

1.5

8.2

257

1700

L20.0

ICD-10 Finland

Besnier prurigo

1.2

8.2

1135

9395

R07.1

ICD-10 Finland

Chest pain on breathing

1.7

8.2

149

855

TNX39

NOMESCO Finland

Other orthopedic bandage, unspecified region

1.7

8.2

160

940

M94.0

ICD-10 Finland

Chondrocostal junction syndrome [Tietze]

1.5

8.2

235

1522

SGA05

NOMESCO Finland

Very demanding and lengthy opening and dilatation of root canal of tooth

1.3

8.2

818

6539

S90.3

ICD-10 Finland

Contusion of other and unspecified parts of foot

1.5

8.2

308

2117

5AB14

NOMESCO Finland

3.4

8.1

108

J11.1

ICD-10 Finland

Influenza with other respiratory manifestations, virus not identified

1.5

8.1

250

1645

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.2

8.1

1238

10341

N03AE01

ATC

clonazepam; systemic

1.3

8.1

523

3943

K02.2

ICD-10 Finland

Caries of cementum

1.4

8.1

315

2179

OAB73

NOMESCO Finland

Prevention and treatment of malnutrition

2.7

8.1

197

Z45.0

ICD-10 Finland

Adjustment and management of cardiac devices

1.6

8.1

193

1193

Z48.8

ICD-10 Finland

Other specified surgical follow-up care

2.1

8.1

408

GD1BD

NOMESCO Finland

Thorax extensive CT-examination

1.4

8.1

368

2620

F11.22

ICD-10 Finland

Addiction-induced dependence is currently independent but uses substitute intermittent medication

2.1

8.1

423

A07EC01

ATC

sulfasalazine; oral, rectal

1.2

8.1

829

6644

ULC02

NOMESCO Finland

Hysteroscopy

1.3

8.0

490

3663

G43.1

ICD-10 Finland

Migraine with aura [classical migraine]

1.2

8.0

1019

8357

A03FA02

ATC

cisapride; oral, rectal

1.3

8.0

577

4421

HA6BA

NOMESCO Finland

Breast tomosynthesis specimen

0.2

8.0

426

J90

ICD-10 Finland

Pleural effusion, not elsewhere classified

1.7

8.0

165

983

WX213

NOMESCO Finland

Lower leg blockade

2.3

8.0

309

QXE10

SPAT

9.9

8.0

JN4KR

NOMESCO Finland

Whole body very extensive metabolic PET with CT

2.3

7.9

280

D01BA02

ATC

terbinafine; oral; topical

1.1

7.9

2393

21117

ENC30

NOMESCO Finland

Plastic operation of pharynx

1.9

7.9

111

586

R06AX27

ATC

desloratadine; oral

1.1

7.9

4223

38578

LX1XE

SPAT

3.8

7.9

H43.8

ICD-10 Finland

Other disorders of vitreous body

1.3

7.9

557

4255

J84.8

ICD-10 Finland

Other specified interstitial pulmonary diseases

2.3

7.9

312

K03.80

ICD-10 Finland

Irradiated enamel

1.3

7.9

563

4307

N02AA05

ATC

oxycodone; systemic

1.2

7.9

950

7750

XG480

NOMESCO Finland

Histamine provocation of respiratroy tract

1.7

7.9

162

964

G03GA01

ATC

chorionic gonadotrophin; parenteral

1.3

7.9

574

4405

A01AB09

ATC

miconazole; local oral

1.3

7.9

785

6271

O26.82

ICD-10 Finland

Exhaustion and fatigue pregnancy-related

1.4

7.8

320

2237

J12.9

ICD-10 Finland

Viral pneumonia, unspecified

2.3

7.8

305

-41

ICPC

Diagnostic radiology/imaging

4.7

7.8

K58.9

ICD-10 Finland

Irritable bowel syndrome without diarrhoea

1.4

7.8

349

2477

ZYC06

SPAT

2.5

7.8

231

I26.9

ICD-10 Finland

Pulmonary embolism without mention of acute cor pulmonale

1.4

7.8

339

2393

NGQ20

NOMESCO Finland

Amputation of lower leg

3.1

7.8

128

SPAT1224

SPAT

Implementation of speech therapy rehabilitation plan

1.8

7.8

129

719

K92.1

ICD-10 Finland

Melaena

1.4

7.8

322

2257

S01.0

ICD-10 Finland

Open wound of scalp

1.3

7.8

603

4668

R1410

NOMESCO Finland

Drawing up a rehabilitation plan

2.2

7.8

328

XKD03

NOMESCO Finland

Urethral pressure profilometry

1.7

7.8

163

977

G03BA03

ATC

testosterone; systemic, rectal, sublingual, transdermal

1.4

7.8

398

2897

3AC01

NOMESCO Finland

1.9

7.8

107

560

NA7DG

NOMESCO Finland

Spine and spinal cord very extensive MRI examination with high intensity magnet

1.8

7.8

117

633

WW500

NOMESCO Finland

Blood transfusion

1.4

7.8

334

2357

O21.9

ICD-10 Finland

Vomiting of pregnancy, unspecified

1.5

7.8

238

1569

R00.0

ICD-10 Finland

Tachycardia, unspecified

1.4

7.7

435

3214

Z71.9

ICD-10 Finland

Counselling, unspecified

1.3

7.7

626

4871

NA3SA

NOMESCO Finland

Lumbar spine X-ray examination in standing position

2.4

7.7

252

R05

ICPC

Cough

1.1

7.7

2846

25449

A78

ICPC

Infectious disease other/NOS

1.5

7.7

257

1722

F90.0

ICD-10 Finland

Disturbance of activity and attention

1.3

7.7

526

4003

WX892

NOMESCO Finland

Monitored bed care

1.3

7.7

634

4947

WX321

NOMESCO Finland

Acute spinal anesthesia for delivery

1.3

7.7

644

5037

JA1AE

NOMESCO Finland

Ultrasound examination of groin and abdominal wall

1.7

7.7

137

781

G04BD11

ATC

fesoterodine; oral

1.6

7.7

172

1049

N40

ICD-10 Finland

Hyperplasia of prostate

1.2

7.7

944

7719

120

Kela drug reimbursment

Hypogammaglobulinaemia

3.4

7.7

103

NA2AA

NOMESCO Finland

Thoracal spine X-ray examination without contrast

1.6

7.7

198

1253

O42.9

ICD-10 Finland

Premature rupture of membranes, unspecified

1.3

7.6

507

3841

R01AD09

ATC

mometasone; nasal

1.1

7.6

6669

62422

H31

ICPC

Ear, Medical examin/health eval partial

3.5

7.6

Z32.1

ICD-10 Finland

Pregnancy confirmed

1.2

7.6

1755

15188

TKE00

NOMESCO Finland

Needle biopsy of prostate

1.7

7.6

151

891

Z36.4

ICD-10 Finland

Antenatal screening for fetal growth retardation using ultrasound and other physical methods

0.6

7.6

1430

YVIID

NOMESCO Finland

5.5

7.6

H10.2

ICD-10 Finland

Other acute conjunctivitis

1.7

7.5

150

887

WX726

NOMESCO Finland

High-flow oxygen therapy

6.6

7.5

E11.7

ICD-10 Finland

Type 2 diabetes mellitus, with multiple complications

1.5

7.5

238

1578

R27

ICPC

Fear of respiratory disease other

1.6

7.5

167

1018

WYA10

NOMESCO Finland

First aid or other corresponding healthcare contact

1.2

7.5

1049

8690

RJ420

NOMESCO Finland

2.8

7.5

166

TNH33

NOMESCO Finland

Custom moulded brace, ankle or foot

1.7

7.5

148

873

JN3DE

NOMESCO Finland

Abdominal extensive ultrasoudn examination with blood flow measurements after transplantation

2.3

7.5

281

NGD05

NOMESCO Finland

Partial excision of meniscus of knee, arthroscopic

1.2

7.5

956

7850

R12

ICD-10 Finland

Heartburn

1.3

7.4

737

5883

ZYC01

SPAT

1.2

7.4

850

6897

R04.0

ICD-10 Finland

Epistaxis

1.3

7.4

471

3544

ND2BA

NOMESCO Finland

Hand and fingers extensive X-ray examination

1.5

7.4

208

1341

KAC00

NOMESCO Finland

Nephrectomy

3.1

7.4

122

Z01.3

ICD-10 Finland

Examination of blood pressure

2.0

7.4

417

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

1.3

7.4

493

3739

F13.22

ICD-10 Finland

Addiction relationship caused by sedatives and hypnotics currently independent but uses substitute intermittent medication

2.3

7.4

276

R03AL01

ATC

fenoterol and ipratropium bromide; inhalant

1.6

7.4

167

1022

C01DA14

ATC

isosorbide mononitrate; oral

1.3

7.3

586

4555

S63.6

ICD-10 Finland

Sprain and strain of finger(s)

1.3

7.3

494

3753

N81.6

ICD-10 Finland

Rectocele

1.3

7.3

439

3277

R1210

NOMESCO Finland

Medical assessment of need and possibilities to rehabilitation

1.7

7.3

136

789

S22.0

ICD-10 Finland

Fracture of thoracic vertebra

1.8

7.3

127

722

Z94.4

ICD-10 Finland

Liver transplant status

2.7

7.3

163

U04

ICPC

Incontinence urine

1.4

7.3

287

1991

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

1.1

7.3

2118

18636

DFF15

NOMESCO Finland

Speech audiometry

0.6

7.3

1661

WQ000

NOMESCO Finland

Hyposensibilisation

1.9

7.3

101

530

XQ855

NOMESCO Finland

Skin temperature measurement

2.7

7.3

173

PB1AC

NOMESCO Finland

Angiography of upper extremity with X-ray

4.5

7.3

TDM10

NOMESCO Finland

Puncture of maxillary antrum

1.3

7.3

433

3229

N62

ICD-10 Finland

Hypertrophy of breast

1.3

7.3

429

3197

B21.0

ICD-10 Finland

HIV disease resulting in Kaposi sarcoma

+∞

7.3

J06BA01

ATC

immunoglobulins, normal human, for extravascular adm.; systemic

3.5

7.3

PA7CD

NOMESCO Finland

CT angiography of neck and brain, extensive

2.0

7.2

402

TUPEI

NOMESCO Finland

0.7

7.2

297

4018

D23.5

ICD-10 Finland

Benign neoplasm: Skin of trunk

1.5

7.2

221

1455

O20.9

ICD-10 Finland

Haemorrhage in early pregnancy, unspecified

1.3

7.2

420

3120

Z50.0

ICD-10 Finland

Cardiac rehabilitation

2.3

7.2

262

WZC10

NOMESCO Finland

Extensive specialist consultion with written report

1.3

7.2

492

3746

N04BC05

ATC

pramipexole; oral

1.3

7.2

501

3824

I80.3

ICD-10 Finland

Phlebitis and thrombophlebitis of lower extremities, unspecified

1.5

7.2

254

1728

WZC00

SPAT

0.8

7.2

374

4892

-60

ICPC

Result test/procedure

0.7

7.2

325

4337

I10

ICD-10 Finland

Essential (primary) hypertension

1.1

7.2

4389

40355

SDE03

NOMESCO Finland

Periodontal treatment by dental hygienist, extensive

0.9

7.2

2622

28753

Z23.1

ICD-10 Finland

Need for immunization against typhoid-paratyphoid alone [TAB]

6.2

7.2

TPH30

NOMESCO Finland

Insertion of central venous catheter through periferal vein

1.8

7.2

116

645

JA3BT

NOMESCO Finland

Cathetrisation of abdominal cavity with X-ray guidance

3.1

7.2

120

Y96.2

ICD-10 Finland

School or kindergarten related condition

3.6

7.2

K01.16

ICD-10 Finland

Retained molar with obstruction in the upper jaw

1.5

7.2

214

1403

I50.0

ICD-10 Finland

Congestive heart failure

1.5

7.1

256

1748

PD4CG

NOMESCO Finland

Extensive MRI examination of abdominal aortta and vasculature of lower extremities with high intensity magnet

2.2

7.1

307

B01AB04

ATC

dalteparin; parenteral

1.4

7.1

365

2656

Z03.0

ICD-10 Finland

Observation for suspected tuberculosis

2.7

7.1

160

Z86.5

ICD-10 Finland

Personal history of other mental and behavioural disorders

7.2

7.1

N39.3

ICD-10 Finland

Stress incontinence

1.3

7.1

568

4419

SPAT1339

SPAT

New appointment

2.7

7.1

170

B20.9

ICD-10 Finland

HIV disease resulting in unspecified infectious or parasitic disease

29.8

7.1

K08.80

ICD-10 Finland

Toothache NOS

1.2

7.1

1020

8478

A33

ICPC

General and Unspecified, Microbiological/immunological test

2.5

7.1

212

K59.01

ICD-10 Finland

Constipation outlet obstruction type

2.0

7.1

439

EB1JA

NOMESCO Finland

Double panorama tomography of teeth and jaws or similar X-ray examination

2.0

7.0

417

P19

ICPC

Drug abuse

1.7

7.0

145

866

M53.0

ICD-10 Finland

Cervicocranial syndrome

1.2

7.0

964

7974

M80.0

ICD-10 Finland

Postmenopausal osteoporosis with pathological fracture

2.0

7.0

406

NA1EA

NOMESCO Finland

Cervical spine X-ray examination with flexion

1.8

7.0

115

644

JN4AD

NOMESCO Finland

Body CT examination

1.3

7.0

492

3764

H53.1

ICD-10 Finland

Subjective visual disturbances

1.3

7.0

589

4617

SPAT1281

SPAT

Other administrative function

1.2

7.0

913

7522

R07

ICPC

Sneezing/nasal congestion

1.2

6.9

1000

8311

D80.9

ICD-10 Finland

Immunodeficiency with predominantly antibody defects, unspecified

3.2

6.9

101

S92.5

ICD-10 Finland

Fracture of other toe

1.4

6.9

296

2088

K02.9

ICD-10 Finland

Dental caries, unspecified

1.6

6.9

179

1136

LDB20

NOMESCO Finland

Electrocoagulation or laser therapy of cervix uteri

1.8

6.9

112

623

K43.9

ICD-10 Finland

Other and unspecified ventral hernia without obstruction or gangrene

1.4

6.9

325

2331

YG1AD

NOMESCO Finland

CT examination of thorax for dose design of radiotherapy

0.4

6.9

755

K03.60

ICD-10 Finland

Deposits [accretions] on teeth black

2.0

6.9

424

SFA10

NOMESCO Finland

Fillning on one surface of tooth

1.1

6.9

8361

79268

Z13.5

ICD-10 Finland

Special screening examination for eye and ear disorders

2.1

6.9

354

EMB10

NOMESCO Finland

Tonsillectomy

1.2

6.9

1043

8714

H81.1

ICD-10 Finland

Benign paroxysmal vertigo

1.2

6.9

766

6201

DFF59

NOMESCO Finland

Other assessment of balance

0.3

6.9

524

F11.24

ICD-10 Finland

Addiction-induced dependence caused by opiates active addiction

2.3

6.9

257

F43.0

ICD-10 Finland

Acute stress reaction

1.3

6.9

661

5264

WD415

NOMESCO Finland

Demanding antibody therapy of methastized malignancy

1.8

6.8

111

616

IHA21

NOMESCO Finland

Mini-intervention for hazardous and harmful alcohol use

7.4

6.8

XF405

NOMESCO Finland

Symptom ECG

2.0

6.8

369

QD9S1

NOMESCO Finland

Photography of skin or subcutaneous tissue in lower extremities, unspecified

2.4

6.8

212

L03.9

ICD-10 Finland

Cellulitis, unspecified

1.6

6.8

184

1179

Z50.1

ICD-10 Finland

Other physical therapy

0.7

6.8

240

3324

R49.01

ICD-10 Finland

Functional dysphonia

1.4

6.8

259

1790

JDF11

NOMESCO Finland

Laparoscopic gastric bypass

1.6

6.8

184

1181

M81.8

ICD-10 Finland

Other osteoporosis

2.4

6.8

220

N18

ICD-10 Finland

Chronic kidney disease

2.6

6.8

177

L04AB01

ATC

etanercept; parenteral

1.6

6.8

171

1078

Z70.8

ICD-10 Finland

Other sex counselling

2.1

6.8

348

Z30.8

ICD-10 Finland

Other contraceptive management

1.3

6.8

435

3282

K21

ICD-10 Finland

Gastro-oesophageal reflux disease

1.3

6.8

516

3990

N95.1

ICD-10 Finland

Menopausal and female climacteric states

1.2

6.8

905

7469

ZA8.0

ICD-10 Finland

Fault, injury or disease in the skull

8.2

6.8

O28

ICD-10 Finland

Abnormal findings on antenatal screening of mother

10.8

6.8

D80.1

ICD-10 Finland

Nonfamilial hypogammaglobulinaemia

3.0

6.7

120

MA2XE

SPAT

9.2

6.7

Z24.0

ICD-10 Finland

Need for immunization against poliomyelitis

9.2

6.7

H16.0

ICD-10 Finland

Corneal ulcer

1.3

6.7

500

3853

S63.5

ICD-10 Finland

Sprain and strain of wrist

1.3

6.7

420

3159

A09AA02

ATC

multienzymes (lipase, protease etc.)

1.7

6.7

125

728

R15

ICD-10 Finland

Faecal incontinence

1.6

6.7

159

989

Z43.3

ICD-10 Finland

Attention to colostomy

4.1

6.7

DMB20

NOMESCO Finland

Functional endoscopic opening of maxillary antrum

1.3

6.7

584

4596

L40.0

ICD-10 Finland

Psoriasis vulgaris

1.3

6.7

388

2885

3025

Kela drug reimbursment

Calcium carbonate

3.2

6.7

104

SFA20

NOMESCO Finland

Filling on two surfaces of tooth

1.1

6.7

8993

85582

NH1BA

NOMESCO Finland

Ankle extensive X-ray examination

1.4

6.7

283

1997

GD1RA

NOMESCO Finland

Dynamic X-ray examination of respiratory organs with convetional X-ray picture

3.9

6.7

N76.6

ICD-10 Finland

Ulceration of vulva

1.9

6.7

485

TAB00

NOMESCO Finland

Lumbar puncture

1.3

6.7

491

3782

Z03.8

ICD-10 Finland

Observation for other suspected diseases and conditions

0.7

6.6

218

3052

E11.6

ICD-10 Finland

Type 2 diabetes mellitus, with other specified complications

1.9

6.6

488

R59.0

ICD-10 Finland

Localized enlarged lymph nodes

1.4

6.6

333

2422

F13.25

ICD-10 Finland

Addiction caused by sedative and hypnotic continuous use

2.2

6.6

268

GD1BA

NOMESCO Finland

Extensive X-ray examination of thorax

2.0

6.6

369

NK6BQ

NOMESCO Finland

Whole body extensive bone SPET with low dose CT

2.6

6.6

168

G43.9

ICD-10 Finland

Migraine, unspecified

1.2

6.6

890

7352

I25.9

ICD-10 Finland

Chronic ischaemic heart disease, unspecified

1.3

6.6

370

2737

WGA11

SPAT

1.8

6.6

109

612

Z93

ICD-10 Finland

Artificial opening status

3.0

6.6

111

IDY13

SPAT

6.4

6.6

S89.9

ICD-10 Finland

Unspecified injury of lower leg

1.3

6.6

375

2782

A52.1

ICD-10 Finland

Symptomatic neurosyphilis

7.7

6.6

KAD00

NOMESCO Finland

Partial nephrectomy

2.9

6.5

132

H05BX02

ATC

paricalcitol; systemic

5.4

6.5

CK2S4

SPAT

0.2

6.5

327

R60.9

ICD-10 Finland

Oedema, unspecified

1.4

6.5

345

2531

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

0.8

6.5

334

4377

B86

ICD-10 Finland

Scabies

1.4

6.5

239

1643

N25.8

ICD-10 Finland

Other disorders resulting from impaired renal tubular function

2.4

6.5

206

JFA55

NOMESCO Finland

Other endoscopic procedure using diathermy or heat in colon

3.8

6.5

H43

ICPC

Ear, Other diagnostic procedure

3.8

6.5

R83

ICPC

Respiratory infection other

0.9

6.5

3803

40702

D80.3

ICD-10 Finland

Selective deficiency of immunoglobulin G [IgG] subclasses

3.2

6.5

S01GX05

ATC

lodoxamide; ophthalmic

1.7

6.5

121

707

-40

ICPC

Diagnostic endoscopy

3.1

6.5

107

IHZ01

SPAT

2.3

6.5

256

K04.1

ICD-10 Finland

Necrosis of pulp

1.2

6.5

1251

10684

R06.8

ICD-10 Finland

Other and unspecified abnormalities of breathing

1.7

6.4

136

820

L85.9

ICD-10 Finland

Epidermal thickening, unspecified

3.1

6.4

102

8090/3-C44.3

ICD-O-3

Basal cell carcinoma, NOS, of skin of other and unspecified parts of face

1.7

6.4

129

767

CKD95

NOMESCO Finland

Extended combined vitectomy and lens procedure through pars plana

3.9

6.4

O36.5

ICD-10 Finland

Maternal care for poor fetal growth

1.3

6.4

388

2905

L40.5

ICD-10 Finland

Arthropathic psoriasis

1.6

6.4

147

907

L02

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle

1.3

6.4

393

2949

H04.10

ICD-10 Finland

Dry eye syndrome

1.2

6.4

919

7644

I48

ICD-10 Finland

Atrial fibrillation and flutter

1.2

6.4

1038

8733

D07AB08

ATC

desonide; topical

1.2

6.4

1228

10483

NE1AD

NOMESCO Finland

Pelvis and hip bones CT examination

1.8

6.4

103

573

E27.4

ICD-10 Finland

Other and unspecified adrenocortical insufficiency

3.0

6.4

114

SPAT1195

SPAT

Antenatal classes

0.8

6.4

379

4865

G43.0

ICD-10 Finland

Migraine without aura [common migraine]

1.2

6.4

889

7371

SPAT1054

SPAT

Examination of peripheral nervous system

1.7

6.3

116

672

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

1.2

6.3

1491

12927

K56.6

ICD-10 Finland

Other and unspecified intestinal obstruction

1.5

6.3

177

1148

F10.09

ICD-10 Finland

Alcohol intoxication UNS

1.4

6.3

231

1587

JN4JR

NOMESCO Finland

Whole body extensive metabolic PET with CT

2.1

6.3

328

M79.9

ICD-10 Finland

Soft tissue disorder, unspecified

1.9

6.3

445

C08DB01

ATC

diltiazem; oral

1.5

6.3

207

1389

U01

ICPC

Dysuria/painful urination

1.2

6.3

851

7034

SGB30

NOMESCO Finland

Other demanding filling of root channel of tooth

1.1

6.3

1631

14243

M54.1

ICD-10 Finland

Radiculopathy

1.4

6.3

328

2401

J01FA09

ATC

clarithromycin; systemic

1.1

6.3

4226

39006

M24.9

ICD-10 Finland

Joint derangement, unspecified

2.2

6.3

254

JFB47

NOMESCO Finland

Laparoscopic resection of sigmoid colon

2.0

6.3

382

FN1AD

NOMESCO Finland

CT of coronary arteries

0.4

6.3

641

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

1.4

6.3

333

2447

AS4

Physiological pacemaker insertion DDD (R)

2.1

6.3

287

N05BA06

ATC

lorazepam; systemic, sublingual

1.3

6.3

374

2796

XJH10

NOMESCO Finland

Anorectal manometry

2.5

6.3

179

K02

ICD-10 Finland

Dental caries

1.2

6.2

825

6803

O99.89

ICD-10 Finland

Other specified diseases and conditions complicating pregnancy, childbirth and the puerperium

1.4

6.2

292

2100

PA2BD

NOMESCO Finland

Extensive CT angiography of brain

1.6

6.2

144

890

I49.3

ICD-10 Finland

Ventricular premature depolarization

1.3

6.2

541

4257

M32.9

ICD-10 Finland

Systemic lupus erythematosus, unspecified

2.0

6.2

371

F19.21

ICD-10 Finland

Addiction caused by several drugs in combination and by other psychoactive substances currently independent but staying in a controlling environment

2.3

6.2

236

K56.1

ICD-10 Finland

Intussusception

2.5

6.2

180

B20.1

ICD-10 Finland

HIV disease resulting in other bacterial infections

26.5

6.2

M10.3

ICD-10 Finland

Gout due to impairment of renal function

3.5

6.2

O41.0

ICD-10 Finland

Oligohydramnios

1.4

6.2

266

1881

Z11.3

ICD-10 Finland

Special screening examination for infections with a predominantly sexual mode of transmission

1.2

6.2

1076

9102

D06AX01

ATC

fusidic acid; topical (antibiotics for topical use)

1.2

6.2

1177

10033

XF600

NOMESCO Finland

Bloodpressure measurement

1.3

6.2

592

4713

F19.25

ICD-10 Finland

Addiction caused by several drugs in combination and by other psychoactive substances continuously used

2.4

6.2

199

R01AD58

ATC

fluticasone, combinations; inhalant, nasal

1.1

6.2

3094

28135

W17

ICD-10 Finland

Other fall from one level to another

1.3

6.2

486

3779

JJ1LE

NOMESCO Finland

Ultrasound elastography of liver

1.9

6.2

415

R4180

SPAT

3.3

6.1

N92.6

ICD-10 Finland

Irregular menstruation, unspecified

1.2

6.1

846

7009

I11.9

ICD-10 Finland

Hypertensive heart disease without (congestive) heart failure

1.5

6.1

187

1237

N31.9

ICD-10 Finland

Neuromuscular dysfunction of bladder, unspecified

2.0

6.1

366

G02BA03

ATC

plastic IUD with progestogen

1.1

6.1

1658

14524

S81.8

ICD-10 Finland

Open wound of other parts of lower leg

1.4

6.1

252

1770

PWE00

NOMESCO Finland

Reoperation for deep haemorrhage in surgery of peripheral vessels and lymphatic system

3.6

6.1

S83.2

ICD-10 Finland

Tear of meniscus, current

1.2

6.1

702

5712

A07EA02

ATC

hydrocortisone; rectal

1.4

6.1

225

1550

RJ414

NOMESCO Finland

3.2

6.1

SPAT1308

SPAT

Sexual health counselling

1.1

6.1

2818

25513

EB1WA

NOMESCO Finland

2.0

6.1

332

H53.9

ICD-10 Finland

Visual disturbance, unspecified

1.4

6.1

249

1747

NB1AE

NOMESCO Finland

Shoulder ultrasound examination

1.6

6.1

149

938

D02AE01

ATC

carbamide; topical

1.2

6.1

699

5683

L29.9

ICD-10 Finland

Pruritus, unspecified

1.5

6.1

210

1426

D39.10

ICD-10 Finland

Tumor of uncertain or unknown nature in the ovary without histology

1.5

6.1

198

1328

A52.9

ICD-10 Finland

Late syphilis, unspecified

12.4

6.0

TJA35

NOMESCO Finland

Removal of peritoneal dialysis catheter

2.5

6.0

177

S50.0

ICD-10 Finland

Contusion of elbow

1.4

6.0

312

2284

LEB00

NOMESCO Finland

Biopsy of vagina

1.6

6.0

158

1010

B97.2

ICD-10 Finland

Coronavirus as the cause of diseases classified to other chapters

8.5

6.0

M05.8

ICD-10 Finland

Other seropositive rheumatoid arthritis

1.3

6.0

387

2928

K92.2

ICD-10 Finland

Gastrointestinal haemorrhage, unspecified

1.5

6.0

167

1081

D11

ICPC

Diarrhoea

1.1

6.0

1618

14167

I79.2*E11.5

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic peripheral angiopathy

3.5

6.0

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(40767503) Oxygen content in Capillary blood by calculation

938

2386

4.04

321.05

2.7

2.3

17.1

17.0

0.27

461

1206

(3045424) Erythrocytes [Presence] in Urine

908

2272

4.10

317.81

1.7

1.4

—

(3026782) Osmolality of Urine

5835

25795

2.75

307.65

3.4

2.5

529.7

552.0

mosm/kgh2o

10.47

5309

21832

(3002385) Erythrocyte distribution width [Ratio]

17842

144095

2.92

307.65

20.5

13.1

13.4

0.49

17555

141282

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

2551

6978

4.00

307.65

2.0

1.4

—

(3021589) Normoblasts [#/volume] in Blood

13353

69225

3.68

307.65

12.1

8.4

0.0

e9/l

2.32

11910

56245

(3002179) Metamyelocytes/100 leukocytes in Blood

2795

10491

2.90

307.65

4.3

4.0

0.5

0.6

0.60

464

2136

(40761536) Microorganisms panel - Urine sediment

3438

13388

2.86

307.65

3.9

3.4

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

3028

12041

2.76

307.65

3.3

2.9

—

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

705

863

8.36

307.65

1.5

1.4

5.3

5.4

mmol/l

1.37

694

806

(3041096) Erythrocytes [Presence] in Urine by Automated

7764

44712

2.17

307.65

3.3

2.7

—

(1761868) Lipid panel - Serum or Plasma

9335

63081

1.87

307.65

2.5

2.3

—

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

476

613

7.86

307.65

13.4

4.4

1056.2

8069.0

u/ml

0.47

236

(42870588) Differential panel, method unspecified - Blood

8176

51840

1.95

307.65

8.4

6.1

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

4313

21236

2.29

307.65

3.6

2.6

4.4

3.4

e6/l

5.85

2993

10663

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

5922

35829

1.90

307.65

1.7

1.6

1.4

mmol/l

0.29

5011

31248

(3022689) Creatine [Moles/volume] in Urine

380

217

17.68

307.65

1.5

1.4

—

(3029937) Albumin [Presence] in Urine by Test strip

6896

40934

2.02

307.65

3.6

3.5

0.0

estimate

0.87

3780

14293

(3021440) Promyelocytes/100 leukocytes in Blood

3214

10735

3.34

307.65

5.5

4.1

0.1

2.56

626

2700

(3018095) Leukocytes [#/volume] in Urine

8487

51292

2.10

307.65

5.3

3.3

84.0

70.0

e6/l

0.80

6694

33782

(3017181) Myelocytes/100 leukocytes in Blood

3250

11294

3.21

307.65

5.5

4.1

0.7

0.9

1.93

632

2926

(3000034) Microalbumin [Mass/volume] in Urine

684

866

8.07

307.65

3.3

2.8

100.1

51.3

mg/l

2.03

482

638

(3025159) Blasts/100 leukocytes in Blood

3182

10210

3.48

307.65

5.5

4.2

0.0

0.2

1.49

593

2274

(3030981) Hyaline casts [#/volume] in Urine by Automated count

2382

5994

4.33

307.65

3.4

2.4

0.2

0.3

e6/l

0.66

2345

5773

(3002582) Erythrocytes [#/volume] in Urine

7344

41499

2.18

307.65

4.1

2.9

73.8

67.4

e6/l

0.13

6136

30946

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

582

272

21.82

307.65

2.3

2.1

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

17799

140330

3.13

307.65

4.3

3.6

—

(40758558) Short blood count panel - Blood

6117

38390

1.83

307.02

7.6

6.8

—

(3000850) Epithelial cells [#/volume] in Urine

4848

28703

1.89

290.25

3.1

2.4

6.9

6.8

e6/l

0.12

3920

25156

(3028271) Lactate [Moles/volume] in Capillary blood

760

1798

4.32

286.31

2.1

1.8

1.7

mmol/l

0.61

745

1755

(3013512) EKG study

5326

33108

1.81

269.34

3.4

3.1

—

(3021601) Nitrite [Presence] in Urine by Test strip

10452

78660

1.66

258.56

4.6

4.4

0.0

estimate

0.35

3886

14739

(3022096) Basophils/100 leukocytes in Blood

9816

72847

1.65

255.36

9.0

6.0

0.7

4.36

9381

68394

(3022217) INR in Platelet poor plasma by Coagulation assay

2541

12549

2.15

250.59

13.1

17.3

1.3

1.2

inr

0.62

134

2206

(3003338) MCHC [Mass/volume]

13393

154030

0.59

244.25

17.8

13.6

333.2

333.4

g/l

2.76

13263

152910

(3009261) Glucose [Presence] in Urine by Test strip

10435

79335

1.63

240.92

3.6

3.2

0.0

estimate

0.78

3790

14303

(3035350) Ketones [Presence] in Urine by Test strip

10351

78579

1.63

240.12

3.5

3.2

0.0

estimate

0.72

3411

14365

(3006504) Eosinophils/100 leukocytes in Blood

10004

75428

1.62

237.68

8.9

5.9

2.7

2.8

4.38

9528

70793

(3019069) Monocytes/100 leukocytes in Blood

10040

75857

1.62

235.79

9.1

6.2

8.4

8.2

8.26

9624

71679

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

2072

9681

2.25

233.71

4.0

3.6

1.2

mmol/l

6.77

1757

8533

(3030467) Casts [#/volume] in Urine by Automated count

5791

38327

1.70

227.68

3.7

2.9

0.3

e6/l

0.24

4600

28058

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

1861

8485

2.29

222.05

9.1

8.4

24.4

24.6

mmol/l

1.55

1845

8433

(3012501) Base excess in Blood by calculation

880

2745

3.28

220.93

3.6

3.8

2.0

2.3

mmol/l

3.42

559

1746

(3013290) Carbon dioxide [Partial pressure] in Blood

880

2746

3.28

220.80

3.6

3.8

5.0

kpa

1.50

863

2696

(40760892) CBC W Ordered Manual Differential panel - Blood

5839

39019

1.68

219.85

5.0

4.1

—

(3027315) Oxygen [Partial pressure] in Blood

880

2765

3.25

218.29

3.6

3.8

9.1

9.0

kpa

0.91

863

2714

(3002030) Lymphocytes/100 leukocytes in Blood

10299

79250

1.59

216.67

8.8

5.9

29.5

29.8

1.64

9873

74610

(3018010) Neutrophils/100 leukocytes in Blood

10143

78120

1.58

209.88

8.6

5.8

56.3

56.1

1.10

9723

73818

(3003458) Phosphate [Moles/volume] in Serum or Plasma

2986

16586

1.92

209.65

11.7

6.2

1.1

mmol/l

0.12

2878

15618

(3010421) pH of Blood

947

3189

3.04

208.75

3.5

3.8

7.4

0.52

863

2699

(21494815) CD4 cells/100 lymphocytes in Specimen

585

1452

4.08

206.30

2.5

2.4

36.2

43.9

2.32

213

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

857

2774

3.15

202.12

1.5

1.4

6.6

6.8

mmol/l

1.13

816

1851

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

8294

61414

1.57

200.61

3.4

3.2

—

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

406

794

5.15

192.59

2.9

2.7

35.5

42.5

5.75

108

291

(3044889) 12 lead EKG panel

12055

97767

1.55

189.38

3.5

3.0

—

(3022806) Fractional oxyhemoglobin in Capillary blood

580

1526

3.85

188.52

1.9

1.8

91.1

90.7

1.02

569

1506

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

977

3560

2.81

186.30

1.8

1.7

—

(3023368) Bacteria identified in Blood by Culture

4855

32260

1.65

180.33

5.6

4.0

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

480

15721

0.29

176.61

5.0

5.4

—

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

16722

147608

1.71

173.75

15.8

9.3

91.5

92.1

ml/min/173m2

3.36

14758

118917

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

13396

112384

1.54

170.50

9.0

6.8

75.7

75.3

u/l

0.47

12754

106169

(3013707) Erythrocyte sedimentation rate by Westergren method

13636

114958

1.54

168.61

4.9

3.7

9.9

9.6

mm/h

1.98

12855

107785

(3032080) INR in Blood by Coagulation assay

6558

47731

1.54

161.47

7.7

6.5

1.1

inr

14.22

3658

14634

(46235355) HIV 1 and 2 tests - Meaningful Use set

7404

55306

1.52

161.41

2.6

2.0

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

4207

27820

1.63

155.85

2.4

1.6

—

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

7662

57957

1.50

155.59

8.8

5.8

1.2

mmol/l

0.09

7131

53096

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

9180

72176

1.48

152.88

6.9

5.6

10.5

10.9

umol/l

2.70

8676

67995

(1616796) Gas panel - Central venous blood

771

2758

2.84

151.82

3.7

3.4

—

(3015235) Bicarbonate [Moles/volume] in Capillary blood

791

2913

2.76

147.38

4.5

3.3

23.8

24.3

mmol/l

3.20

713

2562

(3019832) Treponema pallidum Ab [Presence] in Serum

5144

36082

1.55

146.91

2.3

1.7

—

(3012095) Magnesium [Moles/volume] in Serum or Plasma

3287

20692

1.69

146.51

5.0

3.8

0.8

mmol/l

0.27

3099

19447

(3006315) Basophils [#/volume] in Blood

10024

80590

1.46

146.37

8.8

5.9

0.0

e9/l

2.99

8907

70736

(36304419) Bacteria [Presence] in Urine

5412

38429

1.54

146.09

3.7

2.8

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

1013

4246

2.44

144.69

8.4

5.5

1.5

1.3

mg/l

4.86

965

4017

(3001604) Monocytes [#/volume] in Blood

9984

80325

1.46

144.49

8.7

5.9

0.6

e9/l

5.78

8907

70574

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

262

447

5.88

144.16

2.6

1.5

—

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

8135

62986

1.47

143.38

2.7

2.3

75.0

1472.1

nmol/l

0.50

7666

58628

(3002256) Pathology report gross observation

2981

18379

1.71

143.26

1.3

1.2

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

597

15846

0.35

143.10

3.8

3.5

32.2

31.9

0.28

423

11757

(3013115) Eosinophils [#/volume] in Blood

10288

83456

1.45

141.21

9.2

6.1

0.2

e9/l

1.73

9341

74437

(3001122) Ferritin [Mass/volume] in Serum or Plasma

10143

82080

1.45

140.90

3.5

2.9

104.7

88.6

ug/l

6.34

9477

77822

(3019198) Lymphocytes [#/volume] in Blood

10283

83715

1.44

136.50

8.7

5.8

2.0

e9/l

0.54

9406

74944

(3013826) Glucose [Moles/volume] in Serum or Plasma

10355

84447

1.44

135.94

6.0

4.4

6.3

6.4

mmol/l

8.84

9786

76515

(3029634) Reagin Ab [Titer] in Serum by VDRL

810

3158

2.61

134.71

5.0

1.7

8.8

3.9

titre

1.40

(3024561) Albumin [Mass/volume] in Serum or Plasma

7431

57148

1.46

132.47

6.7

4.7

36.2

36.7

g/l

13.29

6971

53332

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

14857

130117

1.50

131.42

4.4

3.9

14.5

14.4

pmol/l

5.55

13751

120696

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

5738

42069

1.49

129.95

2.9

2.2

—

(3021901) Oxygen saturation in Capillary blood

596

2026

2.98

128.64

3.4

2.9

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

971

4234

2.34

126.62

1.7

1.8

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

1691

9139

1.91

125.07

1.9

1.8

—

(3037121) Protein [Mass/volume] in Urine

1018

4564

2.28

124.35

5.0

3.4

0.3

0.4

g/l

2.84

778

2069

(3013650) Neutrophils [#/volume] in Blood by Automated count

10993

91918

1.41

117.72

11.8

8.6

4.0

e9/l

0.00

9855

80739

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

417

1208

3.47

117.35

2.4

2.7

1553.6

803.7

e6/l

0.46

513

(3022145) Colonoscopy Study observation

2540

15831

1.68

115.14

1.4

—

(40761511) CBC panel - Blood by Automated count

18843

175889

1.90

114.94

14.7

10.0

—

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

8098

64562

1.41

112.62

10.4

6.3

1.2

mmol/l

0.06

6466

55140

(3004789) Transferrin [Mass/volume] in Serum or Plasma

2969

19382

1.61

111.63

3.5

2.4

g/l

6.22

2760

18093

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

669

2609

2.60

111.01

4.0

1.5

3358.7

3075.1

titre

0.09

125

(3021879) Hepatitis B virus core Ab [Presence] in Serum

2748

17639

1.63

110.63

2.0

1.5

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

137

154

8.88

109.79

16.2

8.4

5.4

5.8

mmol/l

0.48

137

154

(40768797) Stomach Pathology biopsy report

2863

18645

1.61

108.45

1.3

1.2

—

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

2731

17652

1.62

106.55

3.7

2.5

23.7

23.8

0.21

2473

15320

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

16638

151205

1.51

104.35

5.1

4.5

1.7

2.1

mu/l

6.22

15673

142475

(40761535) Cells panel - Urine sediment

376

10786

0.33

104.19

3.3

—

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

5887

44860

1.42

103.70

2.8

2.5

58.3

56.8

u/l

0.44

5406

41680

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

18019

166821

1.65

103.13

16.8

10.8

19.5

21.0

mg/l

9.13

14945

127399

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

6823

53404

1.40

102.92

4.0

3.1

31.0

32.0

u/l

0.80

6511

50900

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

5129

38204

1.44

102.05

2.8

2.1

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

1607

9098

1.82

101.78

1.3

236.0

228.2

miu/ml

0.38

827

4410

(3031040) Bacteria [#/volume] in Urine by Automated count

12109

104228

1.38

101.19

4.8

3.9

1206.8

1415.8

e6/l

0.21

224

1205

(3005719) IgG [Mass/volume] in Serum or Plasma

2013

12221

1.70

99.81

3.2

2.5

10.2

10.5

g/l

2.47

1840

11250

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

2177

13503

1.67

99.55

4.0

4.2

230.4

235.5

u/l

1.11

2099

12851

(3022948) Iron [Moles/volume] in Serum or Plasma

3139

21380

1.54

96.76

3.4

2.4

13.8

14.2

umol/l

2.75

2939

20006

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

299

790

3.79

96.54

1.8

1.5

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

1594

9186

1.78

94.87

1.8

1.7

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

414

1374

3.03

93.16

1.9

1.6

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

5916

45934

1.39

90.77

3.4

2.8

41.2

58.7

ng/l

0.61

2653

23638

(3007164) IgA [Mass/volume] in Serum or Plasma

5031

38008

1.42

90.52

1.7

1.4

2.2

g/l

0.26

3498

23987

(3013762) Body weight Measured

16.36

87.37

1.1

1.2

—

(3015377) Calcium [Moles/volume] in Serum or Plasma

5726

44487

1.39

86.61

3.5

3.1

2.3

mmol/l

4.07

5297

39795

(3028626) Oxygen [Partial pressure] in Capillary blood

809

3821

2.15

86.44

6.6

5.4

8.9

9.0

kpa

1.13

781

3595

(3026008) Bacteria identified in Urine by Culture

5314

40807

1.40

86.12

3.0

2.5

—

(3014111) Lactate [Moles/volume] in Serum or Plasma

1741

10585

1.69

85.20

11.3

7.5

1.2

1.3

mmol/l

3.03

1467

10263

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

590

2463

2.42

84.59

4.2

3.1

—

(3037467) Urinalysis macro (dipstick) panel - Urine

12579

110347

1.34

84.45

4.7

3.9

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

530

2124

2.51

83.01

1.8

1.5

—

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

3627

26204

1.45

82.18

3.1

2.8

1630.5

984.0

ng/l

5.12

3019

21585

(4035726)

1739

10676

1.67

81.88

1.5

1.4

—

(3028026) IgM [Mass/volume] in Serum or Plasma

1572

9418

1.71

81.08

2.3

1.8

1.2

1.3

g/l

0.18

1480

8733

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

310

8670

0.34

80.82

1.4

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

17231

159707

1.47

78.59

17.4

11.4

3.9

mmol/l

10.56

16769

155029

(3019550) Sodium [Moles/volume] in Serum or Plasma

17183

159218

1.46

78.07

17.1

11.3

139.4

139.6

mmol/l

14.93

16737

154970

(3018418) pH of Serum or Plasma

4899

37664

1.38

77.23

5.8

3.8

7.4

2.99

1650

6902

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

1062

5755

1.88

76.81

13.3

10.3

24.2

24.1

mmol/l

0.66

992

5438

(3045414) Leukocytes [Presence] in Urine

1181

6617

1.82

76.75

1.9

1.7

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

628

2811

2.25

76.63

2.6

2.1

133.7

132.3

g/l

0.78

534

2080

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

2281

15220

1.55

75.65

2.5

2.3

5701.4

6479.6

u/l

0.59

1122

5932

(3019225) pH of Specimen

571

11972

0.46

74.92

9.1

3.7

—

(3013727) Leukocytes other/100 leukocytes in Blood

168

357

4.70

72.40

3.4

3.3

48.3

51.4

0.85

163

348

(3042936) Bacteria identified in Isolate by Culture

2770

19451

1.48

71.68

2.4

1.9

—

(3036481) Cortisol [Moles/volume] in Serum or Plasma

2263

15312

1.52

70.03

2.3

2.1

359.4

375.5

nmol/l

3.10

2168

14119

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

206

536

3.84

68.09

1.8

1.5

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

16080

148109

1.37

68.04

3.8

3.6

5.6

5.7

mmol/l

13.31

14929

138599

(3027945) Reticulocytes/100 erythrocytes in Blood

1918

12600

1.56

67.76

4.0

2.9

1.7

0.25

1763

11306

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

1223

7209

1.73

66.52

1.6

1.5

—

(3020779) Urea [Moles/volume] in Serum or Plasma

1669

10661

1.60

66.46

14.0

8.3

9.4

8.0

mmol/l

13.14

1613

10252

(3025941) Bacteria identified in Stool by Culture

1640

10497

1.60

64.68

1.3

1.2

—

(3018677) aPTT in Platelet poor plasma by Coagulation assay

2742

19601

1.45

64.05

3.3

2.3

30.7

29.6

15.62

2671

19017

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

419

1699

2.48

64.02

1.9

1.5

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

5521

44262

1.33

63.70

1.4

1.3

1.2

1.7

u/ml

3.85

2169

12028

(3007461) Platelets [#/volume] in Blood

19689

189634

2.07

63.30

23.3

16.0

259.4

259.8

e9/l

0.46

19397

185474

(3023520) Reticulocytes [#/volume] in Blood

1420

8825

1.64

63.12

4.2

2.7

68.1

70.9

e9/l

1.88

924

6481

(3035941) MCH [Entitic mass]

19699

189840

2.07

62.01

23.1

15.9

30.1

30.0

0.66

19546

187869

(3024731) MCV [Entitic volume]

19700

189855

2.07

61.98

23.2

15.9

89.9

0.09

19543

187881

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

198

536

3.69

61.85

1.8

1.5

—

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

4631

36322

1.34

61.75

2.5

2.2

2.8

2.7

mg/l

1.76

4045

31362

(3026361) Erythrocytes [#/volume] in Blood

19701

189888

2.07

61.64

23.2

15.9

4.5

4.6

e12/l

17.41

19401

185379

(3037522) Nuclear Ab [Titer] in Serum

3218

23826

1.40

61.55

1.5

1.4

524.8

528.8

titre

0.04

596

4478

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

590

2821

2.11

60.95

2.1

1.9

0.0

g/l

0.21

557

2619

(3010813) Leukocytes [#/volume] in Blood

19702

189951

2.06

60.78

23.3

16.0

6.8

6.7

e9/l

3.42

19399

185396

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

2031

13819

1.51

60.68

3.0

2.5

33.0

41.4

u/l

1.50

1792

11881

(3000963) Hemoglobin [Mass/volume] in Blood

19703

189980

2.05

60.51

23.4

16.0

135.4

136.4

g/l

20.95

19548

188017

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

627

3088

2.05

59.83

2.5

2.1

0.6

0.7

g/l

0.10

565

2745

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

5576

45147

1.31

58.94

1.9

1.7

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

208

601

3.46

58.92

1.8

1.4

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

3532

26741

1.38

58.75

1.7

1.6

439.8

33792995.4

pmol/l

20.17

2702

23227

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

3136

23293

1.40

58.56

3.8

3.1

351.5

494.0

ng/l

0.86

1935

14280

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

1260

7788

1.64

57.08

1.5

—

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

927

5278

1.78

56.79

3.9

3.1

3.7

3.5

g/l

3.03

881

5018

(40768804) Tissue Pathology biopsy report

7378

62169

1.28

56.78

2.0

1.9

—

(3033658) Prothrombin time (PT) actual/Normal

4645

36948

1.32

55.10

5.6

3.8

92.9

94.0

2.48

4524

35945

(3048689) Calprotectin [Mass/mass] in Stool

3296

24952

1.37

54.36

2.9

2.6

131.6

117.9

ug/g

1.38

2514

19856

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

4712

37639

1.31

54.05

2.3

2.1

208.8

209.2

u/l

0.01

4453

35645

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

6243

51856

1.28

52.90

2.0

1.8

95.4

97.9

pmol/l

4.87

3531

28291

(3000991) Gas panel - Venous blood

1613

10791

1.52

51.83

14.9

8.8

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

459

2131

2.16

51.18

1.9

1.7

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

1537

10203

1.53

51.18

1.6

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

652

3439

1.91

51.05

2.2

2.0

3.0

g/l

0.13

438

2788

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

4396

35050

1.31

50.53

2.2

1.8

1.1

1.0

mg/l

0.65

3134

25842

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

1905

13261

1.47

50.32

1.9

1.6

—

(3050129) First trimester maternal screen panel - Serum or Plasma

910

14735

0.59

50.31

1.4

—

(3021960) Folate [Moles/volume] in Serum or Plasma

3610

28008

1.34

50.26

1.6

1.5

20.7

20.2

nmol/l

1.60

3213

24775

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

613

3188

1.94

50.08

1.4

1.3

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

954

5677

1.70

49.86

1.8

1.6

24.4

2.2

iu/ml

0.71

230

1119

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

615

3208

1.93

49.79

6.4

4.2

0.3

u/ml

0.21

328

1787

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

544

2724

2.01

49.58

1.4

1.2

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

2875

21580

1.37

49.55

3.0

2.7

2.4

mmol/l

9.66

2541

18790

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

544

2726

2.01

49.48

1.4

1.2

—

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

317

1277

2.48

49.20

1.2

1.3

1.9

mmol/l

0.22

304

1189

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

2730

20358

1.38

48.93

3.1

1.8

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

320

1301

2.46

48.69

2.6

2.3

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

623

3288

1.91

48.69

7.6

5.8

825.5

1269.5

iu/ml

0.36

417

(3020630) Protein [Mass/volume] in Serum or Plasma

1298

8391

1.57

48.60

2.5

2.3

65.8

67.0

g/l

6.47

1217

7798

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

504

2494

2.03

47.48

4.9

3.5

524.8

4939.4

u/ml

0.56

132

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

18329

174572

1.43

47.24

11.7

8.6

26.9

26.8

u/l

0.48

17805

169569

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

1337

8762

1.55

47.09

7.0

4.2

109.3

82.5

ng/l

11.97

1192

7853

(4034850)

158

4727

0.33

46.88

5.2

7.8

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

685

11662

0.57

45.69

1.5

1.4

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

685

11657

0.57

45.62

1.5

1.4

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

684

11599

0.57

44.94

1.5

1.4

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

656

3612

1.83

44.88

2.2

2.0

7.3

7.2

g/l

0.23

440

2838

(3004588) Protein electrophoresis panel - Serum or Plasma

1028

6411

1.62

44.72

2.4

2.0

—

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

655

3611

1.83

44.63

2.2

2.0

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

655

3611

1.83

44.63

2.2

2.0

3.8

g/l

0.24

435

2689

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

689

11627

0.57

44.43

1.4

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

3671

29007

1.31

44.20

1.3

28.3

29.3

iu/ml

0.15

1078

8777

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

737

4243

1.75

43.36

1.8

1.5

—

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

248

947

2.62

43.07

2.0

1.6

1625729.5

1575404.0

iu/ml

0.02

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

1882

13466

1.43

42.56

2.0

1.7

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

141

395

3.56

42.01

3.7

4.0

—

(3026493) Urate [Moles/volume] in Serum or Plasma

4336

35267

1.28

41.43

2.9

2.3

1420.2

2997.2

umol/l

5.06

3815

31556

(3048929) Epstein Barr virus Ab [Presence] in Serum

1281

8557

1.52

41.17

1.4

1.3

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

335

1500

2.24

40.94

7.5

6.8

11.1

10.7

mg/l

0.71

305

1405

(3011397) Hemoglobin [Presence] in Urine by Test strip

2923

36665

0.76

40.91

3.1

3.2

—

(3017569) Oxygen content in Arterial blood

141

403

3.49

40.76

2.0

2.3

—

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

1079

6972

1.56

40.34

10.2

5.1

24.0

mmol/l

0.12

1043

6349

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

4534

37205

1.27

40.08

1.6

1.5

—

(3024263) Appearance of Synovial fluid

179

598

2.99

40.05

3.6

1.7

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

3456

27430

1.30

39.73

1.3

15.2

9.8

u/ml

1.54

1488

11333

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

2249

16808

1.37

39.10

3.5

2.8

6.8

7.3

umol/l

0.65

1846

14361

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

565

3105

1.83

38.91

1.9

1.6

—

(3000012) Reticulocyte production index

164

531

3.08

38.76

1.5

1.4

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

550

3016

1.83

38.15

1.9

1.7

—

(3026250) Tacrolimus [Mass/volume] in Blood

208

776

2.68

37.90

44.9

37.8

7.2

7.5

ug/l

1.41

196

720

(3018133) Calcium [Moles/volume] in Urine

126

353

3.56

37.59

2.8

2.5

2.3

2.8

mmol/l

2.22

119

317

(3005322) IgE [Units/volume] in Serum or Plasma

1744

12614

1.41

36.85

1.4

1.3

243.6

253.1

u/ml

0.13

1628

11688

(40768446) Kidney Pathology biopsy report

186

667

2.78

36.61

2.1

1.7

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

490

2627

1.87

36.53

3.4

2.9

49.6

70.1

mg/l

0.46

358

2127

(3007853) Bacteria identified in Skin by Aerobe culture

2385

18168

1.34

36.45

2.0

1.7

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

489

2624

1.87

36.36

3.4

2.9

49.5

43.5

mg/l

0.18

358

2131

(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid

217

846

2.56

36.21

1.2

1.3

73.2

69.6

0.21

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

477

2547

1.88

36.02

3.4

2.9

3.5

2.1

ratio

0.33

240

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

14520

135288

1.23

35.48

5.0

4.5

37.8

38.0

mmol/mol

2.57

13593

128016

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

16458

155521

1.26

35.01

4.1

3.6

4.7

mmol/l

12.39

15457

147911

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

16361

154505

1.26

34.95

3.9

3.5

1.4

1.5

mmol/l

3.41

15318

146622

(3003694) ABO and Rh group [Type] in Blood

6504

56172

1.22

34.95

1.8

1.7

—

(3042631) Mycobacterium sp identified in Specimen

282

1258

2.24

34.85

2.9

2.5

—

(3000330) Specific gravity of Urine by Test strip

320

6283

0.50

34.13

2.9

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

5720

48873

1.22

33.96

1.8

1.7

—

(3043409) Potassium [Moles/volume] in Arterial blood

109

3306

0.32

33.27

2.7

4.2

3.9

3.8

mmol/l

0.36

3106

(3049717) Cytology report of Urine Cyto stain

557

3195

1.75

33.22

2.6

2.4

—

(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood

401

2079

1.93

33.15

1.2

1.1

1.8

2.0

iu/ml

0.08

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

115

330

3.47

33.13

6.8

6.6

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

662

3990

1.67

32.92

1.8

1.5

101.5

108.2

u/ml

0.47

157

825

(3043410) Blood group antigens tested for on Red Blood Cells

124

376

3.28

32.76

1.4

1.6

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

3200

25756

1.28

32.21

3.1

2.0

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

16554

156931

1.25

31.76

4.2

3.8

2.8

2.9

mmol/l

9.27

15420

148262

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

131

420

3.11

31.58

2.2

2.0

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

222

936

2.37

31.35

1.3

—

(3012565) Volume of 24 hour Urine

171

639

2.67

31.16

2.5

2.1

2213.7

2036.0

1.15

158

590

(3034891) Synovial lining cells/100 cells in Synovial fluid

154

554

2.77

30.22

1.6

1.5

5.6

3.8

0.46

132

(3044640) Blood type and Crossmatch panel - Blood

5608

48254

1.21

30.22

2.8

2.1

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

2560

20181

1.30

30.18

2.1

1.8

—

(3022621) pH of Urine by Test strip

625

9816

0.62

29.89

2.6

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

1645

12190

1.37

29.78

2.7

2.5

0.2

g/l

0.01

1541

11421

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

246

1111

2.21

29.58

1.7

1.5

35.8

34.9

0.12

138

711

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

680

4257

1.60

29.08

1.8

1.4

26.2

20.7

u/ml

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

293

1434

2.04

28.62

1.8

1.6

56.1

52.1

0.81

174

938

(3021788) Differential panel - Synovial fluid

400

2177

1.84

28.52

1.6

1.5

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

149

544

2.73

28.45

3.4

2.7

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

1000

6843

1.47

28.40

1.3

0.3

0.9

u/ml

3.93

586

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

774

5029

1.55

28.18

2.2

1.9

1.4

g/l

0.40

670

4371

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

1559

11565

1.36

27.98

3.5

3.4

4.6

pmol/l

0.58

1428

10420

(3024928) Oxygen saturation in Venous blood

460

2637

1.75

27.55

8.2

4.4

—

(3042733) HLA Ab [Presence] in Serum

156

593

2.62

27.54

5.8

4.7

—

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

1189

8453

1.42

27.51

6.8

4.3

5.0

5.1

kpa

2.86

1144

7900

(40760888) Immunoglobulin light chains.free panel - Serum

368

1974

1.86

27.49

3.5

3.0

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

295

1469

2.01

27.49

1.8

1.4

—

(21494814) CD8 cells/100 lymphocytes in Specimen

153

577

2.64

27.44

2.1

2.0

—

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

138

498

2.76

26.98

1.3

1.2

15.2

17.5

0.14

(3004809) Band form neutrophils/100 leukocytes in Blood

360

1931

1.86

26.91

3.3

3.0

1.5

1.3

0.28

319

1467

(3043238) Trisomy 21 risk [Likelihood] in Fetus

625

9577

0.64

26.75

1.5

—

(3011648) Oxygen content in Venous blood

237

1099

2.15

26.73

10.5

4.5

11.5

11.3

0.34

237

1099

(3016650) Hepatitis A virus Ab [Presence] in Serum

525

3155

1.67

26.46

1.1

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

608

3800

1.60

26.20

1.7

1.5

20.4

25.9

e6/l

0.44

442

2934

(3012920) Ethanol [Mass/volume] in Serum or Plasma

9.08

26.19

1.6

1.2

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

362

1963

1.84

26.15

1.3

1.1

—

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

283

1414

2.00

26.14

2.4

2.2

11.3

12.4

0.82

130

824

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

608

3802

1.60

26.14

1.7

1.5

1336.1

2118.7

e6/l

0.24

511

3053

(3005033) Fetal Nuchal fold Thickness US

611

9359

0.64

26.10

1.5

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

613

9372

0.64

25.96

1.5

—

(3020961) Endomysium IgA Ab [Titer] in Serum

1391

10256

1.37

25.89

1.1

336.4

196.3

titre

0.52

292

(3016018) Differential panel - Cerebral spinal fluid

349

1879

1.86

25.80

1.7

1.5

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

264

1295

2.04

25.68

1.3

0.8

1.0

u/ml

0.31

514

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

251

4860

0.51

25.67

6.5

3.9

53.3

50.2

0.99

234

4803

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

1938

15046

1.31

25.37

1.3

1.2

124.6

146.5

iu/ml

1.23

754

5742

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

312

1635

1.91

25.09

1.8

1.4

—

(3013293) Extractable nuclear Ab [Presence] in Serum

225

3.58

24.63

1.7

1.8

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

1130

8127

1.40

24.43

6.8

4.3

1.6

1.3

mmol/l

1.68

742

5846

(3035637) Corticotropin [Mass/volume] in Plasma

375

2103

1.78

24.29

1.6

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

383

2166

1.77

24.11

1.8

1.4

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

538

3332

1.62

24.10

2.8

2.5

—

(3036782) Glucose [Moles/volume] in Pleural fluid

181

786

2.30

24.01

1.3

6.2

6.1

mmol/l

0.30

164

727

(3042111) Morphology [Interpretation] in Bone marrow Narrative

305

1613

1.89

23.88

1.8

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

847

5818

1.46

23.59

4.4

2.8

93.2

93.7

0.28

769

5431

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

15673

148868

1.19

23.42

3.5

3.3

1.3

mmol/l

0.10

14687

140935

(3020891) Body temperature

234

4490

0.51

23.29

3.1

4.8

—

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

189

847

2.22

23.28

2.0

1.7

3.5

mg/l

0.07

183

804

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

173

747

2.31

23.28

2.6

2.9

1.3

ug/l

0.07

167

705

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

667

4377

1.53

23.24

1.5

1.3

256.8

244.2

u/ml

0.59

448

2764

(3017446) Testosterone [Moles/volume] in Serum or Plasma

1590

12153

1.32

23.23

2.3

2.1

12.2

11.8

nmol/l

1.14

1402

10900

(3009343) pH of Capillary blood

1150

8369

1.38

23.17

6.8

4.3

7.4

1.00

259

929

(3004451) EKG impression Narrative

116

417

2.77

22.92

1.3

1.2

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

1699

13130

1.31

22.92

1.4

20.9

22.7

iu/l

1.61

1463

11196

(3020650) Glucose [Presence] in Urine

127

479

2.64

22.86

1.7

1.3

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

312

3.06

22.75

1.4

1.2

—

(3000494) Fungus identified in Specimen by Culture

2164

17270

1.27

22.72

1.5

1.4

—

(3037756) Immunofixation for Serum or Plasma

311

1683

1.85

22.68

1.8

1.6

—

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

492

3032

1.62

22.51

1.6

7.3

7.5

mmol/l

1.83

406

1725

(3010375) cycloSPORINE [Mass/volume] in Blood

170

740

2.29

22.46

29.9

26.1

120.4

123.4

ug/l

0.20

138

622

(3003181) Sodium [Moles/volume] in Urine

312

1703

1.83

22.15

1.6

68.1

66.9

mmol/l

0.16

240

1357

(3002173) Hemoglobin [Mass/volume] in Arterial blood

1373

10358

1.34

21.94

11.0

8.5

120.6

123.2

g/l

5.13

1314

9977

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

237

1186

1.99

21.89

1.2

1.1

—

(21494755) Public health laboratory ask at order entry panel

2090

25510

0.79

21.80

1.3

—

(3011412) CD3 cells [#/volume] in Blood

319

1763

1.81

21.75

2.7

2.5

1.3

e9/l

0.45

217

1022

(3052851) Hemolysis interference index of Serum or Plasma

627

4132

1.52

21.44

3.6

2.8

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

882

6227

1.42

21.20

13.5

10.2

—

(4198724)

267

1408

1.89

21.15

3.3

2.4

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

775

5348

1.45

21.08

3.4

2.8

185.1

171.2

4.52

728

5082

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

114

425

2.67

21.04

1.2

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

3181

37019

0.82

21.00

3.0

2.1

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

687

4635

1.49

20.98

1.4

1.3

—

(4062490)

324

1821

1.78

20.90

1.5

1.3

—

(3023410) Appearance of Cerebral spinal fluid

324

1822

1.78

20.86

2.2

1.8

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

461

2851

1.62

20.82

2.0

1.9

37.8

38.6

g/l

1.73

411

2530

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

484

3036

1.60

20.62

1.1

—

(3003396) Base excess in Arterial blood by calculation

1614

12562

1.30

20.59

10.4

7.6

0.5

0.8

mmol/l

2.58

1312

9605

(3027801) Oxygen [Partial pressure] in Arterial blood

1611

12548

1.30

20.43

10.6

7.6

12.9

13.2

kpa

1.45

1542

11987

(3013005) Retinol [Moles/volume] in Serum or Plasma

195

933

2.08

20.40

2.4

2.2

1.9

umol/l

0.82

190

876

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

1611

12554

1.30

20.35

10.6

7.6

5.1

kpa

1.99

1545

11993

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

151

653

2.30

20.32

1.2

—

(3044242) Glucose [Moles/volume] in Arterial blood

120

470

2.54

20.07

1.9

2.2

—

(3009508) Creatinine [Moles/volume] in Urine

4689

40912

1.18

19.92

4.0

3.3

8.0

8.6

mmol/l

0.90

3976

35564

(40768795) Lymph node Pathology biopsy report

240

1252

1.91

19.69

1.3

1.2

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

426

2622

1.62

19.65

2.1

2.0

0.0

g/l

1.01

400

2425

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

317

1808

1.75

19.47

1.8

1.4

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

421

2593

1.62

19.37

2.1

2.0

0.0

g/l

0.00

399

2421

(3036489) Thrombin time

901

6489

1.39

19.32

3.3

2.4

21.8

21.1

2.16

767

5519

(3013139) Helicobacter pylori Ag [Presence] in Stool

1397

10765

1.31

19.17

1.3

1.2

—

(3014576) Chloride [Moles/volume] in Serum or Plasma

1834

14647

1.27

19.00

11.0

7.3

104.8

104.7

mmol/l

0.51

1786

14358

(3009214) Lutropin [Units/volume] in Serum or Plasma

1085

8082

1.35

18.85

1.4

8.9

u/l

0.01

917

6573

(1761482) Bacteria [#/volume] in Urine by Culture

406

2501

1.62

18.68

2.2

3.6

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

331

1936

1.71

18.60

4.1

3.5

864.8

424.5

u/ml

0.38

310

1787

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

138

3.89

18.60

1.1

—

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

636

4330

1.47

18.59

1.6

1.4

480.4

463.0

mg/l

0.25

603

4136

(3014891) Appearance of Pleural fluid

4.90

18.48

2.4

1.6

—

(3023419) Bacteria identified in Sputum by Culture

238

1267

1.87

18.38

3.0

2.7

—

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

757

5340

1.42

18.31

2.1

1.8

0.2

g/l

1.53

723

5108

(4281824)

252

1372

1.83

18.14

1.2

1.1

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

579

3893

1.49

18.03

2.2

2.0

1.6

2.1

ug/l

0.76

528

3461

(3025315) Body weight

107

4.27

17.97

5.4

3.3

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

498

3255

1.53

17.76

1.3

—

(3028707) Methadone [Presence] in Urine by Screen method

821

5909

1.39

17.69

4.0

2.9

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

362

5694

0.62

17.42

2.5

2.0

—

(3016502) Oxygen saturation in Arterial blood

1418

11090

1.29

17.37

11.5

8.2

95.3

96.1

3.82

1378

10649

(3003327) Ova and parasites identified in Stool by Light microscopy

944

6973

1.36

17.33

1.9

1.7

—

(3045142) Bone marrow Pathology biopsy report

222

1180

1.88

17.27

1.4

—

(3040151) Glucose [Moles/volume] in Capillary blood

259

1450

1.78

17.03

2.8

8.9

6.9

7.2

mmol/l

0.43

235

1178

(3035947) Staphylolysin Ab [Units/volume] in Serum

147

680

2.15

16.89

1.2

1.1

3.8

3.9

iu/ml

0.02

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

687

4836

1.42

16.83

1.9

1.6

366.5

302.9

titre

0.18

169

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

329

1982

1.66

16.60

1.3

0.2

nmol/l

0.03

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

267

2.87

16.41

1.3

1.4

68.5

58.9

1.45

225

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

251

2.93

16.41

1.4

1.3

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

325

5162

0.62

16.33

2.5

1.8

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

322

1938

1.66

16.31

1.4

1.7

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

298

1760

1.69

16.23

1.3

—

(3028192) IgG subclass 2 [Mass/volume] in Serum

306

1822

1.68

16.16

1.4

1.3

2.6

2.9

g/l

2.22

184

1313

(3024139) IgG subclass 3 [Mass/volume] in Serum

306

1822

1.68

16.16

1.4

1.3

0.3

0.4

g/l

5.52

185

1313

(3027135) IgG subclass 1 [Mass/volume] in Serum

306

1822

1.68

16.16

1.4

1.3

6.3

6.7

g/l

1.11

185

1307

(3021387) Prolactin [Units/volume] in Serum or Plasma

1420

11219

1.27

16.02

1.6

301.5

313.8

mu/l

0.72

1189

10104

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

761

5507

1.38

15.90

2.1

1.8

1.2

g/l

0.13

727

5272

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

395

2516

1.57

15.87

1.3

1.2

93.3

172.9

titre

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

435

2838

1.53

15.70

1.7

1.6

0.6

0.7

g/l

1.01

299

2195

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

145

688

2.10

15.64

1.2

1.1

—

(3018405) Lactate [Moles/volume] in Arterial blood

223

3849

0.57

15.61

2.6

4.0

1.5

1.4

mmol/l

0.41

212

3787

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

5.12

15.57

1.0

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

707

5079

1.39

15.44

1.2

1.1

—

(3012441) Differential panel - Pleural fluid

159

788

2.01

15.26

1.5

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

549

3782

1.45

15.17

1.4

285.4

291.2

ug/g

0.25

332

2022

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

157

778

2.01

15.08

1.8

1.7

—

(3003434) Protein [Mass/volume] in Pleural fluid

188

996

1.88

14.85

1.4

33.2

34.6

g/l

0.70

162

912

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

322

1990

1.61

14.73

1.3

0.5

1.2

nmol/l

0.62

309

1924

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

313

2.60

14.59

1.3

1.2

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

551

3829

1.44

14.55

1.5

1.4

3.6

mmol/l

0.58

525

3596

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

179

3.16

14.47

4.5

3.5

—

(3011985) Renin [Units/volume] in Plasma

317

1962

1.61

14.43

1.6

1.7

64.6

66.1

mu/l

0.05

284

1786

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

235

1345

1.74

14.40

1.3

1.2

76.2

69.4

u/l

0.21

185

913

(3009542) Hematocrit [Volume Fraction] of Blood

16087

164040

0.87

14.35

16.5

11.6

40.6

40.3

6.80

12921

133919

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

649

8783

0.72

14.30

1.6

2.0

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

179

948

1.88

14.18

4.5

4.1

—

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

140

682

2.04

14.13

1.3

708.1

410.8

u/l

0.40

128

656

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

12512

118430

1.12

14.04

3.3

2.9

40.1

39.1

u/l

0.81

11840

113149

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

864

6504

1.33

14.02

2.0

37.5

39.8

u/l

3.14

795

5987

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

308

1909

1.61

13.96

1.3

—

(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection

107

3.81

13.80

4.9

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

792

5903

1.34

13.75

1.4

1.3

—

(3019309) Folate [Moles/volume] in Red Blood Cells

2396

20309

1.19

13.75

2.0

1.7

1301.3

1159.6

nmol/l

10.54

1742

15902

(3011288) Drugs identified in Urine by Screen method

1212

9570

1.27

13.74

4.3

3.0

—

(3014007) Fractional oxyhemoglobin in Arterial blood

912

6948

1.32

13.61

15.5

9.8

94.3

94.2

0.13

906

6922

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

241

1412

1.70

13.61

1.4

1.3

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

2495

21255

1.19

13.50

1.5

—

(3027273) Bicarbonate [Moles/volume] in Venous blood

355

5284

0.66

13.30

9.1

3.5

24.5

25.2

mmol/l

2.43

297

5112

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

1489

0.37

13.28

2.0

1.9

32.9

23.7

mg/l

0.43

402

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

302

1887

1.60

13.26

2.4

2.5

21.9

21.3

nmol/l

0.41

295

1803

(3026389) Candida sp identified in Specimen by Organism specific culture

375

2464

1.52

13.17

1.3

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

360

2.40

13.12

1.7

1.6

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

337

2169

1.55

13.02

1.8

1.6

—

(40768806) Pleura Pathology biopsy report

153

793

1.92

12.99

1.4

1.5

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

489

3405

1.43

12.82

2.1

2.0

10.1

10.3

g/l

0.64

438

2931

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

1263

10106

1.26

12.80

4.3

3.9

16.6

24.9

ug/l

0.56

971

7626

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

104

3.72

12.75

4.8

4.9

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

555

3961

1.40

12.67

1.3

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

360

2366

1.52

12.65

1.9

1.6

—

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

112

525

2.12

12.57

1.2

19.0

13.6

u/l

0.66

100

489

(3017986) Aspergillus versicolor IgE Ab [Units/volume] in Serum

7.44

12.55

1.1

1.0

—

(3038515) Glucose [Moles/volume] in Venous blood

2014

0.48

12.44

4.6

2.8

7.1

7.3

mmol/l

0.33

1975

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

130

3.36

12.37

1.4

1.3

—

(40768793) Breast Pathology biopsy report

470

3275

1.43

12.30

1.3

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

475

3319

1.43

12.24

1.1

1.2

—

(3016976) Cortisol [Moles/volume] in Serum or Plasma --baseline

9.92

12.11

1.2

1.1

248.5

247.1

nmol/l

0.01

(3032567) Hepatitis B virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

437

2.21

12.05

2.0

1.6

608.2

269.5

iu/ml

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

287

1816

1.58

11.99

1.4

302.4

360.0

pmol/l

1.11

230

1425

(40768443) Skin Pathology biopsy report

783

5954

1.32

11.88

1.2

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

442

3066

1.44

11.87

1.6

1.4

—

(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma

123

611

2.00

11.85

1.9

1.8

149.9

142.6

au/ml

0.05

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

116

566

2.04

11.75

2.2

1.7

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

116

566

2.04

11.75

2.2

1.7

—

(3007566) Smooth muscle Ab [Titer] in Serum

632

4676

1.35

11.58

1.5

1.3

96.2

121.5

titre

0.55

444

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

1780

20788

0.83

11.55

1.6

—

(3042517) Benzodiazepines panel - Urine

388

2.25

11.54

3.5

3.0

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

213

1268

1.67

11.42

1.7

1.5

—

(3009445) Proteinase 3 Ab [Units/volume] in Serum

780

5962

1.31

11.41

1.6

12.4

11.5

u/ml

0.09

186

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

323

2124

1.52

11.38

1.3

1.4

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

218

1308

1.66

11.35

1.2

1.1

ratio

0.17

120

439

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

143

760

1.87

11.32

1.3

1.2

109.8

91.6

u/l

0.57

129

676

(3047189) Immunofixation for 24 hour Urine

379

2.26

11.30

1.9

1.7

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

3265

28775

1.15

11.29

4.3

4.0

3.4

2.5

ug/l

0.42

2937

26222

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

139

737

1.88

11.09

1.3

1.2

26.5

19.2

u/l

0.58

123

643

(3035285) Chloride [Moles/volume] in Venous blood

1152

0.35

11.05

3.1

2.1

106.6

105.6

mmol/l

0.94

1140

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

208

1242

1.67

11.04

3.0

2.5

100.2

97.6

0.57

195

1145

(3009871) Measles virus Ab [Titer] in Serum

124

637

1.94

10.89

1.7

—

(4027681)

230

1416

1.62

10.83

1.5

1.2

—

(3041354) Potassium [Moles/volume] in Venous blood

1153

0.36

10.78

3.1

2.1

4.0

mmol/l

0.05

1141

(3046861) Legionella sp Ag [Presence] in Urine

5.34

10.73

1.2

1.0

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

853

10669

0.78

10.68

2.0

1.8

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

1117

0.35

10.66

3.2

2.1

—

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

115

581

1.97

10.62

1.6

1.2

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

996

12205

0.80

10.45

1.5

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

343

4894

0.69

10.40

1.6

1.5

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

161

2.90

10.39

1.8

1.6

—

(3023183) Ammonium ion [Moles/volume] in Plasma

397

2776

1.43

10.27

3.2

3.1

33.5

34.7

umol/l

0.52

349

2406

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

544

4011

1.35

10.25

2.8

2.4

739.0

483.4

ug/l

0.23

493

3680

(3044290) Cell count panel - Cerebral spinal fluid

499

3634

1.37

10.17

1.7

1.5

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

1314

10826

1.22

10.15

3.2

2.2

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

448

3212

1.39

10.05

1.4

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

144

798

1.80

10.02

1.7

1.6

8.1

5.2

u/l

1.34

374

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

400

2816

1.42

9.98

2.3

2.6

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

1944

16621

1.18

9.97

3.0

2.6

0.7

ug/l

0.95

1228

9443

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

131

707

1.84

9.94

1.1

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

1084

8775

1.24

9.93

2.9

2.7

25.2

38.7

u/ml

7.18

1047

8467

(3019150) Specific gravity of Urine by Refractometry

3878

34839

1.13

9.86

3.1

3.4

1.0

kg/l

0.18

269

5355

(4024509)

1204

0.40

9.84

1.6

1.5

—

(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine

283

2.35

9.77

2.9

2.6

18.1

31.4

mg/l

0.86

(3008037) Lactate [Moles/volume] in Venous blood

123

2178

0.56

9.64

4.2

2.7

1.3

1.5

mmol/l

1.45

117

2128

(3001019) Free T4 and TSH panel - Serum or Plasma

1085

13055

0.81

9.59

1.5

1.6

—

(3000475) Leukocytes [#/volume] in Synovial fluid

396

2807

1.41

9.52

1.9

1.7

10651.8

11531.9

e6/l

0.25

248

2074

(3027944) Amphetamines [Presence] in Urine

1623

13726

1.19

9.47

2.8

2.0

—

(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis

227

2.49

9.46

5.9

5.0

44.2

43.1

ug/min

0.04

156

(3011325) HIV 1+2 Ab [Presence] in Serum

3.45

9.45

1.0

1.1

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

367

2579

1.42

9.28

1.2

1.3

—

(3051651) Icteric interference index of Serum or Plasma

152

877

1.72

9.25

4.3

3.6

—

(3029856) Leukocytes [#/volume] in Peritoneal dialysis fluid

3.46

9.18

13.7

8.7

244.3

420.8

e6/l

0.35

(3016879) Cocaine [Presence] in Urine

1530

12910

1.19

9.16

3.0

2.1

—

(3020682) Albumin/Creatinine [Ratio] in Urine

3752

33778

1.12

9.13

4.9

4.1

20.5

10.1

mg/mmol

1.64

2519

22261

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

244

2.40

9.05

1.3

1.2

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

119

644

1.84

9.00

6.2

4.9

3041.1

2980.5

mg/l

0.01

483

(3028029) Mesothelial cells/100 leukocytes in Pleural fluid

110

3.16

9.00

1.3

1.5

14.7

10.4

0.42

(3034770) Mitochondria Ab [Titer] in Serum

598

4562

1.31

8.96

1.4

1.3

660.9

935.2

titre

0.53

124

(3008898) HLA-B27 [Presence]

1000

8123

1.23

8.90

1.1

—

(3024471) HLA-A [Type]

112

599

1.86

8.81

1.0

—

(3021691) Plasmodium malariae Ab [Titer] in Serum

7.94

8.77

2.3

2.5

—

(3024932) HLA-DR beta [Type]

110

589

1.86

8.63

1.1

—

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

499

3732

1.33

8.62

2.0

1.9

197.7

187.6

pmol/l

1.09

475

3571

(1617658) Protocol used for examination of sentinel lymph nodes

158

941

1.67

8.59

1.1

1.0

—

(3000764) Benzodiazepines [Presence] in Urine

1627

13877

1.18

8.58

3.0

2.1

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

217

1397

1.55

8.56

1.3

166.6

215.4

titre

0.43

250

(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum

217

1397

1.55

8.56

1.3

88.6

181.3

titre

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

191

2.55

8.54

1.8

1.6

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

119

3.00

8.53

4.6

3.2

—

(4146454)

1043

0.41

8.45

2.8

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

2960

26383

1.13

8.44

1.8

1.4

3.84

2581

23908

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

137

789

1.73

8.44

2.2

2.1

8.8

9.4

mg/l

0.65

100

651

(3027008) Opiates [Presence] in Urine

1634

13967

1.17

8.40

3.0

2.1

—

(21494890) Protein electrophoresis panel - 24 hour Urine

150

890

1.68

8.29

1.9

—

(40757494) Bilirubin.total [Moles/volume] in Blood

678

0.28

8.26

2.6

2.5

123.4

63.7

umol/l

—

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

990

0.40

8.26

1.1

4.7

13.2

u/ml

—

189

(3028300) Cannabinoids [Presence] in Urine

1635

14001

1.17

8.21

3.0

2.1

—

(3013466) aPTT in Blood by Coagulation assay

128

2.87

8.11

1.1

36.2

36.1

0.04

106

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

234

1552

1.50

8.07

1.1

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

675

5307

1.27

8.05

2.6

1.9

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

285

1968

1.44

8.01

1.2

—

(3000492) Spirometry study

1961

17067

1.15

7.96

1.4

—

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

167

1034

1.61

7.83

1.2

4.6

14.3

u/ml

—

130

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

230

1530

1.50

7.83

1.6

1.5

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

280

2.20

7.82

1.1

1.2

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

1370

0.50

7.74

1.2

1.4

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

697

8581

0.80

7.68

2.0

2.1

11.5

7.3

ug/l

1.98

593

7576

(3014051) Protein [Presence] in Urine by Test strip

236

3401

0.68

7.68

2.5

2.0

—

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

150

911

1.64

7.62

3.3

2.8

140.4

130.8

au/ml

0.09

131

(3020876) Protein [Mass/time] in 24 hour Urine

155

953

1.62

7.50

2.2

2.0

1.1

1.3

g/24h

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

1364

11599

1.18

7.48

1.1

—

(3016750) Collection duration of Urine

113

641

1.75

7.40

2.5

2.2

498.2

505.8

min

0.35

526

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

533

4115

1.29

7.38

2.0

2.1

9.7

10.5

mg/l

1.40

498

3877

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

722

5783

1.25

7.37

1.7

41.1

40.7

nmol/l

0.13

713

5667

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

195

1270

1.53

7.37

1.3

1.4

10.9

11.1

umol/l

0.16

184

1220

(3051611) Lipemic interference index of Serum or Plasma

201

1318

1.52

7.36

3.9

3.3

—

(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum

224

2.31

7.36

1.6

1.7

1.9

mg/l

0.11

149

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

748

6019

1.24

7.33

2.3

—

(3005665) Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum

219

2.31

7.27

1.6

1.7

3.9

1.9

mg/l

1.03

150

(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum

219

2.31

7.27

1.6

1.7

1.8

1.0

mg/l

0.41

140

(36204094) Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum

219

2.31

7.27

1.6

1.7

2.8

2.6

mg/l

0.07

152

(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum

219

2.31

7.27

1.6

1.7

5.3

3.4

mg/l

0.86

137

(3006665) Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum

219

2.31

7.27

1.6

1.7

1.9

2.2

mg/l

0.16

159

(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum

219

2.31

7.27

1.6

1.7

0.8

1.0

mg/l

0.20

147

(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum

219

2.31

7.27

1.6

1.7

2.5

1.7

mg/l

0.45

141

(36204005) Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum

219

2.31

7.27

1.6

1.7

4.8

2.6

mg/l

1.14

149

(3000899) Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum

219

2.31

7.27

1.6

1.7

1.8

1.7

mg/l

0.09

158

(3034274) Bile acid [Moles/volume] in Serum --fasting

611

4819

1.27

7.14

2.6

2.3

5.3

6.0

umol/l

0.93

395

3599

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

590

0.29

7.10

1.4

1.2

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

814

6634

1.23

7.09

1.6

1.7

—

(3041184) Isoniazid [Presence] in Urine

6.82

7.07

2.8

2.2

—

(3022764) Mononuclear cells/100 leukocytes in Peritoneal fluid

4.67

7.07

3.5

10.4

43.2

45.4

—

(3016135) IgD [Mass/volume] in Serum

4.33

6.86

1.2

37.5

58.7

mg/l

0.58

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

208

1396

1.48

6.84

3.0

2.6

855.2

523.1

e6/l

1.05

160

1140

(3016038) Potassium [Moles/volume] in Urine

123

732

1.67

6.81

1.7

1.6

35.2

34.5

mmol/l

0.11

110

649

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

815

6672

1.22

6.80

1.8

1.5

—

(3037556) Urate [Mass/volume] in Serum or Plasma

313

0.19

6.80

1.0

1.3

—

(21491868) Cryoglobulin [Mass/volume] in Serum

556

1.77

6.75

1.1

1.2

1.1

0.2

g/l

—

(3021447) Carbon dioxide [Partial pressure] in Venous blood

1371

11766

1.17

6.73

10.3

4.5

5.9

5.8

kpa

0.39

1283

11405

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

454

5771

0.78

6.60

10.1

4.7

24.1

24.5

mmol/l

2.81

445

5470

(42870560) Thyrotropin [Units/volume] in Cord blood

382

1.92

6.60

1.0

8.9

8.8

mu/l

0.05

327

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

1180

0.51

6.58

1.4

1.2

65.4

45.9

u/ml

—

(3004437) Lymphocytes/100 leukocytes in Peritoneal fluid

3.18

6.58

2.0

1.7

61.8

55.8

0.30

(40762365) Oxygen content in Arterial blood by calculation

168

2.42

6.52

2.9

2.8

15.0

14.8

ml/dl

0.14

158

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

1175

0.51

6.50

1.4

1.2

53.8

60.4

u/ml

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

149

946

1.57

6.38

1.2

1.1

—

(3012544) pH of Venous blood

1402

12112

1.16

6.32

10.2

4.5

7.4

0.32

(3038026) Centromere Ab [Units/volume] in Serum

1202

0.53

6.31

1.4

1.2

46.5

45.0

u/ml

—

(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay

1135

0.51

6.28

1.4

1.2

7.6

11.4

u/ml

—

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

155

997

1.55

6.27

3.9

3.4

9.0

8.2

mg/l

0.56

107

815

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

178

1181

1.50

6.24

1.6

1.5

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

397

1.88

6.23

1.6

1.5

—

(3032773) Endomysium IgG Ab [Titer] in Serum

259

1846

1.40

6.21

1.1

—

42.5

titre

—

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

246

1739

1.41

6.19

1.1

248.6

233.4

mg/l

0.18

200

1538

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

444

3435

1.29

6.13

1.1

—

(3023199) Leukocytes [#/volume] in Pleural fluid

146

937

1.55

5.99

1.5

1.4

13771.4

2719.4

e6/l

0.66

680

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

3.72

5.99

1.0

—

(3002032) Base excess in Venous blood by calculation

1354

11718

1.16

5.97

10.5

4.5

1.2

1.7

mmol/l

4.30

1111

9439

(3004616) Nuclear Ab [Presence] in Serum

126

1950

0.64

5.95

1.4

1.3

—

(3050794) Legionella sp Ab [Presence] in Serum

111

2.68

5.89

1.1

—

(3019060) Gas panel - Arterial blood

571

6967

0.81

5.88

3.9

4.9

—

(40761895) Polymorphonuclear cells/100 leukocytes in Peritoneal dialysis fluid

14.87

5.87

1.9

2.3

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

334

2502

1.33

5.86

6.3

5.3

373.3

377.4

umol/l

0.21

299

2200

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

568

4554

1.24

5.84

1.4

1.5

0.3

0.5

nmol/l

4.50

419

3740

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

302

1.97

5.81

1.3

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

1266

14383

0.86

5.80

1.4

1.3

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

173

1160

1.48

5.80

1.1

1.0

u/l

0.26

496

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

325

2431

1.33

5.77

1.2

—

(3043138) Epithelial cells.renal [#/area] in Urine by Computer assisted method

3.87

5.63

1.1

1.3

1.2

u/field

0.22

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

248

1793

1.38

5.51

1.2

46.7

39.6

mg/l

0.29

167

1517

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

141

918

1.53

5.47

1.1

1.2

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

665

5464

1.21

5.43

1.3

1.2

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

527

1.70

5.39

1.7

1.5

—

(40768800) Prostate Pathology biopsy report

204

1437

1.41

5.31

1.3

1.2

—

(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid

185

2.20

5.31

1.3

1.4

25.8

25.4

0.02

158

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

3.69

5.28

1.3

1.1

—

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

124

2.48

5.25

1.0

1.1

—

(3020393) Adenovirus Ag [Presence] in Stool

279

1.96

5.24

2.1

1.5

—

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

2.89

5.20

3.0

3.4

—

(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection

2.89

5.20

7.7

6.6

—

(40768441) Liver Pathology biopsy report

165

1122

1.46

5.20

1.5

1.4

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

458

3638

1.25

5.17

3.6

108.5

1668.3

u/ml

1.34

391

3138

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

235

1707

1.37

5.11

1.1

—

(3000060) B lymphocytes [#/volume] in Blood

116

737

1.56

5.05

2.8

2.5

264.5

267.9

e6/l

0.02

419

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

2571

23377

1.10

5.03

3.5

2.5

0.7

1.1

e6/l

6.05

1236

12758

(3004446) Plasmodium sp identified in Blood by Light microscopy

229

2.04

5.03

3.0

2.5

—

(3000093) Morphology [Interpretation] in Blood Narrative

173

1197

1.44

5.00

1.1

1.2

—

(3008152) Bicarbonate [Moles/volume] in Arterial blood

573

6862

0.82

4.97

4.8

6.9

24.5

24.4

mmol/l

0.50

539

6367

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

194

1373

1.41

4.95

3.5

2.9

11.1

8.3

nmol/l

0.14

189

1321

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

595

1.62

4.91

1.4

1.2

—

(3024354) Oxygen [Partial pressure] in Venous blood

1123

9734

1.15

4.90

8.2

4.1

5.7

4.8

kpa

15.56

1033

9417

(3003157) Bacteria [#/volume] in Mother's milk

2.94

4.89

7.5

6.3

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

111

2.50

4.85

2.4

2.1

—

(3002621) Streptococcal DNAse B [Units/volume] in Serum

193

2.11

4.81

1.1

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

356

4469

0.79

4.80

5.4

5.1

1.0

0.9

0.17

327

4181

(1002224) Polysomnography panel

944

8092

1.16

4.79

1.1

—

(3007463) Buprenorphine [Presence] in Urine

143

2.29

4.73

8.8

7.3

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

190

1352

1.40

4.72

1.2

—

(3013945) Hepatitis B virus e Ab [Presence] in Serum

101

2.55

4.70

1.9

1.5

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

292

2221

1.31

4.70

1.1

1.5

g/l

0.28

275

2027

(3047007) Chlamydophila sp Ab [Presence] in Serum

393

3107

1.26

4.66

1.2

—

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

103

650

1.57

4.65

1.2

1.1

85.9

81.4

u/l

0.25

528

(3039162) Centromere protein B Ab [Units/volume] in Serum

285

2165

1.31

4.63

1.3

47.9

51.3

u/ml

0.09

124

(3001893) Eosinophils/100 leukocytes in Pleural fluid

224

1.99

4.57

1.3

1.4

1.7

3.4

1.53

195

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

102

646

1.57

4.55

1.2

1.1

23.8

20.2

u/l

0.23

503

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

493

1.65

4.52

1.0

1.1

—

(4211845)

842

0.53

4.52

2.4

2.5

—

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

140

951

1.46

4.50

1.1

91.9

94.7

0.49

104

779

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

385

3052

1.26

4.48

1.1

—

(3043681) Transitional cells [#/area] in Urine by Computer assisted method

2.95

4.47

1.1

1.3

1.7

1.1

u/field

0.77

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

250

1876

1.33

4.45

1.1

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

243

0.24

4.44

1.0

1.1

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

132

889

1.48

4.44

1.1

1.2

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

244

0.24

4.43

1.0

1.1

—

(40771922) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood

129

2.31

4.40

1.4

1.3

2.0

ml/s/173m2

0.69

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

153

1063

1.43

4.38

1.0

1.1

1328.2

1470.1

miu/ml

1.28

153

1063

(42528615) Etanercept [Mass/volume] in Serum or Plasma by Immunoassay

2.56

4.38

1.4

1.3

1.5

mg/l

0.67

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

400

3196

1.25

4.36

1.4

1.3

2.7

3.6

u/ml

0.79

163

1072

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

103

661

1.55

4.36

1.1

—

(3018572) Chloride [Moles/volume] in Blood

197

2638

0.74

4.34

6.9

6.8

105.8

105.4

mmol/l

0.88

174

2368

(3039000) Anion gap in Blood

197

2637

0.74

4.33

6.9

6.8

11.3

mmol/l

0.00

174

2367

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

195

2.04

4.32

2.2

1.9

—

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

149

1035

1.43

4.28

1.9

1.7

144.5

127.7

1.53

142

975

(3027505) Alpha-1-Fetoprotein [Units/volume] in Amniotic fluid

3.31

4.25

1.1

1.0

—

(3020491) Glucose [Moles/volume] in Blood

1310

0.63

4.24

1.5

1.6

6.8

6.0

mmol/l

1.46

1027

(3006922) Hepatitis E virus Ab [Presence] in Serum

186

1345

1.37

4.24

1.1

—

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

190

1379

1.37

4.24

3.1

2.6

0.2

e9/l

0.18

148

1149

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

132

899

1.46

4.22

1.1

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

107

2.41

4.21

2.0

1.5

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

1060

0.60

4.18

1.9

2.0

—

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

621

1.55

4.16

1.4

1.5

13.8

14.1

pmol/l

0.12

533

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

113

749

1.50

4.14

1.4

1.2

—

(3017315) Amylase [Enzymatic activity/volume] in Urine

821

0.55

3.99

1.1

1.3

411.0

318.4

u/l

0.23

761

(46234826) Other cells/100 leukocytes in Peritoneal fluid by Manual count

2.83

3.99

1.4

1.7

26.4

19.6

—

(3020047) Haemophilus influenzae B Ab [Mass/volume] in Serum

3.49

3.99

1.3

1.4

—

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

3.31

3.98

1.4

1.1

—

mmol/l

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

140

976

1.43

3.98

1.5

1.7

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

551

4594

1.19

3.97

2.1

2.0

3.6

21.8

iu/l

0.92

277

1820

(3001556) Androgen free Index in Serum or Plasma

384

0.36

3.87

1.3

1.2

—

(3006462) Nitrate [Presence] in Urine

761

0.55

3.85

2.4

2.6

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

446

1.63

3.84

1.1

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

187

1378

1.35

3.83

1.1

7.1

7.3

iu/ml

0.04

382

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

198

1.96

3.81

1.4

1.3

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

417

1.64

3.80

1.2

—

(3008295) Osmolality of Serum or Plasma

182

1338

1.35

3.79

1.6

1.7

285.9

283.3

mosm/kgh2o

0.99

147

1057

(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH

3.76

3.75

1.2

1.3

—

(36660697) Celiac disease serology panel - Serum

1482

16204

0.90

3.74

1.2

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

132

1831

0.71

3.70

1.7

1.4

—

(3051659) 25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

180

1.99

3.68

1.4

1.3

15.7

16.7

nmol/l

—

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

133

934

1.41

3.66

1.5

4.8

5.9

u/l

2.31

108

802

(3034092) Cytoplasmic Ig cells/100 cells in Blood

267

0.33

3.66

1.9

6.3

—

(3009677) Dengue virus Ab [Presence] in Serum

2.43

3.64

1.1

1.2

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

133

1836

0.72

3.63

1.7

1.4

—

(36305790) Ustekinumab [Mass/volume] in Serum or Plasma by Immunoassay

188

1.95

3.62

2.5

2.7

3.2

mg/l

0.02

181

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

133

1834

0.72

3.61

1.7

1.4

—

(3029075) Extractable nuclear Ab panel - Serum

556

1.54

3.59

1.1

—

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

465

3862

1.20

3.54

1.7

1.4

10.2

11.3

iu/ml

0.10

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

169

1245

1.35

3.50

1.1

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

275

2165

1.26

3.49

1.4

1.5

11.4

mmol/l

0.02

358

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

305

0.32

3.48

1.3

1.4

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

7931

76073

1.06

3.45

4.5

3.9

—

(21494434) Karyotype in Bone marrow

129

914

1.40

3.41

1.3

1.2

—

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

207

1.87

3.38

1.3

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

100

2.28

3.35

5.2

4.6

—

(3017509) Phencyclidine [Presence] in Urine

363

1.64

3.33

1.8

2.0

—

(3005011) Chlamydia sp Ab [Titer] in Serum

296

1.71

3.31

1.5

—

(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma

2.81

3.30

1.2

1.3

99.3

145.6

ug/l

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

303

3693

0.81

3.27

1.7

1.6

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

332

2692

1.23

3.27

3.0

2.5

119.4

117.1

ug/min

0.03

222

1737

(44813793)

199

1519

1.30

3.26

1.1

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

360

2945

1.22

3.25

1.1

117.2

117.6

0.07

306

2696

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

168

1254

1.33

3.23

1.1

—

(3017937) Magnesium [Moles/time] in 24 hour Urine

3.00

3.19

1.2

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

199

1524

1.30

3.19

1.5

1.7

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

138

1850

0.74

3.18

1.7

1.4

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

138

1849

0.74

3.17

1.7

1.4

—

(3038702) Sodium [Moles/volume] in Capillary blood

6.31

3.16

2.3

4.8

140.0

139.2

mmol/l

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

2.83

3.13

1.1

2.3

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

599

1.48

3.13

1.1

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

142

1890

0.74

3.13

1.7

1.4

—

(3044941) Cell count panel - Synovial fluid

237

1863

1.26

3.10

1.4

—

(40760512) CD34 cells/100 cells in Bone marrow

4.46

3.08

2.3

1.3

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

128

925

1.37

3.05

1.1

7.0

5.1

nmol/l

0.13

182

(3036071) Salmonella sp Ab [Titer] in Serum

668

1.44

3.04

1.1

—

(4133840)

500

0.52

2.99

1.1

—

(3023420) DNA double strand Ab [Units/volume] in Serum

253

2015

1.25

2.97

1.8

1.7

31.5

33.9

iu/ml

0.09

106

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

167

1.90

2.96

1.2

1.1

—

(42529406) Shigella sp [Presence] in Stool by Culture

589

5073

1.16

2.95

1.2

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

620

5360

1.15

2.95

1.3

—

(43055442) Apixaban [Mass/volume] in Serum or Plasma

2.33

2.92

1.6

1.4

80.4

115.6

ug/l

1.32

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

254

2030

1.24

2.90

3.7

3.1

92.1

843.1

u/ml

0.83

235

1836

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

218

1712

1.27

2.90

1.4

1.3

5.1

5.8

umol/l

2.03

208

1577

(44790047)

215

1686

1.27

2.90

2.1

1.6

—

(44790048)

215

1686

1.27

2.90

2.1

1.6

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

107

2.13

2.89

1.3

1.2

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

104

735

1.41

2.85

1.1

95.8

94.5

0.12

336

(44790049)

214

1686

1.26

2.79

2.1

1.6

—

(44806118)

214

1686

1.26

2.79

2.1

1.6

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

188

1458

1.28

2.79

1.2

—

(3035320) C reactive protein [Mass/volume] in Body fluid

154

1163

1.32

2.78

2.2

2.3

—

(3004775) Volume in Urine collected for unspecified duration

115

831

1.37

2.78

2.4

2.3

697.1

649.7

0.55

626

(3002619) Bacteria identified in Specimen by Culture

312

1.62

2.77

1.5

1.2

—

(3004119) Hemoglobin [Mass/volume] in Venous blood

619

6989

0.87

2.76

7.9

3.8

125.2

131.7

g/l

9.95

599

6827

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

108

774

1.39

2.75

1.2

110.0

109.3

0.06

693

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

189

1470

1.28

2.74

1.2

—

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

2.44

2.73

1.5

1.8

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

910

8107

1.12

2.73

3.3

2.8

214.1

142.8

ng/l

2.61

822

7203

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

189

1471

1.28

2.73

1.2

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

999

10948

0.90

2.71

4.1

2.3

66.1

75.4

ml/min/173m2

9.36

543

3946

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

189

1474

1.27

2.69

1.2

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

116

845

1.36

2.68

1.5

1.4

35506.7

55138.4

e6/l

0.71

493

(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count

2.69

2.67

5.8

9.0

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

105

754

1.38

2.65

1.1

93.7

93.9

0.02

342

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

214

0.37

2.65

1.1

1.0

—

(4010399)

901

9914

0.90

2.64

1.4

—

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

118

865

1.35

2.63

1.6

1.8

12.3

nmol/l

0.92

716

(40761995) Spermatozoa Progressive [#/volume] in Semen

776

0.64

2.63

2.8

3.1

—

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

775

0.64

2.61

5.5

6.3

—

(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay

106

765

1.38

2.61

2.0

1.8

160.9

148.2

0.59

101

717

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

201

1587

1.26

2.60

1.1

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

186

1455

1.27

2.60

1.2

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

186

1457

1.27

2.57

1.2

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

205

1.74

2.57

1.0

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

580

5053

1.14

2.53

1.2

1.1

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

171

1.80

2.47

2.3

1.7

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

150

1.85

2.44

1.2

1.3

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

442

3789

1.16

2.43

1.1

6.8

6.1

u/ml

0.31

209

1708

(3036603) Volume of Urine

117

870

1.34

2.41

1.7

1.6

2153.5

2052.7

—

161

(3000919) Neutrophils/100 leukocytes in Pleural fluid

203

1.71

2.37

1.4

21.2

27.4

0.65

188

(3035880) pH of Pleural fluid

422

1.48

2.36

1.2

1.3

—

(3000690) Aldosterone [Moles/time] in 24 hour Urine

6.20

2.35

1.2

1.0

45.6

24.2

nmol/24h

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

1289

11784

1.09

2.35

2.3

18.5

21.2

au/ml

0.46

877

(3035933) Granulocytes/100 leukocytes in Blood

717

0.65

2.33

1.3

1.7

—

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

890

7999

1.11

2.32

1.1

4.7

14.5

u/ml

0.94

119

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

478

5418

0.87

2.32

8.0

3.6

1.3

1.4

1.53

478

5380

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

876

7868

1.11

2.32

1.6

1.4

—

(3030313) Adrenal Ab [Titer] in Serum

266

1.60

2.29

1.2

1.1

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

361

4164

0.86

2.24

1.4

20.7

20.9

u/l

0.05

331

3439

(3045788) Cell count panel - Pleural fluid

101

744

1.35

2.24

1.6

1.5

—

(3033799) Differential panel - Peritoneal fluid

308

1.55

2.21

1.9

—

(3016816) Cytomegalovirus IgG Ab [Presence] in Serum or Plasma

5.51

2.20

1.2

1.0

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

215

1748

1.22

2.19

1.5

1.3

34.1

36.7

u/l

0.12

197

1540

(44816559) Phosphatidylethanol [Mass/volume] in Blood

469

4074

1.14

2.19

1.3

1.4

—

(3041672) Baker's yeast Ab [Presence] in Serum

142

1.82

2.17

1.1

—

(3018291) Platelet Ab [Presence] in Serum

2.98

2.12

1.1

—

(3024869) Neuronal Ab [Presence] in Serum

203

1.66

2.10

1.1

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

101

1.96

2.10

1.2

1.1

—

(4094501)

387

3329

1.16

2.09

1.1

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

204

0.44

2.06

9.4

7.9

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

3056

28937

1.06

2.05

1.6

1.5

—

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

536

1.39

2.03

2.1

2.3

117.4

112.2

ng/l

0.11

368

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

549

0.63

2.01

5.6

3.2

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

182

1471

1.23

2.00

1.4

1.3

518.9

82.2

pmol/l

0.55

431

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

147

1.75

1.96

1.2

1.1

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

270

1.54

1.95

1.5

1.7

—

(3018738) Hemoglobin F/Hemoglobin.total in Blood

239

1.58

1.94

4.4

2.9

5.3

7.7

0.57

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

1100

0.75

1.92

1.4

1.7

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

1100

0.75

1.92

1.4

1.7

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

1100

0.75

1.92

1.4

1.7

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

400

3475

1.14

1.91

1.2

1.1

12.1

11.1

au/ml

0.09

252

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

358

3086

1.15

1.91

1.1

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

564

5009

1.12

1.90

1.2

1.1

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

273

1.53

1.87

3.7

3.4

—

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

1.90

1.85

1.2

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

113

873

1.29

1.85

2.6

2.5

126.4

158.2

umol/l

0.77

427

(3028433) Virus identified in Specimen by Culture

538

1.37

1.84

1.2

—

(4306422)

358

3096

1.15

1.84

1.2

—

(3019977) pH of Arterial blood

583

1.35

1.80

2.7

7.4

0.59

158

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

474

1.38

1.78

1.1

89.2

84.1

0.41

112

(40760087) Plasmodium sp Ab [Presence] in Serum by Immunofluorescence

3.02

1.78

1.0

—

(3010657) Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma by Dialysis

2.55

1.78

1.0

1.7

—

(3036048) Francisella tularensis Ab [Titer] in Serum

424

1.40

1.78

1.2

1.1

192.0

306.7

titre

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

101

1.87

1.76

1.1

1.3

—

(3017354) Segmented neutrophils/100 leukocytes in Blood

1217

0.77

1.75

3.6

3.1

62.7

55.3

2.64

758

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

347

3007

1.15

1.75

1.5

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

756

8190

0.91

1.73

1.6

3.5

mg/l

0.07

498

5531

(3004268) Protein electrophoresis panel - Cerebral spinal fluid

2.65

1.70

1.3

1.1

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

335

2905

1.15

1.68

1.1

86.5

3593.8

iu/ml

0.64

761

(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma

116

912

1.26

1.68

1.1

281.1

187.3

iu/ml

1.21

116

907

(3036670) Protein [Mass/volume] in Synovial fluid

281

1.48

1.67

1.1

1.2

37.6

39.6

g/l

0.49

149

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

145

0.41

1.63

2.0

0.8

0.7

u/field

—

145

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

104

1.81

1.62

1.2

1.4

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

483

1.36

1.62

1.3

1.2

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

1.96

1.60

1.3

2.0

52.1

44.6

umol/l

0.22

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

467

1.36

1.60

3.4

2.4

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

358

1.41

1.60

1.1

—

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

196

1.57

1.59

1.3

1.1

2.9

4.7

pmol/l

—

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

150

1224

1.22

1.58

1.6

1.4

nmol/l

0.48

137

1097

(3051593) INR in Capillary blood by Coagulation assay

359

0.61

1.56

2.5

8.0

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

939

0.76

1.55

1.6

1.8

1.5

1.9

u/field

0.42

452

(3016244) Insulin [Units/volume] in Serum or Plasma

206

1735

1.18

1.54

3.7

3.3

20.2

27.8

mu/l

3.94

198

1645

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

270

1.47

1.54

2.5

1.2

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

149

1219

1.21

1.53

1.5

1.2

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

506

1.33

1.51

2.4

2.9

27.1

28.2

umol/l

0.34

369

(3026692) Albumin [Mass/volume] in Peritoneal fluid

255

1.48

1.51

1.3

1.4

13.0

13.3

g/l

0.09

185

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

472

1.35

1.51

1.1

65.6

73.7

0.77

106

(3046904) Somatotropin [Units/volume] in Serum or Plasma

0.00

1.49

0.0

1.5

—

2.5

—

(3047181) Lactate [Moles/volume] in Blood

358

3994

0.89

1.48

5.0

5.5

1.2

1.3

mmol/l

1.96

304

3525

(3007733) Chloride [Moles/volume] in Urine

2.05

1.46

1.4

2.1

95.8

82.4

mmol/l

0.42

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

1.98

1.45

1.1

1.2

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

134

1093

1.22

1.44

3.3

3.0

0.8

nmol/l

0.57

104

797

(44806071)

275

1.44

1.43

1.2

1.1

—

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

409

4514

0.90

1.42

4.9

5.0

1.7

1.8

0.25

370

4217

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

423

3771

1.11

1.42

1.3

1.2

42.8

39.5

u/ml

0.17

339

(3004347) Hepatitis D virus Ab [Presence] in Serum

2.10

1.41

1.0

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

530

1.31

1.40

3.7

3.1

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

102

1.75

1.40

1.1

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

211

1.50

1.40

1.0

—

(3036180) Methadone [Presence] in Urine

1.95

1.40

3.8

3.1

—

(3029612) Listeria sp Ab [Titer] in Serum

1.95

1.40

1.4

1.3

—

(3044927) Protein electrophoresis panel - Urine

102

813

1.25

1.37

1.2

1.1

—

(3037377) Propoxyphene + Norpropoxyphene [Presence] in Urine by Confirmatory method

2.16

1.37

1.1

1.3

—

(3020874) Milk IgE Ab [Units/volume] in Serum

154

1813

0.84

1.36

1.1

6.2

2.4

u/ml

1.07

603

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

279

1.42

1.34

1.2

—

(3020717) Zinc [Moles/volume] in Serum or Plasma

125

1022

1.21

1.34

2.0

1.6

23.8

23.9

umol/l

0.02

119

984

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

552

1.29

1.33

2.6

2.0

13.8

129.1

ug/min

1.84

129

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

179

1517

1.17

1.30

1.1

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

442

1.32

1.30

1.1

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

151

1771

0.84

1.29

1.2

1.1

21.6

4.5

u/ml

0.77

528

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

316

0.63

1.29

1.1

1.0

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

171

0.52

1.28

1.0

—

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

265

1.42

1.28

1.4

1.5

134.6

48.6

ng/l

0.75

149

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

567

6116

0.92

1.27

1.1

4.7

5.2

u/ml

0.12

943

(3045716) Anion gap in Serum or Plasma

535

0.72

1.24

1.4

2.7

9.9

9.4

mmol/l

0.40

403

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

798

1.23

1.1

—

(36303858) Crystals [Presence] in Urine

2.38

1.23

1.0

1.2

—

(3033882) Carnitine [Moles/volume] in Serum or Plasma

1.80

1.22

1.9

2.9

34.2

36.3

umol/l

0.26

(40758292) HTLV I+II Ab panel - Serum

310

1.38

1.22

1.2

1.3

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

327

1.37

1.22

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

327

1.37

1.22

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

327

1.37

1.22

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

327

1.37

1.22

1.1

—

(3015076) Soybean IgE Ab [Units/volume] in Serum

138

1618

0.84

1.20

1.1

1.8

0.7

u/ml

0.64

265

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

100

1.69

1.20

1.1

6.7

11.3

u/l

0.69

100

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

147

1.55

1.18

1.1

—

(3036312) Salmon IgE Ab [Units/volume] in Serum

156

1.53

1.16

1.0

1.1

1.4

2.1

u/ml

0.22

117

(3039183) Clostridium tetani toxoid IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

0.00

1.15

0.0

1.0

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

1.73

1.15

6.4

5.4

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

150

1268

1.17

1.15

1.6

1.9

—

(3002331) Protein [Mass/volume] in Peritoneal fluid

213

1.44

1.15

1.5

1.4

27.5

24.3

g/l

0.49

152

(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma

272

1.39

1.14

2.6

4.1

27.6

65.5

u/l

1.58

(3003740) Influenza virus B Ag [Presence] in Specimen

452

4100

1.10

1.14

1.1

—

(3000081) cloZAPine [Moles/volume] in Serum or Plasma

183

1574

1.15

1.13

22.6

19.0

1486.0

2460.6

nmol/l

0.70

174

1517

(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma

307

1.36

1.11

1.1

1.0

72.9

76.1

ug/l

0.27

270

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

176

2010

0.87

1.11

4.1

3.6

32.0

26.8

u/ml

0.29

165

1933

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

315

0.66

1.10

1.1

1.3

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

183

1.46

1.09

4.3

3.4

—

(3002523) Influenza virus A Ag [Presence] in Specimen

451

4106

1.09

1.06

1.1

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

462

0.73

1.05

1.1

—

(40765089) Chromosome analysis panel - Blood by G-banded

1166

0.83

1.04

1.1

1.0

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

587

5409

1.08

1.04

1.3

3.4

3.6

ug/l

0.50

551

5031

(3049233) Organic acids panel - Urine

1.74

1.04

1.1

1.2

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

202

1.42

1.03

1.3

1.2

254.4

312.3

ug/l

—

102

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

176

1530

1.14

0.98

1.1

1.2

—

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

412

1.28

0.95

1.4

1.3

128.5

118.6

nmol/l

0.19

316

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

1.79

0.95

1.0

1.2

214.6

260.6

nmol/l

—

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

554

1.24

0.95

1.8

771.0

9742.2

u/ml

—

(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid

108

1.56

0.93

1.1

20.8

24.5

u/l

—

(3021706) Oxygen [Partial pressure] in Arterial cord blood

344

1.30

0.93

1.0

3.2

3.6

kpa

1.10

298

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

170

1912

0.88

0.91

2.7

1.9

—

(3008536) Aspergillus sp Ab [Presence] in Serum

267

1.34

0.91

1.9

2.4

—

(3003577) Lead [Moles/volume] in Blood

158

1.44

0.90

1.7

1.4

0.2

0.3

umol/l

—

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

1.73

0.87

1.0

1.2

—

(3028717) Thiamine [Mass/volume] in Blood

159

1.43

0.87

1.4

1.2

—

(3000285) Sodium [Moles/volume] in Blood

129

0.54

0.87

1.0

1.1

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

163

1425

1.14

0.86

1.0

—

(3034426) Prothrombin time (PT)

698

1.19

0.85

1.2

1.3

—

(3004959) Base excess in Arterial cord blood by calculation

349

1.28

0.85

1.0

-0.3

-2.2

mmol/l

—

(3041806) Other cells [#/volume] in Blood by Manual count

187

1652

1.12

0.84

1.5

—

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

245

1.34

0.84

1.3

1.6

0.3

0.5

ug/l

1.31

178

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

1.70

0.84

1.1

—

(3001218) Citrate [Mass/time] in 24 hour Urine

1.92

0.83

1.0

1.5

—

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

172

1514

1.13

0.83

16.2

13.5

866.3

816.8

nmol/l

0.62

167

1468

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

1.65

0.82

1.1

1.0

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

2383

22951

1.03

0.82

1.9

2.0

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

154

1348

1.13

0.81

1.4

1.2

—

(3048879) Bone marrow aspiration report

247

0.68

0.81

1.1

2.3

—

(40757373) Influenza virus identified in Isolate

247

1.33

0.81

1.8

1.5

—

(3003932) Carbon dioxide [Partial pressure] in Arterial cord blood

352

1.27

0.80

1.0

7.0

7.2

kpa

0.24

308

(3023511) Choriogonadotropin [Units/volume] in Urine

865

8160

1.05

0.80

1.4

—

(3006598) pH of Arterial cord blood

353

1.26

0.79

1.0

—

(21494567) Legionella sp IgM Ab [Presence] in Serum

1.53

0.78

1.1

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

787

0.83

0.78

1.6

2.0

1.1

1.3

nmol/l

0.68

633

(3010937) Rubella virus Ab [Presence] in Serum

189

1.36

0.77

1.0

1.1

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

457

4848

0.93

0.77

1.1

1.4

1.2

u/ml

0.15

225

2256

(3020356) Listeria sp identified in Specimen by Organism specific culture

232

0.68

0.77

1.0

1.2

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

154

1356

1.13

0.76

1.4

1.2

—

(3042934) Triiodothyronine (T3) Ab [Presence] in Serum

2.16

0.76

1.0

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

439

4066

1.07

0.75

1.1

5.2

u/ml

0.01

198

1720

(3038071) Oxygen [Partial pressure] in Mixed venous blood

303

1.28

0.75

11.0

8.6

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

524

4886

1.07

0.74

1.1

2.8

2.7

u/ml

0.08

161

1323

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

455

0.78

0.73

1.1

—

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

1.63

0.73

1.0

1.1

—

(3046682) IgA [Presence] in Skin by Immunofluorescence

1.98

0.72

1.0

1.1

—

(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood

205

0.68

0.72

2.5

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

341

3140

1.08

0.70

1.4

1.3

4.3

4.0

u/ml

0.17

159

1390

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

340

0.76

0.69

1.1

1.2

—

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

641

1.18

0.69

1.1

100.0

412.4

ng/l

1.03

129

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

229

2074

1.10

0.69

1.1

—

20.3

—

(3015147) Influenza virus A IgG Ab [Units/volume] in Serum

1.69

0.69

1.0

1.1

—

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

299

1.26

0.68

1.0

1.1

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

282

0.74

0.67

1.1

1.0

—

(3027231) Wheat IgE Ab [Units/volume] in Serum

633

0.83

0.67

1.1

—

2.0

—

(40762482) Peach recombinant (rPru p) 3 IgE Ab [Units/volume] in Serum

178

0.67

0.66

1.0

0.0

0.7

u/ml

2.43

159

(3023436) Glucagon [Mass/volume] in Serum or Plasma

1.58

0.66

2.3

1.9

185.4

192.4

ng/l

0.12

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

327

1.24

0.66

11.0

8.4

—

(3039443) Prostate specific Ag panel - Serum or Plasma

216

2341

0.91

0.65

1.6

1.5

—

(3008860) Bordetella pertussis IgM Ab [Presence] in Serum

1.58

0.64

1.6

1.3

—

(4212803)

1.53

0.63

1.1

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

241

1.28

0.62

1.2

1.1

—

(3027570) Oxalate [Moles/time] in 24 hour Urine

120

1.41

0.62

1.3

1.5

346.5

305.2

umol/24h

0.41

120

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

935

0.87

0.61

1.3

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

312

3316

0.93

0.60

1.1

0.4

u/ml

0.06

760

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

121

1070

1.12

0.60

1.2

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

140

0.64

0.60

1.0

1.1

—

(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method

486

1.18

0.60

1.5

1.6

0.2

nmol/l

0.66

350

(3002814) Trichinella spiralis Ab [Titer] in Serum

0.00

0.59

0.0

1.0

—

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

1.45

0.59

14.4

10.2

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

153

1374

1.11

0.58

1.2

1.3

—

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

324

1.22

0.58

1.6

2.0

2155.9

14610.3

e6/l

1.10

163

(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum

316

1.22

0.57

1.2

1.1

0.4

0.1

u/ml

0.31

193

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

0.56

1.0

—

(44806420)

193

0.72

0.55

1.6

2.2

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

147

0.67

0.55

1.0

1.1

—

(40763641) Cell count and Differential panel - Peritoneal dialysis fluid

1.57

0.54

4.5

4.7

—

(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid

1.57

0.54

1.2

1.1

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

203

1.27

0.52

1.0

1.1

—

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

247

0.76

0.52

1.1

—

(4268621)

238

2196

1.08

0.52

2.5

2.4

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

177

1.29

0.52

1.0

1.1

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

177

1.29

0.52

1.2

1.1

—

(3052592) Norovirus Ag [Presence] in Stool

223

0.76

0.50

1.1

1.3

—

(40763480) Human metapneumovirus Ag [Presence] in Specimen

1.43

0.50

1.1

1.4

—

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

126

1.34

0.49

1.0

1.1

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

1219

11740

1.03

0.49

1.4

—

(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma

241

1.23

0.49

1.3

1.6

175005.7

311117.2

nmol/l

0.27

198

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

683

1.13

0.49

1.2

110.9

109.2

0.24

616

(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded

135

1.32

0.48

1.1

—

(3032743) Legionella sp IgG Ab [Presence] in Serum

1.40

0.48

1.1

—

(3008092) Baker's yeast IgG Ab [Units/volume] in Serum

188

1.27

0.48

1.2

1.1

26.9

25.5

u/ml

—

(3004593) Baker's yeast IgA Ab [Units/volume] in Serum

188

1.27

0.48

1.2

1.1

19.5

35.4

u/ml

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

582

1.14

0.47

1.2

1.1

—

(3012494) Peanut IgE Ab [Units/volume] in Serum

883

1.11

0.46

1.1

15.7

17.1

u/ml

0.04

559

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

426

0.84

0.46

1.1

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

556

1.14

0.46

1.1

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

773

1.12

0.44

1.1

1.2

—

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

1.39

0.44

1.0

1.1

—

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

745

1.12

0.44

1.2

0.3

g/l

1.03

612

(3008116) Ketones [Moles/volume] in Urine by Test strip

327

0.82

0.44

1.3

1.4

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

465

1.15

0.44

1.1

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

465

1.15

0.44

1.1

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

465

1.15

0.44

1.1

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

254

1.21

0.44

1.1

—

(3035509) Tobramycin [Mass/volume] in Serum or Plasma

138

1.29

0.43

3.3

3.2

2.1

1.5

mg/l

0.27

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

122

1107

1.09

0.42

2.8

2.7

—

(3044009) aPTT.lupus sensitive (LA screen)

201

1.23

0.42

1.0

1.2

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

493

5097

0.96

0.42

1.1

6.3

6.4

u/ml

0.05

285

2851

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

645

1.12

0.42

1.1

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

674

1.12

0.41

1.4

1.5

15.3

20.1

u/ml

0.96

128

(43055459) Dabigatran [Mass/volume] in Serum or Plasma

0.00

0.41

0.0

1.4

—

107.8

—

(3014178) Parietal cell Ab [Units/volume] in Serum

0.00

0.41

0.0

1.1

—

(3027540) Rickettsia typhi Ab [Titer] in Serum

1.50

0.41

1.4

1.1

—

(42528783) Honey bee recombinant (rApi m) 10 IgE Ab [Units/volume] in Serum

1.50

0.41

1.4

1.0

—

(42868555) Amyloid beta 40 peptide [Mass/volume] in Cerebral spinal fluid

0.00

0.40

0.0

1.0

—

10263.0

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

330

1.17

0.40

1.1

—

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

1.42

0.40

1.1

1.3

286.4

517.7

nmol/l

—

(3017704) Immunofixation for Urine

451

1.14

0.40

1.6

1.5

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

312

2940

1.05

0.39

3.7

2.6

0.9

0.8

nmol/l

0.24

275

2499

(3025130) Human papilloma virus identified in Specimen

375

3551

1.05

0.39

1.8

—

(3027696) Helicobacter pylori Ab [Titer] in Serum

0.00

0.39

0.0

1.1

—

1327.4

—

(3023487) Leukocytes [#/volume] in Peritoneal fluid

360

1.16

0.38

2.1

676.5

3017.3

e6/l

0.53

243

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

245

0.81

0.38

2.3

2.9

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

317

2994

1.05

0.37

3.2

3.0

23.8

25.5

mg/l

0.39

202

1797

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

587

5622

1.04

0.37

1.2

1.1

2.5

1.8

u/ml

0.49

257

2489

(3032057) Clostridioides difficile [Presence] in Stool

233

0.81

0.36

2.5

2.0

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

2269

22862

0.98

0.35

3.5

21.8

21.7

0.05

852

9088

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

448

1.13

0.34

1.1

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

324

3359

0.96

0.34

1.2

—

(42870531) Hazelnut recombinant (rCor a) 1 IgE Ab [Units/volume] in Serum

189

1.21

0.33

1.1

1.0

25.8

21.5

u/ml

0.18

158

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

132

1219

1.07

0.33

1.2

1.3

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

875

1.09

0.33

1.2

1.4

—

(3016031) Almond IgE Ab [Units/volume] in Serum

235

1.18

0.33

1.1

2.2

0.8

u/ml

0.75

153

(40766207) Peanut recombinant (rAra h) 8 IgE Ab [Units/volume] in Serum

217

1.19

0.33

1.1

12.5

9.7

u/ml

0.19

149

(40768453) Hazelnut native (nCor a) 9 IgE Ab [Units/volume] in Serum

245

1.17

0.32

1.1

1.0

2.3

1.5

u/ml

0.20

167

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

146

1356

1.07

0.32

1.7

1.8

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

142

0.77

0.32

1.3

1.1

34.6

1.8

umol/24h

0.47

142

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

442

1.12

0.31

1.1

—

(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma

323

0.86

0.30

1.0

—

(3000936) Kiwifruit IgE Ab [Units/volume] in Serum

1.32

0.28

1.0

0.5

0.7

u/ml

—

(3012215) Mononuclear cells/100 leukocytes in Synovial fluid

310

0.86

0.28

1.6

1.3

40.5

42.1

0.08

215

(3025886) Oxalate [Mass/time] in 24 hour Urine

1.30

0.28

1.1

1.3

—

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

256

0.85

0.27

8.9

7.6

—

(40763590) HLA-DQ beta [Type]

1.24

0.27

1.0

—

(46236302) HLA-C [Type] by High resolution typing

1.24

0.27

1.0

—

(3013336) Amino acids [Identifier] in Serum or Plasma

138

0.79

0.27

2.3

2.7

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

1.22

0.27

1.9

2.0

—

(3029396) Erythrocyte agglutination [Presence] in Blood

121

1127

1.07

0.26

3.4

3.0

—

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

764

0.92

0.26

2.0

2.4

175.3

151.9

nmol/l

0.84

669

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

430

4397

0.97

0.26

1.4

1.3

14.3

10.1

u/ml

0.44

680

(3033923) Metanephrine [Moles/time] in 24 hour Urine

270

1.14

0.25

1.2

1.1

65.1

0.9

umol/24h

0.46

142

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

442

0.90

0.25

1.1

—

(3022475) Manganese [Moles/volume] in Blood

113

1.23

0.25

1.1

1.3

—

(4038314)

232

0.85

0.24

1.2

—

(3012516) Albumin [Mass/volume] in Urine

3302

32435

1.01

0.24

3.7

3.4

403.3

414.4

mg/l

0.05

2000

21253

(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum

604

1.08

0.24

1.2

26.5

6.2

u/ml

1.02

442

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

0.70

0.23

1.3

1.1

—

(3044007) Cell count panel - Peritoneal fluid

291

1.12

0.23

1.6

2.1

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

424

4326

0.97

0.23

1.4

1.3

14.9

7.3

u/ml

0.63

439

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

251

0.87

0.22

1.0

1.1

—

(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum

1.24

0.22

1.0

—

(3020123) Porphyrins [Interpretation] in Serum or Plasma

115

1.21

0.22

1.3

1.1

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

344

0.89

0.22

1.1

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

713

1.07

0.21

1.5

1.4

—

(3041198) Albumin [Mass/volume] in Peritoneal dialysis fluid

0.00

0.21

0.0

5.9

—

(3025566) Toxoplasma gondii IgG Ab [Units/volume] in Cerebral spinal fluid

0.00

0.21

0.0

1.1

—

(3022577) Toxoplasma gondii IgM Ab [Presence] in Cerebral spinal fluid

0.00

0.21

0.0

1.1

—

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

1.18

0.21

1.0

—

(3007542) Rye IgE Ab [Units/volume] in Serum

144

0.83

0.21

1.0

1.1

2.7

15.1

u/ml

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

182

1732

1.04

0.21

4.4

62.7

97.1

u/ml

0.63

552

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

559

0.92

0.20

1.6

1.4

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

559

0.92

0.20

1.6

1.4

—

(21491979) Prolactin monomeric [Units/volume] in Serum or Plasma

108

1130

0.95

0.20

1.2

1.4

467.0

523.9

mu/l

0.33

100

1079

(3011897) Casein IgE Ab [Units/volume] in Serum

572

1.08

0.20

1.4

1.3

14.4

6.9

u/ml

—

134

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

1.21

0.20

1.0

1.2

—

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

814

1.06

0.19

3.0

2.6

51.7

52.4

umol/l

0.07

713

(3015183) Erythrocyte sedimentation rate

122

1153

1.05

0.19

1.2

—

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

1.20

0.18

1.1

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

202

1.13

0.18

1.1

—

(3032641) Amino acids panel - Urine

1.20

0.18

1.0

1.2

—

(3014271) Vancomycin [Susceptibility]

370

0.91

0.18

3.9

2.7

—

(36304617) Golimumab [Mass/volume] in Serum or Plasma by Immunoassay

250

1.11

0.17

1.8

1.7

1.5

1.7

mg/l

0.48

218

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

1.18

0.16

1.0

1.3

—

(40765096) Chromosome analysis panel by Banding

337

0.91

0.16

1.2

1.1

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

597

1.06

0.16

1.1

—

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

0.79

0.15

1.0

—

(3041918) Cholesterol [Moles/volume] in Pleural fluid

160

0.87

0.15

1.1

1.2

2.2

1.8

mmol/l

—

102

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

725

1.05

0.15

1.5

1.4

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

173

1661

1.03

0.15

2.0

1.7

—

(3001820) Epstein Barr virus nuclear Ab [Presence] in Serum

111

1.16

0.14

1.3

1.1

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

1.19

0.14

1.1

1.0

—

(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma

131

1347

0.96

0.14

1.6

1.4

0.9

g/l

0.26

131

1342

(40761847) Hazelnut recombinant (rCor a) 8 IgE Ab [Units/volume] in Serum

334

0.92

0.14

1.0

0.2

u/ml

0.16

207

(3032868) Hemoglobin electrophoresis panel in Blood

217

1.10

0.12

1.4

1.6

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

353

3434

1.02

0.12

1.1

2.9

u/ml

0.01

164

1808

(3005082) Progesterone [Moles/volume] in Serum or Plasma

217

2206

0.98

0.12

1.3

1.4

32.9

31.7

nmol/l

0.28

198

2045

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

222

2149

1.02

0.12

1.2

1.1

89.1

94.9

2.56

206

2023

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

101

966

1.04

0.11

6.7

6.8

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

174

1681

1.03

0.11

1.1

—

(40761873) Peanut recombinant (rAra h) 1 IgE Ab [Units/volume] in Serum

339

0.94

0.10

1.1

18.6

2.6

u/ml

0.42

180

(40761871) Peanut recombinant (rAra h) 3 IgE Ab [Units/volume] in Serum

338

0.94

0.10

1.1

5.4

0.6

u/ml

0.53

186

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

479

4812

0.99

0.10

1.3

50.3

30.6

u/ml

0.72

298

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

1112

10940

1.01

0.09

1.3

34.6

45.1

au/ml

0.78

411

(3049242) von Willebrand panel - Platelet poor plasma

1.05

0.09

3.2

1.5

—

(3004982) Buprenorphine [Mass/volume] in Serum or Plasma

1.05

0.09

6.0

2.3

ug/l

—

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

1.08

0.08

1.2

1.1

—

(3011841) English Walnut IgE Ab [Units/volume] in Serum

348

1.05

0.08

1.1

22.3

4.0

u/ml

0.76

278

(3008691) Amylase [Enzymatic activity/volume] in Peritoneal fluid

0.81

0.08

1.4

1.3

577.0

2261.1

u/l

—

(40760410) HLA-B [Type] by High resolution

1.10

0.08

1.0

—

(40760409) HLA-A [Type] by High resolution

1.10

0.08

1.0

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

671

1.03

0.08

1.4

2.0

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

671

1.03

0.08

1.4

2.0

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

671

1.03

0.08

1.4

2.0

—

(3013862) HLA-DP [Type]

1.07

0.08

1.0

—

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

335

0.95

0.08

2.4

2.6

1.6

1.4

mmol/l

0.22

243

(3033086) Enterovirus NOS Ab [Titer] in Serum

0.83

0.07

1.0

1.1

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

672

1.03

0.07

1.4

2.0

—

(46235168) Fasting glucose [Moles/volume] in Blood

213

0.93

0.07

1.1

5.6

7.5

mmol/l

—

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

800

1.03

0.07

2.2

2.3

21.3

158.9

ug/l

1.07

765

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

534

5345

0.99

0.07

1.2

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

384

0.96

0.07

2.9

2.6

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

352

3451

1.01

0.07

1.3

2.6

4.8

u/ml

0.63

251

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

419

1.04

0.07

1.5

1.6

10.0

8.6

ug/l

1.13

419

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

880

1.03

0.06

1.9

1.5

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

160

1614

0.98

0.06

1.5

1.6

1.4

promille

1.00

112

1230

(3034988) Calcium [Moles/volume] in Capillary blood

292

0.95

0.06

12.0

3.4

1.2

mmol/l

1.08

277

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

215

1.06

0.06

1.6

2.2

6.0

7.5

mmol/l

2.64

118

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

313

1.05

0.06

1.2

1.3

329.3

372.7

pmol/l

0.24

237

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

362

1.04

0.05

2.1

2.8

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

362

1.04

0.05

2.1

2.8

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

962

1.02

0.05

1.2

1.1

—

(42528717) Cashew nut recombinant (rAna o) 3 IgE Ab [Units/volume] in Serum

353

1.04

0.05

1.1

5.2

2.8

u/ml

0.50

280

(3019420) Tryptase [Mass/volume] in Serum or Plasma

114

1111

1.02

0.05

1.3

1.4

7.0

6.4

ug/l

0.25

1014

(3010144) Erythrocytes [#/volume] in Synovial fluid

109

1100

0.98

0.05

1.4

59285.9

72308.1

e6/l

0.15

764

(3007700) Barley IgE Ab [Units/volume] in Serum

129

0.92

0.04

1.0

1.1

1.7

11.7

u/ml

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

149

1.06

0.04

1.1

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

840

1.02

0.03

1.0

—

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

137

1373

0.99

0.03

1.1

294.2

288.4

mg/l

0.30

127

1250

(3042010) Triglyceride [Moles/volume] in Pleural fluid

127

0.94

0.02

1.0

1.3

0.8

1.8

mmol/l

—

(21494262) English walnut recombinant (rJug r) 3 IgE Ab [Units/volume] in Serum

197

0.96

0.02

1.1

1.0

1.7

u/ml

0.02

153

(3031309) Prolactin monomeric/Prolactin.total in Serum or Plasma

115

1153

0.99

0.02

1.2

1.4

74.8

72.6

0.85

107

1102

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

424

4222

1.00

0.02

1.4

78.1

95.9

pmol/l

1.17

407

4108

(3017732) Neutrophils [#/volume] in Blood

1159

11517

1.00

0.02

3.1

2.4

4.3

4.2

e9/l

1.20

1033

9536

(3008757) Leukocyte morphology finding [Identifier] in Blood

142

1397

1.01

0.02

4.4

3.4

—

(3039744) RNA polymerase III Ab [Units/volume] in Serum

146

0.95

0.02

1.0

1.1

—

2.9

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

725

1.01

0.01

1.3

1.5

2.8

2.6

u/field

0.08

523

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

509

1.01

0.01

1.4

2.1

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

509

1.01

0.01

1.4

2.1

—

(4015189)

241

0.99

0.00

2.0

2.1

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

874

1.00

0.00

1.2

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

114

1.04

0.00

1.1

—

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

1.05

0.00

1.8

2.1

—

(3019174) dRVVT (LA screen)

200

0.99

0.00

1.1

1.2

—

(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood

270

0.99

0.00

10.7

3.1

1.2

mmol/l

0.96

254

(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma

152

1505

1.00

0.00

11.8

11.9

0.6

mmol/l

0.33

134

1390

(3022313) Gas panel - Capillary blood

628

6228

1.00

0.00

8.7

4.6

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

519

0.99

0.00

1.4

2.1

—

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

263

0.98

0.00

1.5

1.2

381.5

61.6

mg/l

1.05

187

(40767665) Peanut recombinant (rAra h) 9 IgE Ab [Units/volume] in Serum

310

0.99

0.00

1.1

0.9

0.4

u/ml

0.30

172

(3022670) pH of Venous cord blood

124

0.96

0.00

1.0

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

441

0.99

0.00

1.1

—

(37021550) Renin [Units/volume] in Plasma --upright

306

1.00

0.00

1.3

1.4

92.6

93.8

mu/l

0.01

244

(40765955) DNA double strand Ab [Titer] in Pleural fluid by Immunofluorescence

0.00

0.0

1.2

—

(3034614) HLA Ag [Interpretation]

0.97

0.00

1.2

—

(3030703) Everolimus [Mass/volume] in Blood

0.00

0.0

17.3

—

5.8

—

(3015057) Respiratory syncytial virus Ab [Titer] in Serum

0.00

0.0

1.0

—

(3025830) Chlamydophila pneumoniae IgM Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3004560) Lymphocytes [#/volume] in Cerebral spinal fluid

0.00

0.0

1.0

—

(3032642) Schistosoma sp Ab [Titer] in Serum

0.00

0.0

1.0

—

(43055187) t(12;21)(p13;q22.3)(ETV6,RUNX1) fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method

0.00

0.0

4.0

—

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

0.90

0.00

6.8

3.5

—

(3029889) Paecilomyces variottii IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3003195) risperiDONE [Mass/volume] in Serum or Plasma

0.00

0.0

1.2

—

(3003220) Varicella zoster virus IgG Ab [Titer] in Serum

0.00

0.0

1.0

—

913.0

—

(3014257) Rhodotorula spp IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(21494671) JAK2 gene exon 14 targeted mutation analysis in Bone marrow by Molecular genetics method

0.00

0.0

1.0

—

(3030940) RBC casts [#/area] in Urine by Computer assisted method

0.00

0.0

1.0

—

(3010801) 5-Hydroxyindoleacetate [Moles/volume] in 24 hour Urine

0.00

0.0

1.0

—

22.1

—

(3008896) Cortisol [Moles/volume] in Urine

0.00

0.0

1.1

—

(3026868) Penicillium brevicompactum IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3042045) Bilirubin.total [Moles/volume] in Peritoneal fluid

0.00

0.0

1.2

—

101.0

—

(3028917) Waxy casts [#/area] in Urine by Computer assisted method

0.00

0.0

1.0

—

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

0.87

0.00

10.8

9.9

—

(3001729) Color of Synovial fluid

0.99

0.00

1.0

1.6

—

(3003843) Paprika IgE Ab [Units/volume] in Serum

0.93

0.00

1.0

0.0

0.1

u/ml

—

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: Z21_PERSONS_W_POTEN_HEALTH_HAZARDS_RELATED_COMMUNICAB_DISEA – Persons with potential health hazards related to communicable diseases

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

≡ Risteys

FG R12 + FR

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Persons with potential health hazards related to communicable diseases

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Upset plot

Case counts by code for Persons with potential health hazards related to communicable diseases (Z21_PERSONS_W_POTEN_HEALTH_HAZARDS_RELATED_COMMUNICAB_DISEA)

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints